{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "13892e49",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "if (typeof require !== 'undefined')\n",
       "    require.config({\n",
       "        paths: {\n",
       "            jquery: 'https://code.jquery.com/jquery-3.5.1.min',\n",
       "            datatables: 'https://cdn.datatables.net/1.11.3/js/jquery.dataTables.min',\n",
       "        }\n",
       "    });\n"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from src import pysetperm as psp\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from itables import init_notebook_mode\n",
    "init_notebook_mode(all_interactive=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "228238e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "n_perms = 100000\n",
    "cores = 4\n",
    "# +-2kb of gene definition: range_modification=2000\n",
    "gene_def_plus=2000\n",
    "# can set minimum size of the candidate gene set.\n",
    "min_size=10\n",
    "annotations = psp.AnnotationSet(annotation_file='data/genes.txt', range_modification=gene_def_plus)\n",
    "function_sets = psp.FunctionSets(function_set_file='data/kegg.txt', min_set_size=min_set, annotation_obj=annotations)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "06f9d907",
   "metadata": {},
   "outputs": [],
   "source": [
    "# specific inputs\n",
    "e_candidates = psp.Variants(variant_file='data/eastern_candidates.txt')\n",
    "e_candidates.annotate_variants(annotation_obj=annotations)\n",
    "e_background = psp.Variants(variant_file='data/eastern_background.txt.gz')\n",
    "e_background.annotate_variants(annotation_obj=annotations)\n",
    "\n",
    "c_candidates = psp.Variants(variant_file='data/central_candidates.txt')\n",
    "c_candidates.annotate_variants(annotation_obj=annotations)\n",
    "c_background = psp.Variants(variant_file='data/central_background.txt.gz')\n",
    "c_background.annotate_variants(annotation_obj=annotations)\n",
    "\n",
    "i_candidates = psp.Variants(variant_file='data/internal_candidates.txt')\n",
    "i_candidates.annotate_variants(annotation_obj=annotations)\n",
    "i_background = psp.Variants(variant_file='data/internal_background.txt.gz')\n",
    "i_background.annotate_variants(annotation_obj=annotations)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "dabb128f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# test objects\n",
    "e_test_obj = psp.TestObject(e_candidates,\n",
    "                            e_background,\n",
    "                            function_sets,\n",
    "                            n_cores=cores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "24fc8c8b",
   "metadata": {},
   "outputs": [],
   "source": [
    "c_test_obj = psp.TestObject(c_candidates,\n",
    "                            c_background,\n",
    "                            function_sets,\n",
    "                            n_cores=cores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "33ad6b17",
   "metadata": {},
   "outputs": [],
   "source": [
    "i_test_obj = psp.TestObject(i_candidates,\n",
    "                            i_background,\n",
    "                            function_sets,\n",
    "                            n_cores=cores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "5ad43a98",
   "metadata": {},
   "outputs": [],
   "source": [
    "e_permutations = psp.Permutation(e_test_obj, n_perms, cores)\n",
    "c_permutations = psp.Permutation(c_test_obj, n_perms, cores)\n",
    "i_permutations = psp.Permutation(i_test_obj, n_perms, cores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0df03725",
   "metadata": {},
   "outputs": [],
   "source": [
    "# distributions across permutations\n",
    "e_per_set = psp.SetPerPerm(e_permutations,\n",
    "                           function_sets,\n",
    "                           e_test_obj,\n",
    "                           cores)\n",
    "\n",
    "c_per_set = psp.SetPerPerm(c_permutations,\n",
    "                           function_sets,\n",
    "                           c_test_obj,\n",
    "                           cores)\n",
    "\n",
    "i_per_set = psp.SetPerPerm(i_permutations,\n",
    "                           function_sets,\n",
    "                           i_test_obj,\n",
    "                           cores)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "9fe4b404",
   "metadata": {},
   "outputs": [],
   "source": [
    "# results tables\n",
    "def make_results_table(test_obj, function_set_obj, set_perm_obj):\n",
    "    out = function_set_obj.function_sets.groupby('Id', as_index=False).agg({'FunctionName': pd.Series.unique})\n",
    "    out = out[out['Id'].isin(function_set_obj.function_array2d_ids)]\n",
    "    out['n_candidates'] = test_obj.n_candidate_per_function\n",
    "    out['mean_n_resample'] = set_perm_obj.mean_per_set\n",
    "    out['emp_p_e'] = set_perm_obj.p_enrichment\n",
    "    out['emp_p_d'] = set_perm_obj.p_depletion\n",
    "    out['fdr_e'] = psp.fdr_from_p_matrix(set_perm_obj.set_n_per_perm, out['emp_p_e'], method='enrichment')\n",
    "    out['fdr_d'] = psp.fdr_from_p_matrix(set_perm_obj.set_n_per_perm, out['emp_p_d'], method='depletion')\n",
    "    out['BH_fdr_e'] = psp.p_adjust_bh(out['emp_p_e'])\n",
    "    out['BH_fdr_d'] = psp.p_adjust_bh(out['emp_p_d'])\n",
    "    out = out.sort_values('emp_p_e')\n",
    "    return out\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "09830d26",
   "metadata": {},
   "outputs": [],
   "source": [
    "e_results = make_results_table(e_test_obj, function_sets, e_per_set)\n",
    "c_results = make_results_table(c_test_obj, function_sets, c_per_set)\n",
    "i_results = make_results_table(i_test_obj, function_sets, i_per_set)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "5b606a6c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"3a1cedc0-e7cb-4e32-85b5-6aa097bac5e4\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \" 11\", 3.71289, 0.00053, 0.99991, 0.09492, 1.0, 0.140399, 0.99991], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"  6\", 1.4397, 0.00094, 0.99987, 0.09492, 1.0, 0.140399, 0.99991], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"  7\", 1.9013, 0.00117, 0.99982, 0.09492, 1.0, 0.140399, 0.99991], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \" 15\", 6.65052, 0.00173, 0.99942, 0.09492, 1.0, 0.155698, 0.99991], [109, \"hsa03009\", \"Ribosome biogenesis\", \" 14\", 6.72918, 0.00531, 0.99784, 0.21647, 1.0, 0.382316, 0.99991], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"  4\", 0.83736, 0.00933, 0.9988, 0.321733, 1.0, 0.504895, 0.99991], [192, \"hsa04260\", \"Cardiac muscle contraction\", \" 11\", 5.82586, 0.01093, 0.99708, 0.325409, 1.0, 0.504895, 0.99991], [317, \"hsa05140\", \"Leishmaniasis\", \"  6\", 2.01061, 0.01122, 0.99757, 0.325409, 1.0, 0.504895, 0.99991], [227, \"hsa04659\", \"Th17 cell differentiation\", \" 10\", 4.68931, 0.01508, 0.99454, 0.344224, 1.0, 0.552144, 0.99991], [84, \"hsa00910\", \"Nitrogen metabolism\", \"  3\", 0.58844, 0.01594, 0.99863, 0.344224, 1.0, 0.552144, 0.99991], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"  4\", 1.10978, 0.01699, 0.99762, 0.344224, 1.0, 0.552144, 0.99991], [327, \"hsa05162\", \"Measles\", \"  9\", 4.21085, 0.0214, 0.99215, 0.383486, 1.0, 0.552144, 0.99991], [215, \"hsa04612\", \"Antigen processing and presentation\", \"  4\", 1.08658, 0.02199, 0.99598, 0.383486, 1.0, 0.552144, 0.99991], [321, \"hsa05145\", \"Toxoplasmosis\", \" 10\", 5.10913, 0.02329, 0.99163, 0.383486, 1.0, 0.552144, 0.99991], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"  5\", 1.67382, 0.0237, 0.99453, 0.383486, 1.0, 0.552144, 0.99991], [5, \"hsa00052\", \"Galactose metabolism\", \"  4\", 1.15496, 0.02454, 0.99554, 0.383486, 1.0, 0.552144, 0.99991], [26, \"hsa00310\", \"Lysine degradation\", \"  7\", 3.16885, 0.02884, 0.9916, 0.383486, 1.0, 0.588194, 0.99991], [362, \"hsa05310\", \"Asthma\", \"  2\", 0.26221, 0.02941, 0.99774, 0.383486, 1.0, 0.588194, 0.99991], [275, \"hsa04931\", \"Insulin resistance\", \" 11\", 6.14574, 0.03272, 0.98697, 0.384821, 1.0, 0.614612, 0.99991], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  9\", 4.70779, 0.03499, 0.98676, 0.39042, 1.0, 0.614612, 0.99991], [123, \"hsa03032\", \"DNA replication proteins\", \"  8\", 3.86945, 0.03724, 0.98617, 0.39377, 1.0, 0.614612, 0.99991], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"  6\", 2.62011, 0.03756, 0.98951, 0.39377, 1.0, 0.614612, 0.99991], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \" 11\", 6.44099, 0.04606, 0.97992, 0.445498, 1.0, 0.720932, 0.99991], [132, \"hsa03320\", \"PPAR signaling pathway\", \"  6\", 2.71294, 0.04837, 0.98482, 0.446019, 1.0, 0.725543, 0.99991], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  7\", 3.54086, 0.052899, 0.98112, 0.474797, 1.0, 0.742693, 0.99991], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \" 11\", 6.57018, 0.053889, 0.97595, 0.474797, 1.0, 0.742693, 0.99991], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \" 14\", 9.5295, 0.059219, 0.97273, 0.493218, 1.0, 0.742693, 0.99991], [181, \"hsa04147\", \"Exosome\", \" 43\", 34.00506, 0.060359, 0.95823, 0.493284, 1.0, 0.742693, 0.99991], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"  3\", 0.94636, 0.064769, 0.98758, 0.508158, 1.0, 0.742693, 0.99991], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  5\", 2.22687, 0.065249, 0.98, 0.508158, 1.0, 0.742693, 0.99991], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"  6\", 3.28704, 0.067669, 0.98164, 0.508158, 1.0, 0.742693, 0.99991], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"  5\", 2.27482, 0.067939, 0.97914, 0.508158, 1.0, 0.742693, 0.99991], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"  2\", 0.46218, 0.071389, 0.99209, 0.508158, 1.0, 0.742693, 0.99991], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \" 15\", 10.16056, 0.072149, 0.96147, 0.508158, 1.0, 0.742693, 0.99991], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"  7\", 4.1591, 0.072899, 0.9769, 0.508158, 1.0, 0.742693, 0.99991], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"  3\", 0.9933, 0.074269, 0.98404, 0.508158, 1.0, 0.742693, 0.99991], [42, \"hsa00511\", \"Other glycan degradation\", \"  2\", 0.48841, 0.080819, 0.99031, 0.508158, 1.0, 0.752932, 0.99991], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \" 14\", 9.42416, 0.081229, 0.95572, 0.508158, 1.0, 0.752932, 0.99991], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  8\", 4.71786, 0.081969, 0.96652, 0.508158, 1.0, 0.752932, 0.99991], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"  4\", 1.67682, 0.083659, 0.97535, 0.508158, 1.0, 0.752932, 0.99991], [338, \"hsa05203\", \"Viral carcinogenesis\", \" 12\", 7.97985, 0.089789, 0.95354, 0.511994, 1.0, 0.786078, 0.99991], [152, \"hsa04054\", \"Pattern recognition receptors\", \"  4\", 1.733, 0.091709, 0.97154, 0.51318, 1.0, 0.786078, 0.99991], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"  4\", 1.7925, 0.096769, 0.97201, 0.532523, 1.0, 0.810159, 0.99991], [367, \"hsa05330\", \"Allograft rejection\", \"  2\", 0.58359, 0.112109, 0.98148, 0.591538, 1.0, 0.908803, 0.99991], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \" 12\", 8.67812, 0.119839, 0.940331, 0.621533, 1.0, 0.908803, 0.99991], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"  5\", 2.7921, 0.122049, 0.95954, 0.621533, 1.0, 0.908803, 0.99991], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \" 13\", 9.48807, 0.125119, 0.933451, 0.628508, 1.0, 0.908803, 0.99991], [140, \"hsa04010\", \"MAPK signaling pathway\", \" 25\", 20.03448, 0.127249, 0.916561, 0.628508, 1.0, 0.908803, 0.99991], [237, \"hsa04714\", \"Thermogenesis\", \" 13\", 9.43394, 0.131299, 0.926731, 0.639331, 1.0, 0.908803, 0.99991], [125, \"hsa03040\", \"Spliceosome\", \"  5\", 2.70929, 0.132329, 0.947151, 0.639331, 1.0, 0.908803, 0.99991], [151, \"hsa04052\", \"Cytokines and growth factors\", \" 10\", 6.91269, 0.132869, 0.933301, 0.639331, 1.0, 0.908803, 0.99991], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"  2\", 0.68051, 0.134969, 0.98156, 0.639331, 1.0, 0.908803, 0.99991], [134, \"hsa03410\", \"Base excision repair\", \"  2\", 0.65358, 0.137219, 0.9744, 0.639331, 1.0, 0.908803, 0.99991], [325, \"hsa05160\", \"Hepatitis C\", \"  9\", 6.04781, 0.144049, 0.926241, 0.639331, 1.0, 0.908803, 0.99991], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  5\", 2.82572, 0.144509, 0.944361, 0.639331, 1.0, 0.908803, 0.99991], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"  3\", 1.35916, 0.147469, 0.96088, 0.639331, 1.0, 0.908803, 0.99991], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"  6\", 3.77738, 0.149819, 0.942091, 0.639331, 1.0, 0.908803, 0.99991], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"  2\", 0.69923, 0.151108, 0.97228, 0.639331, 1.0, 0.908803, 0.99991], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \" 13\", 9.59276, 0.153598, 0.910001, 0.639331, 1.0, 0.908803, 0.99991], [135, \"hsa03420\", \"Nucleotide excision repair\", \"  3\", 1.37952, 0.154548, 0.95612, 0.639331, 1.0, 0.908803, 0.99991], [185, \"hsa04210\", \"Apoptosis\", \"  8\", 5.3987, 0.159748, 0.920421, 0.64164, 1.0, 0.908803, 0.99991], [36, \"hsa00450\", \"Selenocompound metabolism\", \"  2\", 0.72504, 0.160228, 0.9694, 0.64164, 1.0, 0.908803, 0.99991], [94, \"hsa01006\", \"Prenyltransferases\", \"  2\", 0.74121, 0.160798, 0.97254, 0.64164, 1.0, 0.908803, 0.99991], [329, \"hsa05164\", \"Influenza A\", \"  8\", 5.393, 0.163578, 0.917331, 0.64164, 1.0, 0.908803, 0.99991], [369, \"hsa05340\", \"Primary immunodeficiency\", \"  2\", 0.73958, 0.167518, 0.96472, 0.64164, 1.0, 0.908803, 0.99991], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"  6\", 3.8704, 0.169048, 0.929891, 0.64164, 1.0, 0.908803, 0.99991], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \" 12\", 8.98749, 0.169138, 0.904741, 0.64164, 1.0, 0.908803, 0.99991], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 68\", 60.9049, 0.172908, 0.860521, 0.64164, 1.0, 0.910582, 0.99991], [360, \"hsa05231\", \"Choline metabolism in cancer\", \" 10\", 7.32491, 0.174528, 0.905901, 0.64164, 1.0, 0.910582, 0.99991], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"  3\", 1.48281, 0.182708, 0.940591, 0.64164, 1.0, 0.936085, 0.99991], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  9\", 6.54381, 0.188678, 0.902361, 0.655779, 1.0, 0.936085, 0.99991], [120, \"hsa03022\", \"Basal transcription factors\", \"  3\", 1.53831, 0.194058, 0.939331, 0.675925, 1.0, 0.936085, 0.99991], [273, \"hsa04929\", \"GnRH secretion\", \"  9\", 6.65858, 0.195228, 0.901121, 0.675925, 1.0, 0.936085, 0.99991], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \" 15\", 12.02699, 0.195708, 0.882351, 0.675925, 1.0, 0.936085, 0.99991], [306, \"hsa05033\", \"Nicotine addiction\", \"  6\", 4.02469, 0.197288, 0.912711, 0.675925, 1.0, 0.936085, 0.99991], [153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  9\", 6.4654, 0.197618, 0.888841, 0.675925, 1.0, 0.936085, 0.99991], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  8\", 5.78962, 0.200308, 0.901201, 0.675925, 1.0, 0.936505, 0.99991], [307, \"hsa05034\", \"Alcoholism\", \"  9\", 6.713, 0.213098, 0.883121, 0.689724, 1.0, 0.967006, 0.99991], [100, \"hsa01523\", \"Antifolate resistance\", \"  2\", 0.89147, 0.218318, 0.95215, 0.692726, 1.0, 0.967006, 0.99991], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"  5\", 3.26371, 0.218998, 0.903701, 0.692726, 1.0, 0.967006, 0.99991], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \" 11\", 8.62619, 0.219488, 0.876721, 0.692726, 1.0, 0.967006, 0.99991], [128, \"hsa03051\", \"Proteasome\", \"  3\", 1.63449, 0.223498, 0.921471, 0.692726, 1.0, 0.967006, 0.99991], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"  6\", 4.27246, 0.227838, 0.899581, 0.692726, 1.0, 0.967006, 0.99991], [163, \"hsa04090\", \"CD molecules\", \" 18\", 14.92369, 0.229898, 0.841862, 0.692726, 1.0, 0.967006, 0.99991], [107, \"hsa03000\", \"Transcription factors\", \" 44\", 39.52162, 0.235658, 0.814282, 0.698216, 1.0, 0.967006, 0.99991], [72, \"hsa00670\", \"One carbon pool by folate\", \"  2\", 0.93881, 0.238048, 0.943561, 0.698216, 1.0, 0.967006, 0.99991], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  9\", 6.90286, 0.242648, 0.861291, 0.698216, 1.0, 0.967006, 0.99991], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \" 15\", 12.42728, 0.243108, 0.843802, 0.698216, 1.0, 0.967006, 0.99991], [313, \"hsa05132\", \"Salmonella infection\", \" 12\", 9.57811, 0.244028, 0.846262, 0.698216, 1.0, 0.967006, 0.99991], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"  4\", 2.52271, 0.244278, 0.895311, 0.698216, 1.0, 0.967006, 0.99991], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \" 13\", 10.63802, 0.249558, 0.843832, 0.698216, 1.0, 0.967006, 0.99991], [190, \"hsa04217\", \"Necroptosis\", \"  6\", 4.31317, 0.257347, 0.865141, 0.702774, 1.0, 0.967006, 0.99991], [126, \"hsa03041\", \"Spliceosome\", \" 15\", 12.51718, 0.258347, 0.827662, 0.702774, 1.0, 0.967006, 0.99991], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"  2\", 1.00875, 0.263547, 0.934321, 0.707769, 1.0, 0.967006, 0.99991], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  5\", 3.4899, 0.264697, 0.873401, 0.707769, 1.0, 0.967006, 0.99991], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \" 10\", 8.01528, 0.268817, 0.838242, 0.707769, 1.0, 0.967006, 0.99991], [326, \"hsa05161\", \"Hepatitis B\", \"  9\", 7.08284, 0.270597, 0.839382, 0.707769, 1.0, 0.967006, 0.99991], [150, \"hsa04050\", \"Cytokine receptors\", \"  5\", 3.50957, 0.271637, 0.865121, 0.707769, 1.0, 0.967006, 0.99991], [179, \"hsa04145\", \"Phagosome\", \"  6\", 4.39604, 0.273557, 0.854911, 0.707769, 1.0, 0.967006, 0.99991], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"  4\", 2.64996, 0.273627, 0.876111, 0.707769, 1.0, 0.967006, 0.99991], [302, \"hsa05020\", \"Prion diseases\", \"  3\", 1.86574, 0.274607, 0.905261, 0.707769, 1.0, 0.967006, 0.99991], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  8\", 6.23407, 0.278247, 0.839652, 0.707769, 1.0, 0.967006, 0.99991], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \" 12\", 9.81089, 0.278647, 0.813982, 0.707769, 1.0, 0.967006, 0.99991], [178, \"hsa04144\", \"Endocytosis\", \" 17\", 14.55707, 0.279357, 0.805962, 0.707769, 1.0, 0.967006, 0.99991], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \" 11\", 9.15034, 0.283597, 0.830502, 0.707769, 1.0, 0.972333, 0.99991], [129, \"hsa03060\", \"Protein export\", \"  2\", 1.14055, 0.286767, 0.939761, 0.707769, 1.0, 0.973926, 0.99991], [127, \"hsa03050\", \"Proteasome\", \"  2\", 1.07917, 0.293947, 0.909511, 0.707769, 1.0, 0.983707, 0.99991], [232, \"hsa04668\", \"TNF signaling pathway\", \"  6\", 4.54939, 0.296227, 0.841812, 0.707769, 1.0, 0.983707, 0.99991], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"  2\", 1.09136, 0.298787, 0.907251, 0.707769, 1.0, 0.983707, 0.99991], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"  2\", 1.09997, 0.300577, 0.912671, 0.707769, 1.0, 0.983707, 0.99991], [182, \"hsa04150\", \"mTOR signaling pathway\", \" 10\", 8.2491, 0.303627, 0.809762, 0.707769, 1.0, 0.984736, 0.99991], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"  4\", 2.82248, 0.308417, 0.861441, 0.707769, 1.0, 0.989485, 0.99991], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  9\", 7.40467, 0.313077, 0.808202, 0.712831, 1.0, 0.989485, 0.99991], [172, \"hsa04131\", \"Membrane trafficking\", \" 96\", 91.64855, 0.313337, 0.728663, 0.712831, 1.0, 0.989485, 0.99991], [200, \"hsa04370\", \"VEGF signaling pathway\", \"  5\", 3.80034, 0.325157, 0.838822, 0.745634, 1.0, 1.0, 0.99991], [316, \"hsa05135\", \"Yersinia infection\", \"  9\", 7.48746, 0.326057, 0.797702, 0.745634, 1.0, 1.0, 0.99991], [292, \"hsa04975\", \"Fat digestion and absorption\", \"  2\", 1.17067, 0.328517, 0.890461, 0.745634, 1.0, 1.0, 0.99991], [85, \"hsa00920\", \"Sulfur metabolism\", \"  1\", 0.38781, 0.328887, 0.946541, 0.745634, 1.0, 1.0, 0.99991], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"  4\", 2.93169, 0.333337, 0.850281, 0.745634, 1.0, 1.0, 0.99991], [9, \"hsa00071\", \"Fatty acid degradation\", \"  2\", 1.2042, 0.341367, 0.881941, 0.753463, 1.0, 1.0, 0.99991], [110, \"hsa03010\", \"Ribosome\", \"  2\", 1.20977, 0.341637, 0.879341, 0.753463, 1.0, 1.0, 0.99991], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  7\", 5.71732, 0.342217, 0.800862, 0.753463, 1.0, 1.0, 0.99991], [11, \"hsa00100\", \"Steroid biosynthesis\", \"  1\", 0.43055, 0.355096, 0.933251, 0.768101, 1.0, 1.0, 0.99991], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"  3\", 2.13011, 0.357806, 0.846192, 0.769575, 1.0, 1.0, 0.99991], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"  3\", 2.15328, 0.363576, 0.847562, 0.777833, 1.0, 1.0, 0.99991], [373, \"hsa05416\", \"Viral myocarditis\", \"  4\", 3.06857, 0.365016, 0.828822, 0.777833, 1.0, 1.0, 0.99991], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"  2\", 1.26924, 0.366736, 0.884041, 0.777833, 1.0, 1.0, 0.99991], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"  3\", 2.17931, 0.371486, 0.839692, 0.777833, 1.0, 1.0, 0.99991], [196, \"hsa04330\", \"Notch signaling pathway\", \"  3\", 2.17838, 0.372236, 0.836332, 0.777833, 1.0, 1.0, 0.99991], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  6\", 4.94754, 0.372516, 0.781572, 0.777833, 1.0, 1.0, 0.99991], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  5\", 4.03677, 0.377466, 0.793572, 0.777833, 1.0, 1.0, 0.99991], [189, \"hsa04216\", \"Ferroptosis\", \"  2\", 1.34749, 0.394966, 0.854581, 0.801139, 1.0, 1.0, 0.99991], [253, \"hsa04812\", \"Cytoskeleton proteins\", \" 30\", 28.55686, 0.414426, 0.664923, 0.837456, 1.0, 1.0, 0.99991], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"  3\", 2.33574, 0.416696, 0.798862, 0.841233, 1.0, 1.0, 0.99991], [105, \"hsa02044\", \"Secretion system\", \"  1\", 0.535, 0.420856, 0.902261, 0.841233, 1.0, 1.0, 0.99991], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  6\", 5.20051, 0.420946, 0.740203, 0.841233, 1.0, 1.0, 0.99991], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \" 13\", 12.01174, 0.424226, 0.696043, 0.841233, 1.0, 1.0, 0.99991], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"  2\", 1.43148, 0.424236, 0.830762, 0.841233, 1.0, 1.0, 0.99991], [296, \"hsa04979\", \"Cholesterol metabolism\", \"  3\", 2.38686, 0.431906, 0.793962, 0.84669, 1.0, 1.0, 0.99991], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"  3\", 2.39999, 0.432026, 0.799812, 0.84669, 1.0, 1.0, 0.99991], [167, \"hsa04115\", \"p53 signaling pathway\", \"  3\", 2.41456, 0.438746, 0.782002, 0.84669, 1.0, 1.0, 0.99991], [236, \"hsa04713\", \"Circadian entrainment\", \" 12\", 11.18273, 0.442506, 0.693083, 0.84669, 1.0, 1.0, 0.99991], [68, \"hsa00620\", \"Pyruvate metabolism\", \"  2\", 1.47865, 0.443706, 0.822372, 0.84669, 1.0, 1.0, 0.99991], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  7\", 6.31207, 0.444996, 0.711063, 0.84669, 1.0, 1.0, 0.99991], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"  3\", 2.4439, 0.447786, 0.789742, 0.84669, 1.0, 1.0, 0.99991], [312, \"hsa05131\", \"Shigellosis\", \" 13\", 12.21145, 0.448666, 0.670653, 0.84669, 1.0, 1.0, 0.99991], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \" 10\", 9.3019, 0.453685, 0.686893, 0.84669, 1.0, 1.0, 0.99991], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  6\", 5.39227, 0.455665, 0.715903, 0.84669, 1.0, 1.0, 0.99991], [368, \"hsa05332\", \"Graft-versus-host disease\", \"  1\", 0.59303, 0.456265, 0.885411, 0.84669, 1.0, 1.0, 0.99991], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"  2\", 1.51517, 0.462025, 0.836032, 0.84669, 1.0, 1.0, 0.99991], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  4\", 3.48987, 0.469385, 0.737073, 0.84669, 1.0, 1.0, 0.99991], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"  2\", 1.58543, 0.476715, 0.791932, 0.85245, 1.0, 1.0, 0.99991], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  8\", 7.46594, 0.477345, 0.680163, 0.85245, 1.0, 1.0, 0.99991], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  7\", 6.50575, 0.481745, 0.682723, 0.85245, 1.0, 1.0, 0.99991], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"  2\", 1.61161, 0.488705, 0.787782, 0.855952, 1.0, 1.0, 0.99991], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \" 14\", 13.53436, 0.490615, 0.627064, 0.855952, 1.0, 1.0, 0.99991], [103, \"hsa02010\", \"ABC transporters\", \"  4\", 3.58426, 0.493365, 0.720703, 0.857221, 1.0, 1.0, 0.99991], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  6\", 5.61551, 0.497685, 0.672513, 0.861983, 1.0, 1.0, 0.99991], [164, \"hsa04091\", \"Lectins\", \"  3\", 2.67364, 0.503285, 0.724523, 0.874465, 1.0, 1.0, 0.99991], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \"  7\", 6.65766, 0.503355, 0.654763, 0.874465, 1.0, 1.0, 0.99991], [201, \"hsa04371\", \"Apelin signaling pathway\", \" 11\", 10.63726, 0.505455, 0.633114, 0.874465, 1.0, 1.0, 0.99991], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  7\", 6.64446, 0.508265, 0.662013, 0.874465, 1.0, 1.0, 0.99991], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"  1\", 0.71893, 0.522445, 0.840972, 0.891094, 1.0, 1.0, 0.99991], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"  1\", 0.70396, 0.527205, 0.850321, 0.897434, 1.0, 1.0, 0.99991], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"  1\", 0.71589, 0.527625, 0.843772, 0.897434, 1.0, 1.0, 0.99991], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  8\", 7.81138, 0.528825, 0.626184, 0.897434, 1.0, 1.0, 0.99991], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"  1\", 0.69169, 0.529875, 0.861481, 0.897434, 1.0, 1.0, 0.99991], [137, \"hsa03440\", \"Homologous recombination\", \"  2\", 1.7572, 0.533295, 0.744793, 0.897434, 1.0, 1.0, 0.99991], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"  1\", 0.71958, 0.534955, 0.846182, 0.897434, 1.0, 1.0, 0.99991], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \" 10\", 9.84933, 0.535395, 0.607164, 0.897434, 1.0, 1.0, 0.99991], [304, \"hsa05031\", \"Amphetamine addiction\", \"  6\", 5.78697, 0.538545, 0.648904, 0.897434, 1.0, 1.0, 0.99991], [101, \"hsa01524\", \"Platinum drug resistance\", \"  3\", 2.79445, 0.540885, 0.696973, 0.897434, 1.0, 1.0, 0.99991], [18, \"hsa00230\", \"Purine metabolism\", \"  9\", 8.9058, 0.543605, 0.602794, 0.897434, 1.0, 1.0, 0.99991], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  5\", 4.82975, 0.543775, 0.650703, 0.897434, 1.0, 1.0, 0.99991], [341, \"hsa05206\", \"MicroRNAs in cancer\", \" 11\", 10.96651, 0.550074, 0.585774, 0.897434, 1.0, 1.0, 0.99991], [111, \"hsa03011\", \"Ribosome\", \"  2\", 1.8381, 0.551684, 0.720403, 0.897434, 1.0, 1.0, 0.99991], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"  1\", 0.7895, 0.555384, 0.814872, 0.897434, 1.0, 1.0, 0.99991], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"  1\", 0.78382, 0.557354, 0.818332, 0.897434, 1.0, 1.0, 0.99991], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"  3\", 2.8769, 0.565824, 0.678513, 0.902005, 1.0, 1.0, 0.99991], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  7\", 7.02418, 0.566904, 0.596394, 0.902005, 1.0, 1.0, 0.99991], [295, \"hsa04978\", \"Mineral absorption\", \"  2\", 1.86113, 0.571794, 0.718813, 0.902005, 1.0, 1.0, 0.99991], [95, \"hsa01007\", \"Amino acid related enzymes\", \"  3\", 2.91648, 0.573484, 0.670123, 0.902005, 1.0, 1.0, 0.99991], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  6\", 6.05863, 0.576254, 0.596524, 0.902005, 1.0, 1.0, 0.99991], [149, \"hsa04040\", \"Ion channels\", \" 27\", 27.44569, 0.576514, 0.512525, 0.902005, 1.0, 1.0, 0.99991], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  5\", 5.04164, 0.580134, 0.609024, 0.902005, 1.0, 1.0, 0.99991], [278, \"hsa04934\", \"Cushing syndrome\", \" 10\", 10.22458, 0.586434, 0.553684, 0.902005, 1.0, 1.0, 0.99991], [169, \"hsa04121\", \"Ubiquitin system\", \" 36\", 36.81142, 0.588114, 0.484655, 0.902005, 1.0, 1.0, 0.99991], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"  3\", 2.9718, 0.590054, 0.655393, 0.902005, 1.0, 1.0, 0.99991], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  6\", 6.13243, 0.590654, 0.586094, 0.902005, 1.0, 1.0, 0.99991], [138, \"hsa03450\", \"Non-homologous end-joining\", \"  1\", 0.83435, 0.590754, 0.802432, 0.902005, 1.0, 1.0, 0.99991], [165, \"hsa04110\", \"Cell cycle\", \"  5\", 5.10306, 0.591124, 0.598424, 0.902005, 1.0, 1.0, 0.99991], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  7\", 7.19215, 0.595444, 0.570724, 0.902005, 1.0, 1.0, 0.99991], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \" 12\", 12.39425, 0.596774, 0.529565, 0.902005, 1.0, 1.0, 0.99991], [235, \"hsa04710\", \"Circadian rhythm\", \"  2\", 1.95685, 0.600774, 0.691373, 0.902005, 1.0, 1.0, 0.99991], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  6\", 6.16817, 0.603704, 0.577484, 0.902005, 1.0, 1.0, 0.99991], [39, \"hsa00480\", \"Glutathione metabolism\", \"  1\", 0.91402, 0.604254, 0.768242, 0.902005, 1.0, 1.0, 0.99991], [347, \"hsa05215\", \"Prostate cancer\", \"  6\", 6.21017, 0.604764, 0.571064, 0.902005, 1.0, 1.0, 0.99991], [244, \"hsa04726\", \"Serotonergic synapse\", \"  9\", 9.31969, 0.609504, 0.541545, 0.902005, 1.0, 1.0, 0.99991], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"  5\", 5.17455, 0.609734, 0.584754, 0.902005, 1.0, 1.0, 0.99991], [216, \"hsa04614\", \"Renin-angiotensin system\", \"  1\", 0.92532, 0.620504, 0.765272, 0.902005, 1.0, 1.0, 0.99991], [303, \"hsa05030\", \"Cocaine addiction\", \"  3\", 3.08909, 0.620594, 0.629364, 0.902005, 1.0, 1.0, 0.99991], [205, \"hsa04510\", \"Focal adhesion\", \" 16\", 16.75156, 0.628184, 0.481295, 0.902005, 1.0, 1.0, 0.99991], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"  3\", 3.13834, 0.631104, 0.615014, 0.902005, 1.0, 1.0, 0.99991], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  6\", 6.34818, 0.632294, 0.546045, 0.902005, 1.0, 1.0, 0.99991], [122, \"hsa03030\", \"DNA replication\", \"  1\", 0.97047, 0.634454, 0.746793, 0.902005, 1.0, 1.0, 0.99991], [136, \"hsa03430\", \"Mismatch repair\", \"  1\", 0.95214, 0.635534, 0.755022, 0.902005, 1.0, 1.0, 0.99991], [155, \"hsa04062\", \"Chemokine signaling pathway\", \" 10\", 10.59087, 0.635864, 0.503275, 0.902005, 1.0, 1.0, 0.99991], [191, \"hsa04218\", \"Cellular senescence\", \"  7\", 7.52877, 0.642654, 0.514985, 0.902005, 1.0, 1.0, 0.99991], [92, \"hsa01003\", \"Glycosyltransferases\", \" 14\", 14.79512, 0.642924, 0.476405, 0.902005, 1.0, 1.0, 0.99991], [298, \"hsa05012\", \"Parkinson disease\", \"  8\", 8.57207, 0.646444, 0.506895, 0.902005, 1.0, 1.0, 0.99991], [291, \"hsa04974\", \"Protein digestion and absorption\", \"  5\", 5.41413, 0.648014, 0.536085, 0.902005, 1.0, 1.0, 0.99991], [305, \"hsa05032\", \"Morphine addiction\", \"  9\", 9.68208, 0.654853, 0.487745, 0.902194, 1.0, 1.0, 0.99991], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \" 12\", 13.02667, 0.662913, 0.453455, 0.90782, 1.0, 1.0, 0.99991], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  3\", 3.33491, 0.666013, 0.567624, 0.910181, 1.0, 1.0, 0.99991], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"  5\", 5.47387, 0.669093, 0.524245, 0.911918, 1.0, 1.0, 0.99991], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  5\", 5.46311, 0.670703, 0.526215, 0.911918, 1.0, 1.0, 0.99991], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"  1\", 1.06783, 0.672383, 0.709603, 0.913259, 1.0, 1.0, 0.99991], [60, \"hsa00565\", \"Ether lipid metabolism\", \"  2\", 2.25129, 0.673073, 0.605274, 0.913259, 1.0, 1.0, 0.99991], [293, \"hsa04976\", \"Bile secretion\", \"  4\", 4.47644, 0.676013, 0.530255, 0.913259, 1.0, 1.0, 0.99991], [315, \"hsa05134\", \"Legionellosis\", \"  1\", 1.09927, 0.676423, 0.699203, 0.913259, 1.0, 1.0, 0.99991], [80, \"hsa00790\", \"Folate biosynthesis\", \"  1\", 1.04419, 0.686613, 0.723683, 0.918735, 1.0, 1.0, 0.99991], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \" 10\", 10.99108, 0.688633, 0.443956, 0.918735, 1.0, 1.0, 0.99991], [148, \"hsa04031\", \"GTP-binding proteins\", \"  6\", 6.83189, 0.694343, 0.466215, 0.922159, 1.0, 1.0, 0.99991], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"  4\", 4.50749, 0.695393, 0.518415, 0.922159, 1.0, 1.0, 0.99991], [248, \"hsa04740\", \"Olfactory transduction\", \"  5\", 5.6142, 0.695603, 0.498945, 0.922159, 1.0, 1.0, 0.99991], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"  1\", 1.13803, 0.700123, 0.682843, 0.922159, 1.0, 1.0, 0.99991], [8, \"hsa00062\", \"Fatty acid elongation\", \"  1\", 1.16665, 0.705103, 0.673333, 0.926235, 1.0, 1.0, 0.99991], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  4\", 4.65344, 0.709313, 0.492965, 0.929782, 1.0, 1.0, 0.99991], [319, \"hsa05143\", \"African trypanosomiasis\", \"  2\", 2.27542, 0.710783, 0.594474, 0.929782, 1.0, 1.0, 0.99991], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"  2\", 2.48672, 0.721003, 0.542755, 0.936681, 1.0, 1.0, 0.99991], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"  5\", 5.78587, 0.723273, 0.462615, 0.936681, 1.0, 1.0, 0.99991], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"  1\", 1.25922, 0.724163, 0.640044, 0.936681, 1.0, 1.0, 0.99991], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"  1\", 1.24823, 0.725033, 0.641384, 0.936681, 1.0, 1.0, 0.99991], [320, \"hsa05144\", \"Malaria\", \"  1\", 1.24546, 0.725873, 0.643534, 0.936681, 1.0, 1.0, 0.99991], [177, \"hsa04142\", \"Lysosome\", \"  4\", 4.79322, 0.726923, 0.467655, 0.936681, 1.0, 1.0, 0.99991], [73, \"hsa00730\", \"Thiamine metabolism\", \"  1\", 1.15509, 0.731843, 0.675763, 0.936681, 1.0, 1.0, 0.99991], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"  3\", 3.71673, 0.732303, 0.482775, 0.936681, 1.0, 1.0, 0.99991], [71, \"hsa00650\", \"Butanoate metabolism\", \"  1\", 1.27286, 0.734393, 0.634724, 0.936681, 1.0, 1.0, 0.99991], [245, \"hsa04727\", \"GABAergic synapse\", \"  7\", 8.14186, 0.738113, 0.410596, 0.936681, 1.0, 1.0, 0.99991], [116, \"hsa03018\", \"RNA degradation\", \"  2\", 2.55909, 0.739313, 0.523825, 0.936681, 1.0, 1.0, 0.99991], [146, \"hsa04024\", \"cAMP signaling pathway\", \" 14\", 15.88239, 0.747803, 0.354316, 0.936681, 1.0, 1.0, 0.99991], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"  1\", 1.16973, 0.748233, 0.676183, 0.936681, 1.0, 1.0, 0.99991], [208, \"hsa04515\", \"Cell adhesion molecules\", \" 17\", 19.10787, 0.750422, 0.348267, 0.936681, 1.0, 1.0, 0.99991], [243, \"hsa04725\", \"Cholinergic synapse\", \"  9\", 10.43028, 0.751082, 0.381746, 0.936681, 1.0, 1.0, 0.99991], [119, \"hsa03021\", \"Transcription machinery\", \"  9\", 10.6454, 0.754742, 0.365866, 0.936681, 1.0, 1.0, 0.99991], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"  2\", 2.46566, 0.757672, 0.537245, 0.936681, 1.0, 1.0, 0.99991], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"  1\", 1.41454, 0.761042, 0.584564, 0.936681, 1.0, 1.0, 0.99991], [209, \"hsa04520\", \"Adherens junction\", \"  6\", 7.18924, 0.764132, 0.398376, 0.940047, 1.0, 1.0, 0.99991], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \" 20\", 22.55485, 0.765782, 0.316137, 0.940047, 1.0, 1.0, 0.99991], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \"  7\", 8.51228, 0.766432, 0.368386, 0.940047, 1.0, 1.0, 0.99991], [143, \"hsa04015\", \"Rap1 signaling pathway\", \" 15\", 17.16848, 0.769642, 0.327527, 0.940047, 1.0, 1.0, 0.99991], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"  2\", 2.6441, 0.769662, 0.495445, 0.940047, 1.0, 1.0, 0.99991], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  4\", 5.12433, 0.785312, 0.397596, 0.950277, 1.0, 1.0, 0.99991], [238, \"hsa04720\", \"Long-term potentiation\", \"  6\", 7.36829, 0.788542, 0.364806, 0.951498, 1.0, 1.0, 0.99991], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"  3\", 4.05837, 0.789612, 0.409856, 0.951498, 1.0, 1.0, 0.99991], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"  3\", 3.96318, 0.791652, 0.417566, 0.951498, 1.0, 1.0, 0.99991], [345, \"hsa05213\", \"Endometrial cancer\", \"  3\", 3.97071, 0.791872, 0.419786, 0.951498, 1.0, 1.0, 0.99991], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"  2\", 2.81982, 0.793732, 0.451255, 0.951498, 1.0, 1.0, 0.99991], [90, \"hsa01001\", \"Protein kinases\", \" 36\", 40.02741, 0.794482, 0.262867, 0.951498, 1.0, 1.0, 0.99991], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  6\", 7.55531, 0.797192, 0.346957, 0.951498, 1.0, 1.0, 0.99991], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  4\", 5.29745, 0.799322, 0.370316, 0.951498, 1.0, 1.0, 0.99991], [166, \"hsa04114\", \"Oocyte meiosis\", \"  5\", 6.475, 0.802302, 0.351186, 0.951498, 1.0, 1.0, 0.99991], [255, \"hsa04911\", \"Insulin secretion\", \"  6\", 7.47655, 0.804552, 0.347327, 0.951498, 1.0, 1.0, 0.99991], [344, \"hsa05212\", \"Pancreatic cancer\", \"  3\", 4.20703, 0.811332, 0.377746, 0.951498, 1.0, 1.0, 0.99991], [180, \"hsa04146\", \"Peroxisome\", \"  2\", 3.01265, 0.815022, 0.411766, 0.951498, 1.0, 1.0, 0.99991], [175, \"hsa04140\", \"Autophagy - animal\", \"  6\", 7.80393, 0.816382, 0.316867, 0.951498, 1.0, 1.0, 0.99991], [16, \"hsa00199\", \"Cytochrome P450\", \"  1\", 1.67142, 0.821952, 0.495405, 0.954215, 1.0, 1.0, 0.99991], [142, \"hsa04014\", \"Ras signaling pathway\", \" 13\", 15.88081, 0.829582, 0.255187, 0.958511, 1.0, 1.0, 0.99991], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \" 30\", 34.2442, 0.831702, 0.225238, 0.958511, 1.0, 1.0, 0.99991], [242, \"hsa04724\", \"Glutamatergic synapse\", \" 11\", 13.67593, 0.848382, 0.244838, 0.969284, 1.0, 1.0, 0.99991], [324, \"hsa05152\", \"Tuberculosis\", \"  4\", 5.8335, 0.851621, 0.292127, 0.970909, 1.0, 1.0, 0.99991], [314, \"hsa05133\", \"Pertussis\", \"  1\", 1.83846, 0.856361, 0.439216, 0.975398, 1.0, 1.0, 0.99991], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  6\", 8.05464, 0.857251, 0.268527, 0.975398, 1.0, 1.0, 0.99991], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \" 10\", 12.80589, 0.859581, 0.232178, 0.975398, 1.0, 1.0, 0.99991], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  6\", 8.31353, 0.861881, 0.250047, 0.975398, 1.0, 1.0, 0.99991], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  7\", 9.60216, 0.867881, 0.231898, 0.977443, 1.0, 1.0, 0.99991], [322, \"hsa05146\", \"Amoebiasis\", \"  5\", 7.0958, 0.868171, 0.256937, 0.977443, 1.0, 1.0, 0.99991], [249, \"hsa04742\", \"Taste transduction\", \"  3\", 4.54916, 0.871311, 0.297477, 0.977443, 1.0, 1.0, 0.99991], [300, \"hsa05016\", \"Huntington disease\", \"  9\", 12.04775, 0.872141, 0.213758, 0.977443, 1.0, 1.0, 0.99991], [330, \"hsa05165\", \"Human papillomavirus infection\", \" 15\", 18.91315, 0.874711, 0.190688, 0.977443, 1.0, 1.0, 0.99991], [297, \"hsa05010\", \"Alzheimer disease\", \" 12\", 15.56073, 0.875171, 0.197218, 0.977443, 1.0, 1.0, 0.99991], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \" 13\", 16.60859, 0.879141, 0.192278, 0.977443, 1.0, 1.0, 0.99991], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  4\", 6.03703, 0.880741, 0.251177, 0.977443, 1.0, 1.0, 0.99991], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  9\", 12.0366, 0.884211, 0.201108, 0.977443, 1.0, 1.0, 0.99991], [99, \"hsa01522\", \"Endocrine resistance\", \"  4\", 6.1183, 0.888441, 0.238658, 0.977443, 1.0, 1.0, 0.99991], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  6\", 8.57847, 0.889281, 0.213228, 0.977443, 1.0, 1.0, 0.99991], [340, \"hsa05205\", \"Proteoglycans in cancer\", \" 10\", 13.38404, 0.891501, 0.184498, 0.977443, 1.0, 1.0, 0.99991], [70, \"hsa00640\", \"Propanoate metabolism\", \"  1\", 2.04188, 0.892931, 0.372396, 0.977443, 1.0, 1.0, 0.99991], [91, \"hsa01002\", \"Peptidases and inhibitors\", \" 28\", 33.97443, 0.898251, 0.142829, 0.977443, 1.0, 1.0, 0.99991], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  6\", 8.80704, 0.902451, 0.189988, 0.977443, 1.0, 1.0, 0.99991], [343, \"hsa05211\", \"Renal cell carcinoma\", \"  2\", 3.73216, 0.902871, 0.260487, 0.977443, 1.0, 1.0, 0.99991], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"  1\", 2.1821, 0.903701, 0.337307, 0.977443, 1.0, 1.0, 0.99991], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \" 10\", 13.88027, 0.908071, 0.158108, 0.977443, 1.0, 1.0, 0.99991], [210, \"hsa04530\", \"Tight junction\", \"  8\", 11.33404, 0.910041, 0.167728, 0.977443, 1.0, 1.0, 0.99991], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \" 11\", 14.83789, 0.917061, 0.147039, 0.978839, 1.0, 1.0, 0.99991], [144, \"hsa04020\", \"Calcium signaling pathway\", \" 13\", 17.43146, 0.922001, 0.131789, 0.979691, 1.0, 1.0, 0.99991], [53, \"hsa00535\", \"Proteoglycans\", \"  3\", 4.80221, 0.925231, 0.221958, 0.980226, 1.0, 1.0, 0.99991], [102, \"hsa02000\", \"Transporters\", \" 25\", 31.66017, 0.925381, 0.108759, 0.980226, 1.0, 1.0, 0.99991], [211, \"hsa04540\", \"Gap junction\", \"  5\", 7.88935, 0.931591, 0.156098, 0.983172, 1.0, 1.0, 0.99991], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"  2\", 3.97939, 0.942541, 0.193998, 0.994818, 1.0, 1.0, 0.99991], [350, \"hsa05218\", \"Melanoma\", \"  2\", 4.27183, 0.943351, 0.174368, 0.994818, 1.0, 1.0, 0.99991], [346, \"hsa05214\", \"Glioma\", \"  3\", 5.60836, 0.943711, 0.154868, 0.994818, 1.0, 1.0, 0.99991], [287, \"hsa04970\", \"Salivary secretion\", \"  4\", 6.77272, 0.945461, 0.141759, 0.994818, 1.0, 1.0, 0.99991], [147, \"hsa04030\", \"G protein-coupled receptors\", \" 10\", 15.3102, 0.95794, 0.079099, 0.999611, 1.0, 1.0, 0.99991], [199, \"hsa04360\", \"Axon guidance\", \" 12\", 17.53084, 0.96113, 0.073369, 1.0, 1.0, 1.0, 0.99991], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"  5\", 9.12771, 0.96257, 0.086759, 1.0, 1.0, 1.0, 0.99991], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  4\", 7.4837, 0.96417, 0.097269, 1.0, 1.0, 1.0, 0.99991], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  6\", 10.38195, 0.96445, 0.079959, 1.0, 1.0, 1.0, 0.99991], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \"  2\", 4.75971, 0.9645, 0.120919, 1.0, 1.0, 1.0, 0.99991], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"  1\", 3.35278, 0.9727, 0.131599, 1.0, 1.0, 1.0, 0.99991], [214, \"hsa04611\", \"Platelet activation\", \"  5\", 9.34239, 0.97384, 0.066949, 1.0, 1.0, 1.0, 0.99991], [131, \"hsa03310\", \"Nuclear receptors\", \"  1\", 3.29879, 0.97451, 0.130659, 1.0, 1.0, 1.0, 0.99991], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \" 10\", 16.6072, 0.97523, 0.04802, 1.0, 1.0, 1.0, 0.99991], [247, \"hsa04730\", \"Long-term depression\", \"  4\", 7.78801, 0.97578, 0.070839, 1.0, 1.0, 1.0, 0.99991], [358, \"hsa05226\", \"Gastric cancer\", \"  4\", 8.33357, 0.97682, 0.064689, 1.0, 1.0, 1.0, 0.99991], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  6\", 10.75249, 0.97724, 0.056699, 1.0, 1.0, 1.0, 0.99991], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  4\", 8.11152, 0.97746, 0.064459, 1.0, 1.0, 1.0, 0.99991], [289, \"hsa04972\", \"Pancreatic secretion\", \"  3\", 6.59186, 0.97883, 0.070109, 1.0, 1.0, 1.0, 0.99991], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"  1\", 3.59423, 0.98115, 0.103969, 1.0, 1.0, 1.0, 0.99991], [356, \"hsa05224\", \"Breast cancer\", \"  3\", 7.38913, 0.98394, 0.051229, 1.0, 1.0, 1.0, 0.99991], [174, \"hsa04137\", \"Mitophagy - animal\", \"  1\", 3.22835, 0.98655, 0.114929, 1.0, 1.0, 1.0, 0.99991], [113, \"hsa03013\", \"RNA transport\", \"  1\", 4.26011, 0.98793, 0.066759, 1.0, 1.0, 1.0, 0.99991], [342, \"hsa05210\", \"Colorectal cancer\", \"  2\", 5.63041, 0.98807, 0.053659, 1.0, 1.0, 1.0, 0.99991], [288, \"hsa04971\", \"Gastric acid secretion\", \"  2\", 5.77962, 0.98865, 0.04802, 1.0, 1.0, 1.0, 0.99991], [354, \"hsa05222\", \"Small cell lung cancer\", \"  2\", 5.96546, 0.98916, 0.04638, 1.0, 1.0, 1.0, 0.99991], [260, \"hsa04916\", \"Melanogenesis\", \"  2\", 6.65792, 0.99472, 0.02456, 1.0, 0.74976, 1.0, 0.99991], [336, \"hsa05200\", \"Pathways in cancer\", \" 18\", 29.60899, 0.99578, 0.00809, 1.0, 0.74976, 1.0, 0.99991], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  4\", 10.42819, 0.99663, 0.01149, 1.0, 0.74976, 1.0, 0.99991], [268, \"hsa04924\", \"Renin secretion\", \"  1\", 5.9538, 0.9992, 0.00848, 1.0, 0.74976, 1.0, 0.99991], [17, \"hsa00220\", \"Arginine biosynthesis\", \"  0\", 0.65798, 1.0, 0.505305, 1.0, 1.0, 1.0, 0.99991], [29, \"hsa00350\", \"Tyrosine metabolism\", \"  0\", 0.90795, 1.0, 0.388646, 1.0, 1.0, 1.0, 0.99991], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"  0\", 1.2998, 1.0, 0.245078, 1.0, 1.0, 1.0, 0.99991], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"  0\", 0.35459, 1.0, 0.693273, 1.0, 1.0, 1.0, 0.99991], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"  0\", 0.21973, 1.0, 0.800472, 1.0, 1.0, 1.0, 0.99991], [31, \"hsa00380\", \"Tryptophan metabolism\", \"  0\", 1.49352, 1.0, 0.213538, 1.0, 1.0, 1.0, 0.99991], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"  0\", 1.8742, 1.0, 0.105559, 1.0, 1.0, 1.0, 0.99991], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"  0\", 0.37381, 1.0, 0.683553, 1.0, 1.0, 1.0, 0.99991], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"  0\", 0.79814, 1.0, 0.439506, 1.0, 1.0, 1.0, 0.99991], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"  0\", 0.81235, 1.0, 0.433726, 1.0, 1.0, 1.0, 0.99991], [28, \"hsa00340\", \"Histidine metabolism\", \"  0\", 0.53624, 1.0, 0.579084, 1.0, 1.0, 1.0, 0.99991], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"  0\", 1.34563, 1.0, 0.244188, 1.0, 1.0, 1.0, 0.99991], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"  0\", 0.47228, 1.0, 0.599854, 1.0, 1.0, 1.0, 0.99991], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"  0\", 0.91704, 1.0, 0.381536, 1.0, 1.0, 1.0, 0.99991], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"  0\", 1.05945, 1.0, 0.329247, 1.0, 1.0, 1.0, 0.99991], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"  0\", 1.93641, 1.0, 0.131359, 1.0, 1.0, 1.0, 0.99991], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"  0\", 1.60063, 1.0, 0.137699, 1.0, 1.0, 1.0, 0.99991], [81, \"hsa00830\", \"Retinol metabolism\", \"  0\", 1.28519, 1.0, 0.267027, 1.0, 1.0, 1.0, 0.99991], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"  0\", 0.84357, 1.0, 0.421276, 1.0, 1.0, 1.0, 0.99991], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"  0\", 1.20785, 1.0, 0.298407, 1.0, 1.0, 1.0, 0.99991], [173, \"hsa04136\", \"Autophagy - other\", \"  0\", 1.97323, 1.0, 0.106929, 1.0, 1.0, 1.0, 0.99991], [112, \"hsa03012\", \"Translation factors\", \"  0\", 2.22233, 1.0, 0.095819, 1.0, 1.0, 1.0, 0.99991], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"  0\", 1.64532, 1.0, 0.184308, 1.0, 1.0, 1.0, 0.99991], [118, \"hsa03020\", \"RNA polymerase\", \"  0\", 0.68508, 1.0, 0.494265, 1.0, 1.0, 1.0, 0.99991], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"  0\", 2.2779, 1.0, 0.091409, 1.0, 1.0, 1.0, 0.99991], [348, \"hsa05216\", \"Thyroid cancer\", \"  0\", 1.80712, 1.0, 0.148259, 1.0, 1.0, 1.0, 0.99991], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"  0\", 1.32854, 1.0, 0.233728, 1.0, 1.0, 1.0, 0.99991], [250, \"hsa04744\", \"Phototransduction\", \"  0\", 0.66896, 1.0, 0.501555, 1.0, 1.0, 1.0, 0.99991], [351, \"hsa05219\", \"Bladder cancer\", \"  0\", 1.90175, 1.0, 0.132259, 1.0, 1.0, 1.0, 0.99991], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"  0\", 1.77956, 1.0, 0.128469, 1.0, 1.0, 1.0, 0.99991], [349, \"hsa05217\", \"Basal cell carcinoma\", \"  0\", 2.73618, 1.0, 0.054059, 1.0, 1.0, 1.0, 0.99991]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#3a1cedc0-e7cb-4e32-85b5-6aa097bac5e4').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#3a1cedc0-e7cb-4e32-85b5-6aa097bac5e4').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                                       FunctionName  \\\n",
       "226  hsa04658                   Th1 and Th2 cell differentiation   \n",
       "4    hsa00051                    Fructose and mannose metabolism   \n",
       "47   hsa00520        Amino sugar and nucleotide sugar metabolism   \n",
       "334  hsa05169                       Epstein-Barr virus infection   \n",
       "109  hsa03009                                Ribosome biogenesis   \n",
       "..        ...                                                ...   \n",
       "69   hsa00630            Glyoxylate and dicarboxylate metabolism   \n",
       "250  hsa04744                                  Phototransduction   \n",
       "351  hsa05219                                     Bladder cancer   \n",
       "50   hsa00532  Glycosaminoglycan biosynthesis - chondroitin s...   \n",
       "349  hsa05217                               Basal cell carcinoma   \n",
       "\n",
       "     n_candidates  mean_n_resample  emp_p_e   emp_p_d    fdr_e  fdr_d  \\\n",
       "226            11          3.71289  0.00053  0.999910  0.09492    1.0   \n",
       "4               6          1.43970  0.00094  0.999870  0.09492    1.0   \n",
       "47              7          1.90130  0.00117  0.999820  0.09492    1.0   \n",
       "334            15          6.65052  0.00173  0.999420  0.09492    1.0   \n",
       "109            14          6.72918  0.00531  0.997840  0.21647    1.0   \n",
       "..            ...              ...      ...       ...      ...    ...   \n",
       "69              0          1.32854  1.00000  0.233728  1.00000    1.0   \n",
       "250             0          0.66896  1.00000  0.501555  1.00000    1.0   \n",
       "351             0          1.90175  1.00000  0.132259  1.00000    1.0   \n",
       "50              0          1.77956  1.00000  0.128469  1.00000    1.0   \n",
       "349             0          2.73618  1.00000  0.054059  1.00000    1.0   \n",
       "\n",
       "     BH_fdr_e  BH_fdr_d  \n",
       "226  0.140399   0.99991  \n",
       "4    0.140399   0.99991  \n",
       "47   0.140399   0.99991  \n",
       "334  0.155698   0.99991  \n",
       "109  0.382316   0.99991  \n",
       "..        ...       ...  \n",
       "69   1.000000   0.99991  \n",
       "250  1.000000   0.99991  \n",
       "351  1.000000   0.99991  \n",
       "50   1.000000   0.99991  \n",
       "349  1.000000   0.99991  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "e_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "beaa46be",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"e0adbda7-29d8-4d58-a34d-5d51ca001971\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \" 22\", 6.45869, 1e-05, 1.0, 0.0, 1.0, 0.0036, 1.0], [369, \"hsa05340\", \"Primary immunodeficiency\", \"  6\", 0.73632, 6e-05, 0.99999, 0.004335, 1.0, 0.0108, 1.0], [317, \"hsa05140\", \"Leishmaniasis\", \"  8\", 2.00956, 0.0004, 0.99991, 0.024233, 1.0, 0.048, 1.0], [150, \"hsa04050\", \"Cytokine receptors\", \" 10\", 3.50918, 0.00227, 0.9993, 0.112488, 1.0, 0.204298, 1.0], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"  6\", 1.4881, 0.00355, 0.99936, 0.138956, 1.0, 0.245312, 1.0], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \" 10\", 4.02399, 0.00428, 0.99876, 0.139278, 1.0, 0.245312, 1.0], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \" 11\", 4.75884, 0.00477, 0.99856, 0.139278, 1.0, 0.245312, 1.0], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"  5\", 1.43802, 0.00653, 0.9991, 0.172305, 1.0, 0.293847, 1.0], [226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  9\", 3.70795, 0.00845, 0.99725, 0.196146, 1.0, 0.337997, 1.0], [184, \"hsa04152\", \"AMPK signaling pathway\", \" 14\", 7.39985, 0.01002, 0.99599, 0.207946, 1.0, 0.34756, 1.0], [29, \"hsa00350\", \"Tyrosine metabolism\", \"  4\", 0.91938, 0.01062, 0.99835, 0.207946, 1.0, 0.34756, 1.0], [151, \"hsa04052\", \"Cytokines and growth factors\", \" 13\", 6.91033, 0.01273, 0.99515, 0.21708, 1.0, 0.373496, 1.0], [291, \"hsa04974\", \"Protein digestion and absorption\", \" 11\", 5.4262, 0.01414, 0.99463, 0.218807, 1.0, 0.373496, 1.0], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \" 11\", 5.80788, 0.01642, 0.99445, 0.243136, 1.0, 0.373496, 1.0], [84, \"hsa00910\", \"Nitrogen metabolism\", \"  3\", 0.58971, 0.01659, 0.99829, 0.243136, 1.0, 0.373496, 1.0], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \" 11\", 5.80137, 0.0166, 0.99468, 0.243136, 1.0, 0.373496, 1.0], [202, \"hsa04380\", \"Osteoclast differentiation\", \" 11\", 5.61186, 0.01947, 0.99264, 0.244798, 1.0, 0.412302, 1.0], [303, \"hsa05030\", \"Cocaine addiction\", \"  7\", 3.10237, 0.02329, 0.99373, 0.277122, 1.0, 0.455935, 1.0], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \" 12\", 6.57682, 0.02523, 0.98961, 0.287429, 1.0, 0.455935, 1.0], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \" 10\", 5.18377, 0.02533, 0.99094, 0.287429, 1.0, 0.455935, 1.0], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"  5\", 1.90007, 0.028, 0.9935, 0.290346, 1.0, 0.464539, 1.0], [295, \"hsa04978\", \"Mineral absorption\", \"  5\", 1.85432, 0.03007, 0.99324, 0.295065, 1.0, 0.464539, 1.0], [99, \"hsa01522\", \"Endocrine resistance\", \" 11\", 6.14074, 0.03076, 0.98807, 0.295065, 1.0, 0.464539, 1.0], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \" 12\", 6.65726, 0.03149, 0.98634, 0.295065, 1.0, 0.464539, 1.0], [314, \"hsa05133\", \"Pertussis\", \"  5\", 1.84487, 0.03226, 0.99168, 0.295065, 1.0, 0.464539, 1.0], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"  6\", 2.51745, 0.03773, 0.98854, 0.317067, 1.0, 0.507195, 1.0], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  9\", 4.68864, 0.03804, 0.98533, 0.317067, 1.0, 0.507195, 1.0], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"  2\", 0.35464, 0.04387, 0.99655, 0.350211, 1.0, 0.516311, 1.0], [102, \"hsa02000\", \"Transporters\", \" 41\", 31.72782, 0.04488, 0.96983, 0.350211, 1.0, 0.516311, 1.0], [166, \"hsa04114\", \"Oocyte meiosis\", \" 11\", 6.4847, 0.04684, 0.9805, 0.350211, 1.0, 0.516311, 1.0], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"  3\", 0.83335, 0.04936, 0.99069, 0.354885, 1.0, 0.516311, 1.0], [155, \"hsa04062\", \"Chemokine signaling pathway\", \" 16\", 10.60885, 0.04952, 0.97522, 0.354885, 1.0, 0.516311, 1.0], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"  4\", 1.43568, 0.051379, 0.98783, 0.354885, 1.0, 0.516311, 1.0], [125, \"hsa03040\", \"Spliceosome\", \"  6\", 2.70309, 0.052679, 0.9821, 0.354885, 1.0, 0.516311, 1.0], [85, \"hsa00920\", \"Sulfur metabolism\", \"  2\", 0.38792, 0.053789, 0.99477, 0.354885, 1.0, 0.516311, 1.0], [68, \"hsa00620\", \"Pyruvate metabolism\", \"  4\", 1.47791, 0.054239, 0.98776, 0.354885, 1.0, 0.516311, 1.0], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \" 20\", 13.88123, 0.054259, 0.96889, 0.354885, 1.0, 0.516311, 1.0], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  6\", 2.8216, 0.054499, 0.98262, 0.354885, 1.0, 0.516311, 1.0], [321, \"hsa05145\", \"Toxoplasmosis\", \"  9\", 5.11298, 0.057709, 0.97628, 0.354885, 1.0, 0.518395, 1.0], [216, \"hsa04614\", \"Renin-angiotensin system\", \"  3\", 0.92664, 0.058929, 0.98944, 0.354885, 1.0, 0.518395, 1.0], [307, \"hsa05034\", \"Alcoholism\", \" 11\", 6.73465, 0.059039, 0.97414, 0.354885, 1.0, 0.518395, 1.0], [53, \"hsa00535\", \"Proteoglycans\", \"  8\", 4.81244, 0.060759, 0.98053, 0.354885, 1.0, 0.520795, 1.0], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \" 13\", 8.64965, 0.064509, 0.97068, 0.354885, 1.0, 0.540078, 1.0], [278, \"hsa04934\", \"Cushing syndrome\", \" 15\", 10.25194, 0.073699, 0.96189, 0.387771, 1.0, 0.594454, 1.0], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"  6\", 3.13607, 0.076749, 0.97522, 0.393523, 1.0, 0.594454, 1.0], [296, \"hsa04979\", \"Cholesterol metabolism\", \"  5\", 2.39215, 0.077309, 0.97646, 0.393523, 1.0, 0.594454, 1.0], [180, \"hsa04146\", \"Peroxisome\", \"  6\", 3.02843, 0.077609, 0.97147, 0.393523, 1.0, 0.594454, 1.0], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  8\", 4.70682, 0.082849, 0.96538, 0.399617, 1.0, 0.599292, 1.0], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"  4\", 1.6758, 0.083619, 0.97617, 0.399617, 1.0, 0.599292, 1.0], [107, \"hsa03000\", \"Transcription factors\", \" 48\", 39.60189, 0.084829, 0.938421, 0.399617, 1.0, 0.599292, 1.0], [306, \"hsa05033\", \"Nicotine addiction\", \"  7\", 4.02083, 0.087429, 0.96745, 0.399617, 1.0, 0.599292, 1.0], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"  3\", 1.11019, 0.087449, 0.9837, 0.399617, 1.0, 0.599292, 1.0], [338, \"hsa05203\", \"Viral carcinogenesis\", \" 12\", 7.96482, 0.088229, 0.95473, 0.399617, 1.0, 0.599292, 1.0], [289, \"hsa04972\", \"Pancreatic secretion\", \" 10\", 6.6083, 0.097339, 0.95594, 0.423567, 1.0, 0.648927, 1.0], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  6\", 3.35647, 0.108569, 0.95743, 0.462189, 1.0, 0.698329, 1.0], [292, \"hsa04975\", \"Fat digestion and absorption\", \"  3\", 1.1688, 0.108629, 0.97334, 0.462189, 1.0, 0.698329, 1.0], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \" 15\", 11.01193, 0.115549, 0.937051, 0.474357, 1.0, 0.707698, 1.0], [214, \"hsa04611\", \"Platelet activation\", \" 13\", 9.34545, 0.119359, 0.936211, 0.480043, 1.0, 0.707698, 1.0], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \" 16\", 12.04249, 0.120019, 0.932351, 0.480043, 1.0, 0.707698, 1.0], [324, \"hsa05152\", \"Tuberculosis\", \"  9\", 5.83179, 0.123359, 0.939391, 0.482457, 1.0, 0.707698, 1.0], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"  3\", 1.25131, 0.125169, 0.96796, 0.482457, 1.0, 0.707698, 1.0], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \" 10\", 6.66495, 0.125459, 0.933851, 0.482457, 1.0, 0.707698, 1.0], [246, \"hsa04728\", \"Dopaminergic synapse\", \" 16\", 12.05131, 0.126889, 0.927131, 0.482457, 1.0, 0.707698, 1.0], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \" 13\", 9.50323, 0.127129, 0.932761, 0.482457, 1.0, 0.707698, 1.0], [132, \"hsa03320\", \"PPAR signaling pathway\", \"  5\", 2.712, 0.127779, 0.95162, 0.482457, 1.0, 0.707698, 1.0], [237, \"hsa04714\", \"Thermogenesis\", \" 13\", 9.45358, 0.132389, 0.925901, 0.482457, 1.0, 0.71865, 1.0], [190, \"hsa04217\", \"Necroptosis\", \"  7\", 4.3217, 0.133749, 0.938751, 0.482457, 1.0, 0.71865, 1.0], [134, \"hsa03410\", \"Base excision repair\", \"  2\", 0.6559, 0.137159, 0.97342, 0.483875, 1.0, 0.726134, 1.0], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  8\", 5.20237, 0.143269, 0.929301, 0.497438, 1.0, 0.737343, 1.0], [312, \"hsa05131\", \"Shigellosis\", \" 16\", 12.22233, 0.144989, 0.912591, 0.497896, 1.0, 0.737343, 1.0], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  9\", 6.16727, 0.145709, 0.927491, 0.497896, 1.0, 0.737343, 1.0], [179, \"hsa04145\", \"Phagosome\", \"  7\", 4.4076, 0.147469, 0.931531, 0.499836, 1.0, 0.737343, 1.0], [142, \"hsa04014\", \"Ras signaling pathway\", \" 20\", 15.90815, 0.155898, 0.898991, 0.521023, 1.0, 0.764748, 1.0], [326, \"hsa05161\", \"Hepatitis B\", \" 10\", 7.08918, 0.162498, 0.913951, 0.546284, 1.0, 0.764748, 1.0], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"  5\", 2.98154, 0.164088, 0.936861, 0.546284, 1.0, 0.764748, 1.0], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \" 13\", 9.87382, 0.166828, 0.904371, 0.546284, 1.0, 0.764748, 1.0], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  9\", 6.35743, 0.167328, 0.915641, 0.546284, 1.0, 0.764748, 1.0], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \" 11\", 8.11437, 0.167628, 0.909181, 0.546284, 1.0, 0.764748, 1.0], [18, \"hsa00230\", \"Purine metabolism\", \" 12\", 8.93503, 0.168518, 0.904281, 0.546284, 1.0, 0.764748, 1.0], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  7\", 4.66403, 0.171188, 0.920481, 0.546284, 1.0, 0.764748, 1.0], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \" 12\", 9.16052, 0.172068, 0.908341, 0.546284, 1.0, 0.764748, 1.0], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  4\", 2.23175, 0.177788, 0.934581, 0.546284, 1.0, 0.780534, 1.0], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"  2\", 0.79609, 0.188658, 0.95707, 0.559324, 1.0, 0.809606, 1.0], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  9\", 6.54458, 0.188908, 0.901401, 0.559324, 1.0, 0.809606, 1.0], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \" 16\", 12.82933, 0.191208, 0.879441, 0.560342, 1.0, 0.809822, 1.0], [270, \"hsa04926\", \"Relaxin signaling pathway\", \" 11\", 8.33397, 0.198878, 0.885001, 0.579666, 1.0, 0.818688, 1.0], [138, \"hsa03450\", \"Non-homologous end-joining\", \"  2\", 0.84012, 0.200998, 0.95896, 0.579666, 1.0, 0.818688, 1.0], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"  1\", 0.22221, 0.201778, 0.98068, 0.579666, 1.0, 0.818688, 1.0], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"  4\", 2.34333, 0.202398, 0.919541, 0.579666, 1.0, 0.818688, 1.0], [287, \"hsa04970\", \"Salivary secretion\", \"  9\", 6.7798, 0.207508, 0.894011, 0.588839, 1.0, 0.825262, 1.0], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"  4\", 2.46629, 0.208608, 0.932101, 0.588839, 1.0, 0.825262, 1.0], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"  3\", 1.61607, 0.213868, 0.930431, 0.588839, 1.0, 0.836874, 1.0], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \" 11\", 8.68213, 0.220878, 0.879351, 0.598167, 1.0, 0.836974, 1.0], [247, \"hsa04730\", \"Long-term depression\", \" 10\", 7.79192, 0.224458, 0.876491, 0.599089, 1.0, 0.836974, 1.0], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"  3\", 1.64671, 0.224798, 0.919841, 0.599089, 1.0, 0.836974, 1.0], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \" 12\", 9.44497, 0.227518, 0.859841, 0.599089, 1.0, 0.836974, 1.0], [362, \"hsa05310\", \"Asthma\", \"  1\", 0.26067, 0.229288, 0.97126, 0.599089, 1.0, 0.836974, 1.0], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  7\", 5.02982, 0.232048, 0.879141, 0.599089, 1.0, 0.836974, 1.0], [163, \"hsa04090\", \"CD molecules\", \" 18\", 14.94315, 0.232078, 0.841262, 0.599089, 1.0, 0.836974, 1.0], [39, \"hsa00480\", \"Glutathione metabolism\", \"  2\", 0.91458, 0.233438, 0.937401, 0.599089, 1.0, 0.836974, 1.0], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"  3\", 1.67839, 0.234818, 0.915201, 0.599089, 1.0, 0.836974, 1.0], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  7\", 5.14554, 0.241238, 0.877281, 0.599089, 1.0, 0.851427, 1.0], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  9\", 6.91971, 0.248148, 0.857181, 0.606079, 1.0, 0.85586, 1.0], [305, \"hsa05032\", \"Morphine addiction\", \" 12\", 9.70109, 0.248668, 0.848242, 0.606079, 1.0, 0.85586, 1.0], [140, \"hsa04010\", \"MAPK signaling pathway\", \" 23\", 20.05622, 0.260247, 0.812832, 0.622404, 1.0, 0.85586, 1.0], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"  3\", 1.79056, 0.261927, 0.902421, 0.622404, 1.0, 0.85586, 1.0], [90, \"hsa01001\", \"Protein kinases\", \" 44\", 40.07677, 0.263007, 0.792582, 0.622404, 1.0, 0.85586, 1.0], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"  2\", 1.0042, 0.264097, 0.921461, 0.622404, 1.0, 0.85586, 1.0], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  9\", 7.0423, 0.264177, 0.845252, 0.622404, 1.0, 0.85586, 1.0], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  5\", 3.49147, 0.265477, 0.874821, 0.622404, 1.0, 0.85586, 1.0], [348, \"hsa05216\", \"Thyroid cancer\", \"  3\", 1.80531, 0.266667, 0.900721, 0.622404, 1.0, 0.85586, 1.0], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \" 10\", 8.02451, 0.270537, 0.837322, 0.622404, 1.0, 0.85586, 1.0], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  5\", 3.53218, 0.271957, 0.869491, 0.622404, 1.0, 0.85586, 1.0], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"  4\", 2.65792, 0.272977, 0.876461, 0.622404, 1.0, 0.85586, 1.0], [302, \"hsa05020\", \"Prion diseases\", \"  3\", 1.86462, 0.273957, 0.906971, 0.622404, 1.0, 0.85586, 1.0], [347, \"hsa05215\", \"Prostate cancer\", \"  8\", 6.2231, 0.275777, 0.844462, 0.622404, 1.0, 0.85586, 1.0], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \" 12\", 9.8127, 0.279717, 0.812952, 0.622404, 1.0, 0.860668, 1.0], [293, \"hsa04976\", \"Bile secretion\", \"  6\", 4.48388, 0.283947, 0.852161, 0.622404, 1.0, 0.864082, 1.0], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"  2\", 1.05997, 0.285627, 0.916471, 0.622404, 1.0, 0.864082, 1.0], [215, \"hsa04612\", \"Antigen processing and presentation\", \"  2\", 1.08079, 0.294117, 0.908941, 0.628187, 1.0, 0.87281, 1.0], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"  2\", 1.08586, 0.296337, 0.908221, 0.628194, 1.0, 0.87281, 1.0], [232, \"hsa04668\", \"TNF signaling pathway\", \"  6\", 4.55331, 0.299597, 0.839192, 0.628298, 1.0, 0.87281, 1.0], [315, \"hsa05134\", \"Legionellosis\", \"  2\", 1.10274, 0.301647, 0.904201, 0.628298, 1.0, 0.87281, 1.0], [238, \"hsa04720\", \"Long-term potentiation\", \"  9\", 7.37507, 0.302017, 0.824122, 0.628298, 1.0, 0.87281, 1.0], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"  3\", 1.93273, 0.303207, 0.877571, 0.628298, 1.0, 0.87281, 1.0], [91, \"hsa01002\", \"Peptidases and inhibitors\", \" 37\", 33.98434, 0.306577, 0.757332, 0.628298, 1.0, 0.87281, 1.0], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \"  8\", 6.42609, 0.308327, 0.819832, 0.628298, 1.0, 0.87281, 1.0], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \" 12\", 10.16384, 0.310907, 0.795842, 0.628298, 1.0, 0.87281, 1.0], [236, \"hsa04713\", \"Circadian entrainment\", \" 13\", 11.21583, 0.312757, 0.800122, 0.628298, 1.0, 0.87281, 1.0], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"  5\", 3.78239, 0.315287, 0.851551, 0.628298, 1.0, 0.873102, 1.0], [5, \"hsa00052\", \"Galactose metabolism\", \"  2\", 1.15668, 0.324497, 0.894851, 0.650344, 1.0, 0.885615, 1.0], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  6\", 4.71144, 0.325177, 0.825792, 0.650344, 1.0, 0.885615, 1.0], [70, \"hsa00640\", \"Propanoate metabolism\", \"  3\", 2.04364, 0.332567, 0.866161, 0.664805, 1.0, 0.885615, 1.0], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  9\", 7.54676, 0.332997, 0.792842, 0.664805, 1.0, 0.885615, 1.0], [191, \"hsa04218\", \"Cellular senescence\", \"  9\", 7.55029, 0.339297, 0.784002, 0.664805, 1.0, 0.885615, 1.0], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \" 10\", 8.52134, 0.344607, 0.775202, 0.670428, 1.0, 0.885615, 1.0], [243, \"hsa04725\", \"Cholinergic synapse\", \" 12\", 10.45786, 0.344767, 0.770682, 0.670428, 1.0, 0.885615, 1.0], [123, \"hsa03032\", \"DNA replication proteins\", \"  5\", 3.87533, 0.345637, 0.809652, 0.670428, 1.0, 0.885615, 1.0], [177, \"hsa04142\", \"Lysosome\", \"  6\", 4.81008, 0.346527, 0.804062, 0.670428, 1.0, 0.885615, 1.0], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \" 10\", 8.59243, 0.348907, 0.776252, 0.670428, 1.0, 0.885615, 1.0], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  7\", 5.8399, 0.352006, 0.809842, 0.670428, 1.0, 0.885615, 1.0], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"  3\", 2.12222, 0.355136, 0.849182, 0.670428, 1.0, 0.885615, 1.0], [340, \"hsa05205\", \"Proteoglycans in cancer\", \" 15\", 13.4068, 0.357296, 0.749783, 0.670428, 1.0, 0.885615, 1.0], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  8\", 6.73918, 0.357596, 0.775302, 0.670428, 1.0, 0.885615, 1.0], [320, \"hsa05144\", \"Malaria\", \"  2\", 1.2502, 0.357606, 0.874901, 0.670428, 1.0, 0.885615, 1.0], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"  5\", 3.96925, 0.361886, 0.811202, 0.670428, 1.0, 0.885615, 1.0], [126, \"hsa03041\", \"Spliceosome\", \" 14\", 12.50032, 0.363126, 0.742853, 0.670428, 1.0, 0.885615, 1.0], [201, \"hsa04371\", \"Apelin signaling pathway\", \" 12\", 10.66148, 0.369226, 0.751282, 0.670428, 1.0, 0.885615, 1.0], [71, \"hsa00650\", \"Butanoate metabolism\", \"  2\", 1.27778, 0.369516, 0.869001, 0.670428, 1.0, 0.885615, 1.0], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"  2\", 1.27238, 0.369876, 0.882641, 0.670428, 1.0, 0.885615, 1.0], [196, \"hsa04330\", \"Notch signaling pathway\", \"  3\", 2.17219, 0.371466, 0.838292, 0.670428, 1.0, 0.885615, 1.0], [148, \"hsa04031\", \"GTP-binding proteins\", \"  8\", 6.8411, 0.375706, 0.761942, 0.670428, 1.0, 0.886607, 1.0], [144, \"hsa04020\", \"Calcium signaling pathway\", \" 19\", 17.47921, 0.377536, 0.721143, 0.670428, 1.0, 0.886607, 1.0], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"  1\", 0.46218, 0.381436, 0.928181, 0.670428, 1.0, 0.886607, 1.0], [268, \"hsa04924\", \"Renin secretion\", \"  7\", 5.96718, 0.384176, 0.772942, 0.670428, 1.0, 0.886607, 1.0], [259, \"hsa04915\", \"Estrogen signaling pathway\", \" 10\", 8.81667, 0.384196, 0.746773, 0.670428, 1.0, 0.886607, 1.0], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"  5\", 4.15677, 0.387586, 0.813992, 0.670428, 1.0, 0.888733, 1.0], [26, \"hsa00310\", \"Lysine degradation\", \"  4\", 3.18172, 0.392286, 0.802832, 0.670428, 1.0, 0.890459, 1.0], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"  2\", 1.3368, 0.393286, 0.864621, 0.670428, 1.0, 0.890459, 1.0], [42, \"hsa00511\", \"Other glycan degradation\", \"  1\", 0.49037, 0.398376, 0.918891, 0.670428, 1.0, 0.894613, 1.0], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  7\", 6.05814, 0.400816, 0.746503, 0.670428, 1.0, 0.894613, 1.0], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"  3\", 2.28256, 0.402576, 0.815132, 0.671068, 1.0, 0.894613, 1.0], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"  2\", 1.41193, 0.414806, 0.833332, 0.684001, 1.0, 0.910015, 1.0], [341, \"hsa05206\", \"MicroRNAs in cancer\", \" 12\", 10.9774, 0.415046, 0.707983, 0.684001, 1.0, 0.910015, 1.0], [275, \"hsa04931\", \"Insulin resistance\", \"  7\", 6.1528, 0.418566, 0.736603, 0.6841, 1.0, 0.910015, 1.0], [146, \"hsa04024\", \"cAMP signaling pathway\", \" 17\", 15.89891, 0.421766, 0.685813, 0.686819, 1.0, 0.910015, 1.0], [28, \"hsa00340\", \"Histidine metabolism\", \"  1\", 0.53721, 0.422146, 0.901141, 0.686819, 1.0, 0.910015, 1.0], [300, \"hsa05016\", \"Huntington disease\", \" 13\", 12.05691, 0.428516, 0.686753, 0.690734, 1.0, 0.914945, 1.0], [350, \"hsa05218\", \"Melanoma\", \"  5\", 4.2808, 0.429516, 0.749903, 0.690734, 1.0, 0.914945, 1.0], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  7\", 6.25555, 0.436806, 0.717073, 0.697147, 1.0, 0.923233, 1.0], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  6\", 5.29914, 0.438536, 0.730443, 0.697441, 1.0, 0.923233, 1.0], [244, \"hsa04726\", \"Serotonergic synapse\", \" 10\", 9.35164, 0.463135, 0.679193, 0.729806, 1.0, 0.96402, 1.0], [120, \"hsa03022\", \"Basal transcription factors\", \"  2\", 1.54128, 0.463265, 0.804392, 0.729806, 1.0, 0.96402, 1.0], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \" 13\", 12.41237, 0.474305, 0.645944, 0.73704, 1.0, 0.980548, 1.0], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"  2\", 1.58467, 0.476655, 0.789872, 0.73704, 1.0, 0.980548, 1.0], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"  5\", 4.52425, 0.485225, 0.714743, 0.746908, 1.0, 0.992506, 1.0], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"  4\", 3.59224, 0.494775, 0.719473, 0.761624, 1.0, 1.0, 1.0], [250, \"hsa04744\", \"Phototransduction\", \"  1\", 0.67112, 0.498875, 0.857791, 0.769196, 1.0, 1.0, 1.0], [248, \"hsa04740\", \"Olfactory transduction\", \"  6\", 5.62608, 0.504785, 0.682513, 0.779106, 1.0, 1.0, 1.0], [16, \"hsa00199\", \"Cytochrome P450\", \"  2\", 1.67775, 0.506735, 0.765862, 0.781575, 1.0, 1.0, 1.0], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"  3\", 2.65643, 0.509025, 0.733423, 0.781575, 1.0, 1.0, 1.0], [164, \"hsa04091\", \"Lectins\", \"  3\", 2.69131, 0.509795, 0.718583, 0.781575, 1.0, 1.0, 1.0], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"  1\", 0.69614, 0.513875, 0.849182, 0.781712, 1.0, 1.0, 1.0], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"  1\", 0.71353, 0.521935, 0.843242, 0.790103, 1.0, 1.0, 1.0], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"  1\", 0.7011, 0.527625, 0.852561, 0.796061, 1.0, 1.0, 1.0], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"  1\", 0.69082, 0.528235, 0.861351, 0.796061, 1.0, 1.0, 1.0], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \" 15\", 14.85723, 0.533375, 0.589154, 0.805225, 1.0, 1.0, 1.0], [137, \"hsa03440\", \"Homologous recombination\", \"  2\", 1.75677, 0.534005, 0.745083, 0.805225, 1.0, 1.0, 1.0], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"  1\", 0.71578, 0.535485, 0.849212, 0.805225, 1.0, 1.0, 1.0], [304, \"hsa05031\", \"Amphetamine addiction\", \"  6\", 5.79732, 0.539325, 0.648164, 0.805225, 1.0, 1.0, 1.0], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  5\", 4.82887, 0.543385, 0.649054, 0.805225, 1.0, 1.0, 1.0], [200, \"hsa04370\", \"VEGF signaling pathway\", \"  4\", 3.79934, 0.543575, 0.674343, 0.805225, 1.0, 1.0, 1.0], [211, \"hsa04540\", \"Gap junction\", \"  8\", 7.90417, 0.552864, 0.613484, 0.816034, 1.0, 1.0, 1.0], [172, \"hsa04131\", \"Membrane trafficking\", \" 91\", 91.73181, 0.556164, 0.492895, 0.8164, 1.0, 1.0, 1.0], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"  1\", 0.79649, 0.561834, 0.813022, 0.822662, 1.0, 1.0, 1.0], [143, \"hsa04015\", \"Rap1 signaling pathway\", \" 17\", 17.17682, 0.562474, 0.547915, 0.822662, 1.0, 1.0, 1.0], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"  1\", 0.814, 0.566064, 0.805902, 0.822662, 1.0, 1.0, 1.0], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  6\", 6.04154, 0.578114, 0.602014, 0.830332, 1.0, 1.0, 1.0], [322, \"hsa05146\", \"Amoebiasis\", \"  7\", 7.1003, 0.583504, 0.584304, 0.837207, 1.0, 1.0, 1.0], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"  3\", 2.93244, 0.585004, 0.668043, 0.837207, 1.0, 1.0, 1.0], [351, \"hsa05219\", \"Bladder cancer\", \"  2\", 1.91272, 0.586544, 0.703973, 0.837207, 1.0, 1.0, 1.0], [245, \"hsa04727\", \"GABAergic synapse\", \"  8\", 8.15741, 0.589604, 0.570844, 0.837207, 1.0, 1.0, 1.0], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"  2\", 1.88148, 0.591534, 0.724503, 0.837207, 1.0, 1.0, 1.0], [165, \"hsa04110\", \"Cell cycle\", \"  5\", 5.12186, 0.594784, 0.594324, 0.83947, 1.0, 1.0, 1.0], [182, \"hsa04150\", \"mTOR signaling pathway\", \"  8\", 8.25303, 0.595514, 0.556324, 0.83947, 1.0, 1.0, 1.0], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \" 16\", 16.60885, 0.603384, 0.502145, 0.840737, 1.0, 1.0, 1.0], [297, \"hsa05010\", \"Alzheimer disease\", \" 15\", 15.57455, 0.606974, 0.505025, 0.842359, 1.0, 1.0, 1.0], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  9\", 9.30641, 0.607034, 0.544755, 0.842359, 1.0, 1.0, 1.0], [327, \"hsa05162\", \"Measles\", \"  4\", 4.20993, 0.617874, 0.587324, 0.852246, 1.0, 1.0, 1.0], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"  1\", 0.91548, 0.618134, 0.769492, 0.852246, 1.0, 1.0, 1.0], [100, \"hsa01523\", \"Antifolate resistance\", \"  1\", 0.89725, 0.618264, 0.780252, 0.852246, 1.0, 1.0, 1.0], [373, \"hsa05416\", \"Viral myocarditis\", \"  3\", 3.0773, 0.623934, 0.633084, 0.852788, 1.0, 1.0, 1.0], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"  1\", 0.95199, 0.626994, 0.755312, 0.852788, 1.0, 1.0, 1.0], [113, \"hsa03013\", \"RNA transport\", \"  4\", 4.27341, 0.628074, 0.572614, 0.852788, 1.0, 1.0, 1.0], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 59\", 60.95922, 0.631624, 0.423226, 0.852788, 1.0, 1.0, 1.0], [122, \"hsa03030\", \"DNA replication\", \"  1\", 0.9696, 0.632824, 0.748413, 0.852788, 1.0, 1.0, 1.0], [136, \"hsa03430\", \"Mismatch repair\", \"  1\", 0.94926, 0.633444, 0.755052, 0.852788, 1.0, 1.0, 1.0], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \"  9\", 9.60999, 0.637204, 0.500215, 0.852788, 1.0, 1.0, 1.0], [313, \"hsa05132\", \"Salmonella infection\", \"  9\", 9.61241, 0.638484, 0.501445, 0.852788, 1.0, 1.0, 1.0], [329, \"hsa05164\", \"Influenza A\", \"  5\", 5.38276, 0.639384, 0.545915, 0.852788, 1.0, 1.0, 1.0], [316, \"hsa05135\", \"Yersinia infection\", \"  7\", 7.49183, 0.641114, 0.521515, 0.852788, 1.0, 1.0, 1.0], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  9\", 9.61933, 0.642004, 0.500005, 0.852788, 1.0, 1.0, 1.0], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  7\", 7.50399, 0.651513, 0.515375, 0.852788, 1.0, 1.0, 1.0], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  9\", 9.54316, 0.652333, 0.503805, 0.852788, 1.0, 1.0, 1.0], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"  2\", 2.16526, 0.663823, 0.630574, 0.859829, 1.0, 1.0, 1.0], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \" 10\", 10.76339, 0.666383, 0.475355, 0.861366, 1.0, 1.0, 1.0], [181, \"hsa04147\", \"Exosome\", \" 32\", 34.0472, 0.676713, 0.393616, 0.878753, 1.0, 1.0, 1.0], [80, \"hsa00790\", \"Folate biosynthesis\", \"  1\", 1.04807, 0.689573, 0.724883, 0.893664, 1.0, 1.0, 1.0], [147, \"hsa04030\", \"G protein-coupled receptors\", \" 14\", 15.32711, 0.690163, 0.419686, 0.893664, 1.0, 1.0, 1.0], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"  1\", 1.10035, 0.691173, 0.697193, 0.893664, 1.0, 1.0, 1.0], [273, \"hsa04929\", \"GnRH secretion\", \"  6\", 6.65842, 0.692573, 0.486655, 0.893664, 1.0, 1.0, 1.0], [346, \"hsa05214\", \"Glioma\", \"  5\", 5.62694, 0.693493, 0.494765, 0.893664, 1.0, 1.0, 1.0], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  3\", 3.49627, 0.698413, 0.529885, 0.893664, 1.0, 1.0, 1.0], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"  1\", 1.1368, 0.699923, 0.684073, 0.893664, 1.0, 1.0, 1.0], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"  1\", 1.20576, 0.700373, 0.660213, 0.893664, 1.0, 1.0, 1.0], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  5\", 5.72265, 0.702333, 0.478065, 0.893664, 1.0, 1.0, 1.0], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  8\", 8.98428, 0.702963, 0.441256, 0.893664, 1.0, 1.0, 1.0], [8, \"hsa00062\", \"Fatty acid elongation\", \"  1\", 1.1638, 0.704233, 0.674213, 0.893664, 1.0, 1.0, 1.0], [249, \"hsa04742\", \"Taste transduction\", \"  4\", 4.55955, 0.705243, 0.506125, 0.893664, 1.0, 1.0, 1.0], [9, \"hsa00071\", \"Fatty acid degradation\", \"  1\", 1.21235, 0.709613, 0.657033, 0.893664, 1.0, 1.0, 1.0], [319, \"hsa05143\", \"African trypanosomiasis\", \"  2\", 2.27954, 0.711843, 0.593344, 0.893664, 1.0, 1.0, 1.0], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"  2\", 2.48676, 0.720793, 0.543445, 0.893664, 1.0, 1.0, 1.0], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"  1\", 1.26233, 0.723963, 0.637954, 0.893664, 1.0, 1.0, 1.0], [103, \"hsa02010\", \"ABC transporters\", \"  3\", 3.59098, 0.724153, 0.504065, 0.893664, 1.0, 1.0, 1.0], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"  3\", 3.7212, 0.733533, 0.482365, 0.89842, 1.0, 1.0, 1.0], [343, \"hsa05211\", \"Renal cell carcinoma\", \"  3\", 3.72888, 0.739973, 0.476695, 0.907242, 1.0, 1.0, 1.0], [149, \"hsa04040\", \"Ion channels\", \" 25\", 27.4724, 0.745413, 0.334207, 0.910722, 1.0, 1.0, 1.0], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  4\", 4.95002, 0.747043, 0.437786, 0.910722, 1.0, 1.0, 1.0], [208, \"hsa04515\", \"Cell adhesion molecules\", \" 17\", 19.12204, 0.752412, 0.345097, 0.912674, 1.0, 1.0, 1.0], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"  1\", 1.34902, 0.756352, 0.605044, 0.916041, 1.0, 1.0, 1.0], [242, \"hsa04724\", \"Glutamatergic synapse\", \" 12\", 13.7095, 0.756792, 0.357896, 0.916041, 1.0, 1.0, 1.0], [119, \"hsa03021\", \"Transcription machinery\", \"  9\", 10.65642, 0.757802, 0.363706, 0.916041, 1.0, 1.0, 1.0], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"  2\", 2.61607, 0.758062, 0.504245, 0.916041, 1.0, 1.0, 1.0], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  5\", 6.12637, 0.758242, 0.409106, 0.916041, 1.0, 1.0, 1.0], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"  1\", 1.30713, 0.758652, 0.617644, 0.916041, 1.0, 1.0, 1.0], [135, \"hsa03420\", \"Nucleotide excision repair\", \"  1\", 1.37553, 0.760942, 0.595474, 0.916041, 1.0, 1.0, 1.0], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"  1\", 1.35814, 0.761872, 0.598824, 0.916041, 1.0, 1.0, 1.0], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \" 20\", 22.56087, 0.764652, 0.317187, 0.916041, 1.0, 1.0, 1.0], [356, \"hsa05224\", \"Breast cancer\", \"  6\", 7.4075, 0.767732, 0.376646, 0.916041, 1.0, 1.0, 1.0], [209, \"hsa04520\", \"Adherens junction\", \"  6\", 7.21302, 0.768142, 0.392646, 0.916041, 1.0, 1.0, 1.0], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \"  9\", 10.63423, 0.771952, 0.356136, 0.916041, 1.0, 1.0, 1.0], [129, \"hsa03060\", \"Protein export\", \"  1\", 1.14077, 0.784262, 0.711893, 0.916353, 1.0, 1.0, 1.0], [298, \"hsa05012\", \"Parkinson disease\", \"  7\", 8.58011, 0.785802, 0.351746, 0.916353, 1.0, 1.0, 1.0], [31, \"hsa00380\", \"Tryptophan metabolism\", \"  1\", 1.50425, 0.791092, 0.549625, 0.921174, 1.0, 1.0, 1.0], [345, \"hsa05213\", \"Endometrial cancer\", \"  3\", 3.98219, 0.794292, 0.416986, 0.921174, 1.0, 1.0, 1.0], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"  2\", 2.82849, 0.794352, 0.449706, 0.921174, 1.0, 1.0, 1.0], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \" 10\", 12.04439, 0.794472, 0.316077, 0.921174, 1.0, 1.0, 1.0], [255, \"hsa04911\", \"Insulin secretion\", \"  6\", 7.49046, 0.801882, 0.346577, 0.921174, 1.0, 1.0, 1.0], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \" 14\", 16.61441, 0.806722, 0.282557, 0.923099, 1.0, 1.0, 1.0], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"  3\", 3.98535, 0.807322, 0.410776, 0.923099, 1.0, 1.0, 1.0], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"  2\", 2.7845, 0.807722, 0.450365, 0.923099, 1.0, 1.0, 1.0], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  5\", 6.51938, 0.808952, 0.342077, 0.923099, 1.0, 1.0, 1.0], [95, \"hsa01007\", \"Amino acid related enzymes\", \"  2\", 2.92279, 0.814062, 0.425616, 0.923099, 1.0, 1.0, 1.0], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  5\", 6.65599, 0.831462, 0.316397, 0.938744, 1.0, 1.0, 1.0], [152, \"hsa04054\", \"Pattern recognition receptors\", \"  1\", 1.73322, 0.832832, 0.477685, 0.938744, 1.0, 1.0, 1.0], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  4\", 5.49075, 0.842112, 0.323897, 0.94322, 1.0, 1.0, 1.0], [92, \"hsa01003\", \"Glycosyltransferases\", \" 12\", 14.81381, 0.842642, 0.246898, 0.94322, 1.0, 1.0, 1.0], [111, \"hsa03011\", \"Ribosome\", \"  1\", 1.83648, 0.844992, 0.449396, 0.94322, 1.0, 1.0, 1.0], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  8\", 10.44288, 0.852471, 0.252377, 0.944669, 1.0, 1.0, 1.0], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \" 10\", 13.03473, 0.854371, 0.231688, 0.944669, 1.0, 1.0, 1.0], [336, \"hsa05200\", \"Pathways in cancer\", \" 25\", 29.66749, 0.859591, 0.195178, 0.948616, 1.0, 1.0, 1.0], [288, \"hsa04971\", \"Gastric acid secretion\", \"  4\", 5.78696, 0.863671, 0.279597, 0.95125, 1.0, 1.0, 1.0], [131, \"hsa03310\", \"Nuclear receptors\", \"  2\", 3.3041, 0.869851, 0.332387, 0.955744, 1.0, 1.0, 1.0], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"  2\", 3.36212, 0.870381, 0.324937, 0.955744, 1.0, 1.0, 1.0], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"  1\", 1.77823, 0.870761, 0.436316, 0.955744, 1.0, 1.0, 1.0], [330, \"hsa05165\", \"Human papillomavirus infection\", \" 15\", 18.90965, 0.876061, 0.187978, 0.955744, 1.0, 1.0, 1.0], [205, \"hsa04510\", \"Focal adhesion\", \" 13\", 16.75254, 0.885041, 0.183938, 0.961939, 1.0, 1.0, 1.0], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  5\", 7.32653, 0.889171, 0.224568, 0.966095, 1.0, 1.0, 1.0], [173, \"hsa04136\", \"Autophagy - other\", \"  1\", 1.97564, 0.892301, 0.382246, 0.966802, 1.0, 1.0, 1.0], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  4\", 6.3177, 0.896591, 0.221908, 0.96955, 1.0, 1.0, 1.0], [112, \"hsa03012\", \"Translation factors\", \"  1\", 2.22693, 0.904131, 0.333477, 0.97607, 1.0, 1.0, 1.0], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"  1\", 2.18574, 0.905401, 0.336517, 0.97607, 1.0, 1.0, 1.0], [60, \"hsa00565\", \"Ether lipid metabolism\", \"  1\", 2.24656, 0.906381, 0.327067, 0.97607, 1.0, 1.0, 1.0], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"  1\", 2.27465, 0.907241, 0.322597, 0.97607, 1.0, 1.0, 1.0], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  9\", 12.45386, 0.907631, 0.166298, 0.97607, 1.0, 1.0, 1.0], [175, \"hsa04140\", \"Autophagy - animal\", \"  5\", 7.8076, 0.910581, 0.184818, 0.97607, 1.0, 1.0, 1.0], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"  1\", 2.18308, 0.911161, 0.335177, 0.97607, 1.0, 1.0, 1.0], [210, \"hsa04530\", \"Tight junction\", \"  8\", 11.35364, 0.911511, 0.163788, 0.97607, 1.0, 1.0, 1.0], [169, \"hsa04121\", \"Ubiquitin system\", \" 30\", 36.87095, 0.913571, 0.121249, 0.97607, 1.0, 1.0, 1.0], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  5\", 7.8252, 0.916531, 0.177508, 0.97607, 1.0, 1.0, 1.0], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \" 28\", 34.30453, 0.918391, 0.118729, 0.97607, 1.0, 1.0, 1.0], [167, \"hsa04115\", \"p53 signaling pathway\", \"  1\", 2.41998, 0.922061, 0.289807, 0.97607, 1.0, 1.0, 1.0], [260, \"hsa04916\", \"Melanogenesis\", \"  4\", 6.67259, 0.922131, 0.176678, 0.97607, 1.0, 1.0, 1.0], [185, \"hsa04210\", \"Apoptosis\", \"  3\", 5.4067, 0.925961, 0.187778, 0.97607, 1.0, 1.0, 1.0], [199, \"hsa04360\", \"Axon guidance\", \" 13\", 17.54294, 0.928981, 0.122649, 0.97607, 1.0, 1.0, 1.0], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"  2\", 3.88178, 0.929511, 0.216108, 0.97607, 1.0, 1.0, 1.0], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  3\", 5.40843, 0.929531, 0.182788, 0.97607, 1.0, 1.0, 1.0], [344, \"hsa05212\", \"Pancreatic cancer\", \"  2\", 4.21398, 0.936881, 0.188778, 0.97607, 1.0, 1.0, 1.0], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"  3\", 5.49236, 0.939041, 0.165328, 0.97607, 1.0, 1.0, 1.0], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"  1\", 2.4026, 0.939651, 0.272577, 0.97607, 1.0, 1.0, 1.0], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \"  9\", 13.5265, 0.942691, 0.107479, 0.97607, 1.0, 1.0, 1.0], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"  1\", 2.4446, 0.942741, 0.259937, 0.97607, 1.0, 1.0, 1.0], [342, \"hsa05210\", \"Colorectal cancer\", \"  3\", 5.63791, 0.948161, 0.148949, 0.97607, 1.0, 1.0, 1.0], [101, \"hsa01524\", \"Platinum drug resistance\", \"  1\", 2.79498, 0.949081, 0.213258, 0.97607, 1.0, 1.0, 1.0], [325, \"hsa05160\", \"Hepatitis C\", \"  3\", 6.04958, 0.95174, 0.129609, 0.97607, 1.0, 1.0, 1.0], [354, \"hsa05222\", \"Small cell lung cancer\", \"  3\", 5.98007, 0.95462, 0.126409, 0.97607, 1.0, 1.0, 1.0], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  4\", 7.46119, 0.9617, 0.101129, 0.97607, 1.0, 1.0, 1.0], [178, \"hsa04144\", \"Endocytosis\", \"  9\", 14.59548, 0.96873, 0.064329, 0.97607, 1.0, 1.0, 1.0], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"  1\", 3.26546, 0.96983, 0.143389, 0.97607, 1.0, 1.0, 1.0], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  4\", 8.076, 0.97952, 0.060719, 0.976288, 1.0, 1.0, 1.0], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  3\", 7.20151, 0.9863, 0.04954, 0.97926, 1.0, 1.0, 1.0], [174, \"hsa04137\", \"Mitophagy - animal\", \"  1\", 3.2304, 0.9871, 0.114939, 0.97926, 1.0, 1.0, 1.0], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"  1\", 4.06923, 0.98737, 0.072349, 0.97926, 1.0, 1.0, 1.0], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"  4\", 9.16165, 0.98762, 0.03666, 0.97926, 1.0, 1.0, 1.0], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  5\", 10.3956, 0.98778, 0.03521, 0.97926, 1.0, 1.0, 1.0], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"  1\", 4.28934, 0.99581, 0.03716, 0.97926, 1.0, 1.0, 1.0], [253, \"hsa04812\", \"Cytoskeleton proteins\", \" 16\", 28.58441, 0.99841, 0.00332, 0.97926, 0.273, 1.0, 1.0], [358, \"hsa05226\", \"Gastric cancer\", \"  2\", 8.36507, 0.99893, 0.00623, 0.97926, 0.27322, 1.0, 1.0], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"  0\", 0.37263, 1.0, 0.684553, 1.0, 1.0, 1.0, 1.0], [73, \"hsa00730\", \"Thiamine metabolism\", \"  0\", 1.16331, 1.0, 0.264487, 1.0, 1.0, 1.0, 1.0], [367, \"hsa05330\", \"Allograft rejection\", \"  0\", 0.58301, 1.0, 0.548305, 1.0, 1.0, 1.0, 1.0], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"  0\", 1.01087, 1.0, 0.331247, 1.0, 1.0, 1.0, 1.0], [118, \"hsa03020\", \"RNA polymerase\", \"  0\", 0.68527, 1.0, 0.493505, 1.0, 1.0, 1.0, 1.0], [128, \"hsa03051\", \"Proteasome\", \"  0\", 1.62798, 1.0, 0.186748, 1.0, 1.0, 1.0, 1.0], [368, \"hsa05332\", \"Graft-versus-host disease\", \"  0\", 0.59199, 1.0, 0.543125, 1.0, 1.0, 1.0, 1.0], [116, \"hsa03018\", \"RNA degradation\", \"  0\", 2.5651, 1.0, 0.067759, 1.0, 1.0, 1.0, 1.0], [72, \"hsa00670\", \"One carbon pool by folate\", \"  0\", 0.93889, 1.0, 0.368296, 1.0, 1.0, 1.0, 1.0], [127, \"hsa03050\", \"Proteasome\", \"  0\", 1.07485, 1.0, 0.330507, 1.0, 1.0, 1.0, 1.0], [17, \"hsa00220\", \"Arginine biosynthesis\", \"  0\", 0.6591, 1.0, 0.505815, 1.0, 1.0, 1.0, 1.0], [81, \"hsa00830\", \"Retinol metabolism\", \"  0\", 1.29001, 1.0, 0.265057, 1.0, 1.0, 1.0, 1.0], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"  0\", 2.81448, 1.0, 0.04672, 1.0, 1.0, 1.0, 1.0], [189, \"hsa04216\", \"Ferroptosis\", \"  0\", 1.34467, 1.0, 0.242658, 1.0, 1.0, 1.0, 1.0], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"  0\", 1.51145, 1.0, 0.161818, 1.0, 1.0, 1.0, 1.0], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"  0\", 1.062, 1.0, 0.330297, 1.0, 1.0, 1.0, 1.0], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"  0\", 1.17459, 1.0, 0.249578, 1.0, 1.0, 1.0, 1.0], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"  0\", 0.67733, 1.0, 0.474395, 1.0, 1.0, 1.0, 1.0], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"  0\", 3.29618, 1.0, 0.01219, 1.0, 0.453167, 1.0, 1.0], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"  0\", 0.7184, 1.0, 0.470115, 1.0, 1.0, 1.0, 1.0], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"  0\", 1.60276, 1.0, 0.136969, 1.0, 1.0, 1.0, 1.0], [105, \"hsa02044\", \"Secretion system\", \"  0\", 0.5366, 1.0, 0.578524, 1.0, 1.0, 1.0, 1.0], [11, \"hsa00100\", \"Steroid biosynthesis\", \"  0\", 0.42712, 1.0, 0.646754, 1.0, 1.0, 1.0, 1.0], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"  0\", 0.78674, 1.0, 0.441206, 1.0, 1.0, 1.0, 1.0], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"  0\", 2.87475, 1.0, 0.04483, 1.0, 1.0, 1.0, 1.0], [36, \"hsa00450\", \"Selenocompound metabolism\", \"  0\", 0.72687, 1.0, 0.471095, 1.0, 1.0, 1.0, 1.0], [94, \"hsa01006\", \"Prenyltransferases\", \"  0\", 0.73471, 1.0, 0.452195, 1.0, 1.0, 1.0, 1.0], [110, \"hsa03010\", \"Ribosome\", \"  0\", 1.21265, 1.0, 0.293047, 1.0, 1.0, 1.0, 1.0], [349, \"hsa05217\", \"Basal cell carcinoma\", \"  0\", 2.74442, 1.0, 0.052119, 1.0, 1.0, 1.0, 1.0], [235, \"hsa04710\", \"Circadian rhythm\", \"  0\", 1.96054, 1.0, 0.119539, 1.0, 1.0, 1.0, 1.0], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"  0\", 0.47023, 1.0, 0.601404, 1.0, 1.0, 1.0, 1.0], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"  0\", 0.84256, 1.0, 0.421866, 1.0, 1.0, 1.0, 1.0]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#e0adbda7-29d8-4d58-a34d-5d51ca001971').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#e0adbda7-29d8-4d58-a34d-5d51ca001971').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                                       FunctionName  \\\n",
       "153  hsa04060             Cytokine-cytokine receptor interaction   \n",
       "369  hsa05340                           Primary immunodeficiency   \n",
       "317  hsa05140                                      Leishmaniasis   \n",
       "150  hsa04050                                 Cytokine receptors   \n",
       "154  hsa04061  Viral protein interaction with cytokine and cy...   \n",
       "..        ...                                                ...   \n",
       "110  hsa03010                                           Ribosome   \n",
       "349  hsa05217                               Basal cell carcinoma   \n",
       "235  hsa04710                                   Circadian rhythm   \n",
       "34   hsa00430                 Taurine and hypotaurine metabolism   \n",
       "82   hsa00860               Porphyrin and chlorophyll metabolism   \n",
       "\n",
       "     n_candidates  mean_n_resample  emp_p_e   emp_p_d     fdr_e  fdr_d  \\\n",
       "153            22          6.45869  0.00001  1.000000  0.000000    1.0   \n",
       "369             6          0.73632  0.00006  0.999990  0.004335    1.0   \n",
       "317             8          2.00956  0.00040  0.999910  0.024233    1.0   \n",
       "150            10          3.50918  0.00227  0.999300  0.112488    1.0   \n",
       "154             6          1.48810  0.00355  0.999360  0.138956    1.0   \n",
       "..            ...              ...      ...       ...       ...    ...   \n",
       "110             0          1.21265  1.00000  0.293047  1.000000    1.0   \n",
       "349             0          2.74442  1.00000  0.052119  1.000000    1.0   \n",
       "235             0          1.96054  1.00000  0.119539  1.000000    1.0   \n",
       "34              0          0.47023  1.00000  0.601404  1.000000    1.0   \n",
       "82              0          0.84256  1.00000  0.421866  1.000000    1.0   \n",
       "\n",
       "     BH_fdr_e  BH_fdr_d  \n",
       "153  0.003600       1.0  \n",
       "369  0.010800       1.0  \n",
       "317  0.048000       1.0  \n",
       "150  0.204298       1.0  \n",
       "154  0.245312       1.0  \n",
       "..        ...       ...  \n",
       "110  1.000000       1.0  \n",
       "349  1.000000       1.0  \n",
       "235  1.000000       1.0  \n",
       "34   1.000000       1.0  \n",
       "82   1.000000       1.0  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "c_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "cbf35044",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"dfa9f3f6-0d67-45ee-acdf-6c70c70cfa7f\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[124, \"hsa03036\", \"Chromosome and associated proteins\", \" 84\", 57.93256, 0.00015, 0.99989, 0.02482, 1.0, 0.053999, 0.99989], [119, \"hsa03021\", \"Transcription machinery\", \" 21\", 10.08338, 0.00058, 0.9998, 0.050705, 1.0, 0.104399, 0.99989], [26, \"hsa00310\", \"Lysine degradation\", \"  9\", 3.03488, 0.00139, 0.99978, 0.088307, 1.0, 0.148499, 0.99989], [113, \"hsa03013\", \"RNA transport\", \" 11\", 3.97442, 0.00165, 0.99954, 0.088307, 1.0, 0.148499, 0.99989], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \" 12\", 4.99547, 0.00244, 0.99929, 0.092488, 1.0, 0.175678, 0.99989], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"  7\", 2.14057, 0.00381, 0.99927, 0.125705, 1.0, 0.224278, 0.99989], [351, \"hsa05219\", \"Bladder cancer\", \"  6\", 1.72141, 0.00481, 0.99916, 0.14178, 1.0, 0.224278, 0.99989], [100, \"hsa01523\", \"Antifolate resistance\", \"  4\", 0.84735, 0.00617, 0.99937, 0.156051, 1.0, 0.224278, 0.99989], [169, \"hsa04121\", \"Ubiquitin system\", \" 50\", 35.92201, 0.00788, 0.99536, 0.172527, 1.0, 0.224278, 0.99989], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \" 10\", 4.54371, 0.0096, 0.99703, 0.19029, 1.0, 0.224278, 0.99989], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"  8\", 3.24346, 0.00988, 0.99723, 0.19029, 1.0, 0.224278, 0.99989], [126, \"hsa03041\", \"Spliceosome\", \" 20\", 11.85053, 0.01021, 0.99482, 0.19029, 1.0, 0.224278, 0.99989], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \" 10\", 4.60804, 0.01044, 0.99706, 0.19029, 1.0, 0.224278, 0.99989], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \" 10\", 4.59615, 0.01063, 0.99657, 0.19029, 1.0, 0.224278, 0.99989], [16, \"hsa00199\", \"Cytochrome P450\", \"  5\", 1.41369, 0.01092, 0.99786, 0.19029, 1.0, 0.224278, 0.99989], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \" 22\", 13.46126, 0.01094, 0.99475, 0.19029, 1.0, 0.224278, 0.99989], [297, \"hsa05010\", \"Alzheimer disease\", \" 24\", 15.10518, 0.0112, 0.99459, 0.19029, 1.0, 0.224278, 0.99989], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  7\", 2.6623, 0.01263, 0.99678, 0.19029, 1.0, 0.224278, 0.99989], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  6\", 2.03202, 0.01285, 0.9971, 0.19029, 1.0, 0.224278, 0.99989], [28, \"hsa00340\", \"Histidine metabolism\", \"  3\", 0.51944, 0.01384, 0.99862, 0.19029, 1.0, 0.224278, 0.99989], [329, \"hsa05164\", \"Influenza A\", \" 11\", 5.33993, 0.01391, 0.99492, 0.19029, 1.0, 0.224278, 0.99989], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \" 12\", 6.17017, 0.01576, 0.99379, 0.19029, 1.0, 0.224278, 0.99989], [356, \"hsa05224\", \"Breast cancer\", \" 13\", 6.92302, 0.01637, 0.99335, 0.19029, 1.0, 0.224278, 0.99989], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \" 12\", 6.31518, 0.01697, 0.99379, 0.19029, 1.0, 0.224278, 0.99989], [327, \"hsa05162\", \"Measles\", \"  9\", 4.05661, 0.01698, 0.9944, 0.19029, 1.0, 0.224278, 0.99989], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"  6\", 2.23858, 0.01703, 0.99593, 0.19029, 1.0, 0.224278, 0.99989], [344, \"hsa05212\", \"Pancreatic cancer\", \"  9\", 4.15951, 0.01804, 0.99447, 0.19029, 1.0, 0.224278, 0.99989], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \" 16\", 8.90034, 0.01822, 0.99167, 0.19029, 1.0, 0.224278, 0.99989], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \" 19\", 11.78316, 0.01858, 0.99074, 0.19029, 1.0, 0.224278, 0.99989], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \" 12\", 6.1948, 0.01869, 0.99227, 0.19029, 1.0, 0.224278, 0.99989], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"  2\", 0.23086, 0.02022, 0.99893, 0.19029, 1.0, 0.230735, 0.99989], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"  5\", 1.58959, 0.02051, 0.99541, 0.19029, 1.0, 0.230735, 0.99989], [226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  8\", 3.59121, 0.02151, 0.99351, 0.19029, 1.0, 0.23188, 0.99989], [137, \"hsa03440\", \"Homologous recombination\", \"  5\", 1.65812, 0.0219, 0.99475, 0.19029, 1.0, 0.23188, 0.99989], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  9\", 4.47027, 0.02503, 0.99206, 0.19029, 1.0, 0.257449, 0.99989], [9, \"hsa00071\", \"Fatty acid degradation\", \"  4\", 1.18114, 0.02841, 0.99437, 0.19029, 1.0, 0.284097, 0.99989], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  7\", 3.19338, 0.03255, 0.98982, 0.19029, 1.0, 0.3167, 0.99989], [111, \"hsa03011\", \"Ribosome\", \"  5\", 1.84986, 0.03765, 0.98918, 0.220377, 1.0, 0.356681, 0.99989], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  7\", 3.33339, 0.03968, 0.98719, 0.223474, 1.0, 0.360986, 0.99989], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \" 23\", 15.78536, 0.04011, 0.97669, 0.223474, 1.0, 0.360986, 0.99989], [210, \"hsa04530\", \"Tight junction\", \" 17\", 11.42921, 0.04522, 0.97787, 0.241223, 1.0, 0.381674, 0.99989], [312, \"hsa05131\", \"Shigellosis\", \" 18\", 12.14565, 0.04663, 0.97472, 0.241223, 1.0, 0.381674, 0.99989], [317, \"hsa05140\", \"Leishmaniasis\", \"  5\", 2.04237, 0.04684, 0.98709, 0.241223, 1.0, 0.381674, 0.99989], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  7\", 3.43913, 0.04772, 0.98383, 0.241223, 1.0, 0.381674, 0.99989], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \" 10\", 5.62292, 0.04871, 0.9789, 0.241223, 1.0, 0.381674, 0.99989], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \" 19\", 12.78132, 0.04877, 0.97288, 0.241223, 1.0, 0.381674, 0.99989], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  7\", 3.58497, 0.054709, 0.98123, 0.25651, 1.0, 0.416546, 0.99989], [99, \"hsa01522\", \"Endocrine resistance\", \" 10\", 5.89931, 0.055539, 0.97658, 0.25651, 1.0, 0.416546, 0.99989], [123, \"hsa03032\", \"DNA replication proteins\", \"  7\", 3.54622, 0.060999, 0.97691, 0.275457, 1.0, 0.448159, 0.99989], [95, \"hsa01007\", \"Amino acid related enzymes\", \"  6\", 2.99756, 0.064849, 0.97808, 0.288541, 1.0, 0.466915, 0.99989], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"  3\", 0.95561, 0.067879, 0.98616, 0.298262, 1.0, 0.479148, 0.99989], [31, \"hsa00380\", \"Tryptophan metabolism\", \"  4\", 1.61418, 0.071709, 0.98205, 0.309148, 1.0, 0.488848, 0.99989], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"  3\", 0.98378, 0.071969, 0.98481, 0.309148, 1.0, 0.488848, 0.99989], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"  3\", 0.99541, 0.075489, 0.98419, 0.321075, 1.0, 0.503262, 0.99989], [148, \"hsa04031\", \"GTP-binding proteins\", \" 11\", 6.94921, 0.077939, 0.96234, 0.329129, 1.0, 0.510148, 0.99989], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"  4\", 1.69574, 0.081929, 0.97769, 0.337572, 1.0, 0.526688, 0.99989], [316, \"hsa05135\", \"Yersinia infection\", \" 11\", 7.14227, 0.085949, 0.95883, 0.354907, 1.0, 0.533023, 0.99989], [278, \"hsa04934\", \"Cushing syndrome\", \" 14\", 9.68703, 0.086719, 0.95394, 0.354907, 1.0, 0.533023, 0.99989], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  7\", 3.98233, 0.088979, 0.9652, 0.354907, 1.0, 0.533023, 0.99989], [315, \"hsa05134\", \"Legionellosis\", \"  3\", 1.06791, 0.089179, 0.97976, 0.354907, 1.0, 0.533023, 0.99989], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"  4\", 1.90272, 0.090849, 0.97875, 0.354907, 1.0, 0.533023, 0.99989], [191, \"hsa04218\", \"Cellular senescence\", \" 11\", 7.16534, 0.092759, 0.95331, 0.356446, 1.0, 0.533023, 0.99989], [349, \"hsa05217\", \"Basal cell carcinoma\", \"  5\", 2.48335, 0.093279, 0.96954, 0.356446, 1.0, 0.533023, 0.99989], [367, \"hsa05330\", \"Allograft rejection\", \"  2\", 0.53088, 0.097909, 0.98462, 0.365947, 1.0, 0.550738, 0.99989], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  8\", 4.83277, 0.100159, 0.9556, 0.365947, 1.0, 0.554727, 0.99989], [110, \"hsa03010\", \"Ribosome\", \"  3\", 1.17269, 0.112229, 0.97061, 0.401994, 1.0, 0.612158, 0.99989], [313, \"hsa05132\", \"Salmonella infection\", \" 13\", 9.11898, 0.114589, 0.936581, 0.406707, 1.0, 0.615701, 0.99989], [125, \"hsa03040\", \"Spliceosome\", \"  5\", 2.60045, 0.117529, 0.95551, 0.411981, 1.0, 0.619245, 0.99989], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \" 13\", 9.17997, 0.119499, 0.933321, 0.411981, 1.0, 0.619245, 0.99989], [300, \"hsa05016\", \"Huntington disease\", \" 16\", 11.81175, 0.120409, 0.928631, 0.411981, 1.0, 0.619245, 0.99989], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \" 10\", 6.65743, 0.122929, 0.935871, 0.412811, 1.0, 0.623301, 0.99989], [135, \"hsa03420\", \"Nucleotide excision repair\", \"  3\", 1.25831, 0.126989, 0.96784, 0.417499, 1.0, 0.634944, 0.99989], [320, \"hsa05144\", \"Malaria\", \"  3\", 1.2793, 0.131349, 0.9665, 0.424626, 1.0, 0.647747, 0.99989], [321, \"hsa05145\", \"Toxoplasmosis\", \"  8\", 5.23065, 0.138319, 0.934861, 0.441985, 1.0, 0.672901, 0.99989], [112, \"hsa03012\", \"Translation factors\", \"  4\", 2.04047, 0.140309, 0.95146, 0.443161, 1.0, 0.673481, 0.99989], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \" 12\", 8.73141, 0.151138, 0.915451, 0.479283, 1.0, 0.711504, 0.99989], [185, \"hsa04210\", \"Apoptosis\", \"  8\", 5.35434, 0.153808, 0.925511, 0.48371, 1.0, 0.711504, 0.99989], [182, \"hsa04150\", \"mTOR signaling pathway\", \" 11\", 7.90133, 0.155008, 0.915111, 0.48371, 1.0, 0.711504, 0.99989], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \" 13\", 9.70788, 0.158438, 0.908201, 0.495982, 1.0, 0.711504, 0.99989], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \" 13\", 9.70111, 0.159108, 0.907751, 0.495982, 1.0, 0.711504, 0.99989], [107, \"hsa03000\", \"Transcription factors\", \" 44\", 38.06259, 0.160088, 0.878781, 0.495982, 1.0, 0.711504, 0.99989], [340, \"hsa05205\", \"Proteoglycans in cancer\", \" 17\", 13.3926, 0.162788, 0.898801, 0.495982, 1.0, 0.712099, 0.99989], [165, \"hsa04110\", \"Cell cycle\", \"  7\", 4.56054, 0.164178, 0.921591, 0.495982, 1.0, 0.712099, 0.99989], [369, \"hsa05340\", \"Primary immunodeficiency\", \"  2\", 0.74416, 0.167958, 0.9654, 0.495982, 1.0, 0.719821, 0.99989], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \" 11\", 8.03915, 0.172248, 0.903261, 0.500613, 1.0, 0.729522, 0.99989], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  8\", 5.68396, 0.181388, 0.913941, 0.514768, 1.0, 0.759299, 0.99989], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"  4\", 2.32164, 0.191698, 0.930051, 0.539211, 1.0, 0.773265, 0.99989], [338, \"hsa05203\", \"Viral carcinogenesis\", \" 10\", 7.38083, 0.192008, 0.892611, 0.539211, 1.0, 0.773265, 0.99989], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  9\", 6.50514, 0.194018, 0.893871, 0.539211, 1.0, 0.773265, 0.99989], [90, \"hsa01001\", \"Protein kinases\", \" 45\", 39.97501, 0.199408, 0.846852, 0.539211, 1.0, 0.773265, 0.99989], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  8\", 5.68799, 0.199608, 0.894991, 0.539211, 1.0, 0.773265, 0.99989], [68, \"hsa00620\", \"Pyruvate metabolism\", \"  3\", 1.56806, 0.200248, 0.938591, 0.539211, 1.0, 0.773265, 0.99989], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"  4\", 2.41499, 0.201728, 0.927281, 0.539211, 1.0, 0.773265, 0.99989], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"  6\", 4.00335, 0.201908, 0.904751, 0.539211, 1.0, 0.773265, 0.99989], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \" 12\", 9.24357, 0.206048, 0.875631, 0.539211, 1.0, 0.780813, 0.99989], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"  4\", 2.38138, 0.208548, 0.921141, 0.539211, 1.0, 0.782055, 0.99989], [275, \"hsa04931\", \"Insulin resistance\", \"  8\", 5.86363, 0.218488, 0.884971, 0.559805, 1.0, 0.809367, 0.99989], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  9\", 6.72098, 0.220328, 0.877231, 0.559805, 1.0, 0.809367, 0.99989], [128, \"hsa03051\", \"Proteasome\", \"  3\", 1.64069, 0.224748, 0.922061, 0.563695, 1.0, 0.817265, 0.99989], [122, \"hsa03030\", \"DNA replication\", \"  2\", 0.90809, 0.228038, 0.943311, 0.567119, 1.0, 0.820936, 0.99989], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"  4\", 2.48633, 0.232918, 0.903351, 0.577917, 1.0, 0.830202, 0.99989], [314, \"hsa05133\", \"Pertussis\", \"  3\", 1.69914, 0.238358, 0.916701, 0.584595, 1.0, 0.837848, 0.99989], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  8\", 6.00319, 0.239718, 0.868751, 0.584595, 1.0, 0.837848, 0.99989], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  9\", 6.9336, 0.242278, 0.863071, 0.584595, 1.0, 0.838653, 0.99989], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"  4\", 2.5399, 0.246958, 0.891571, 0.586691, 1.0, 0.846712, 0.99989], [127, \"hsa03050\", \"Proteasome\", \"  2\", 0.96352, 0.250067, 0.931731, 0.591452, 1.0, 0.849286, 0.99989], [179, \"hsa04145\", \"Phagosome\", \"  6\", 4.29518, 0.254977, 0.866311, 0.594861, 1.0, 0.855291, 0.99989], [178, \"hsa04144\", \"Endocytosis\", \" 17\", 14.3532, 0.256587, 0.825622, 0.594861, 1.0, 0.855291, 0.99989], [140, \"hsa04010\", \"MAPK signaling pathway\", \" 23\", 20.08551, 0.261697, 0.812262, 0.604103, 1.0, 0.863116, 0.99989], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"  2\", 1.0068, 0.265237, 0.927331, 0.607518, 1.0, 0.863116, 0.99989], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"  2\", 1.01044, 0.266127, 0.928271, 0.607518, 1.0, 0.863116, 0.99989], [358, \"hsa05226\", \"Gastric cancer\", \" 10\", 8.05839, 0.278547, 0.828622, 0.627793, 1.0, 0.89533, 0.99989], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"  3\", 1.86615, 0.285357, 0.886511, 0.646435, 1.0, 0.907611, 0.99989], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"  2\", 1.07145, 0.289007, 0.923791, 0.653412, 1.0, 0.907611, 0.99989], [203, \"hsa04390\", \"Hippo signaling pathway\", \" 12\", 10.06987, 0.293017, 0.812902, 0.659985, 1.0, 0.907611, 0.99989], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"  2\", 1.08442, 0.296287, 0.912821, 0.664489, 1.0, 0.907611, 0.99989], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  7\", 5.47214, 0.296557, 0.836682, 0.664489, 1.0, 0.907611, 0.99989], [292, \"hsa04975\", \"Fat digestion and absorption\", \"  2\", 1.09016, 0.299717, 0.908091, 0.664489, 1.0, 0.907611, 0.99989], [200, \"hsa04370\", \"VEGF signaling pathway\", \"  5\", 3.70034, 0.302357, 0.855411, 0.664489, 1.0, 0.907611, 0.99989], [101, \"hsa01524\", \"Platinum drug resistance\", \"  4\", 2.79239, 0.302537, 0.862941, 0.664489, 1.0, 0.907611, 0.99989], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"  1\", 0.35299, 0.307627, 0.95777, 0.669268, 1.0, 0.915254, 0.99989], [177, \"hsa04142\", \"Lysosome\", \"  6\", 4.64881, 0.313627, 0.829182, 0.675, 1.0, 0.916277, 0.99989], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  8\", 6.50718, 0.318177, 0.813802, 0.679847, 1.0, 0.916277, 0.99989], [8, \"hsa00062\", \"Fatty acid elongation\", \"  2\", 1.1454, 0.319217, 0.902211, 0.679847, 1.0, 0.916277, 0.99989], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  6\", 4.65723, 0.320007, 0.821912, 0.679847, 1.0, 0.916277, 0.99989], [232, \"hsa04668\", \"TNF signaling pathway\", \"  6\", 4.66844, 0.320697, 0.822892, 0.679847, 1.0, 0.916277, 0.99989], [324, \"hsa05152\", \"Tuberculosis\", \"  7\", 5.78175, 0.355226, 0.784702, 0.728259, 1.0, 0.993972, 0.99989], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"  2\", 1.24152, 0.356826, 0.884201, 0.728259, 1.0, 0.993972, 0.99989], [298, \"hsa05012\", \"Parkinson disease\", \" 10\", 8.68188, 0.359856, 0.768542, 0.728259, 1.0, 0.993972, 0.99989], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"  2\", 1.24901, 0.360216, 0.887791, 0.728259, 1.0, 0.993972, 0.99989], [174, \"hsa04137\", \"Mitophagy - animal\", \"  4\", 3.11185, 0.363746, 0.835852, 0.728259, 1.0, 0.993972, 0.99989], [235, \"hsa04710\", \"Circadian rhythm\", \"  3\", 2.14534, 0.364456, 0.846732, 0.728259, 1.0, 0.993972, 0.99989], [325, \"hsa05160\", \"Hepatitis C\", \"  7\", 5.914, 0.378646, 0.766502, 0.759307, 1.0, 1.0, 0.99989], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"  2\", 1.31425, 0.383036, 0.862521, 0.761051, 1.0, 1.0, 0.99989], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \" 15\", 13.61867, 0.383406, 0.723103, 0.761051, 1.0, 1.0, 0.99989], [167, \"hsa04115\", \"p53 signaling pathway\", \"  3\", 2.22488, 0.384366, 0.822142, 0.761051, 1.0, 1.0, 0.99989], [326, \"hsa05161\", \"Hepatitis B\", \"  8\", 6.91717, 0.387036, 0.754062, 0.761051, 1.0, 1.0, 0.99989], [347, \"hsa05215\", \"Prostate cancer\", \"  7\", 5.99303, 0.390656, 0.760852, 0.761051, 1.0, 1.0, 0.99989], [181, \"hsa04147\", \"Exosome\", \" 36\", 34.12766, 0.391616, 0.678113, 0.761051, 1.0, 1.0, 0.99989], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  7\", 6.00568, 0.391826, 0.760842, 0.761051, 1.0, 1.0, 0.99989], [11, \"hsa00100\", \"Steroid biosynthesis\", \"  1\", 0.49169, 0.397056, 0.917111, 0.761051, 1.0, 1.0, 0.99989], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \" 16\", 14.74643, 0.397226, 0.714733, 0.761051, 1.0, 1.0, 0.99989], [189, \"hsa04216\", \"Ferroptosis\", \"  2\", 1.35045, 0.397676, 0.854681, 0.761051, 1.0, 1.0, 0.99989], [120, \"hsa03022\", \"Basal transcription factors\", \"  2\", 1.3702, 0.403766, 0.850111, 0.761051, 1.0, 1.0, 0.99989], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  7\", 6.08987, 0.407506, 0.751752, 0.761051, 1.0, 1.0, 0.99989], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  7\", 6.11112, 0.410966, 0.741513, 0.761051, 1.0, 1.0, 0.99989], [368, \"hsa05332\", \"Graft-versus-host disease\", \"  1\", 0.52458, 0.411406, 0.903521, 0.761051, 1.0, 1.0, 0.99989], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \"  7\", 6.21471, 0.427316, 0.726703, 0.774658, 1.0, 1.0, 0.99989], [42, \"hsa00511\", \"Other glycan degradation\", \"  1\", 0.5364, 0.428696, 0.906281, 0.775912, 1.0, 1.0, 0.99989], [296, \"hsa04979\", \"Cholesterol metabolism\", \"  3\", 2.39074, 0.434226, 0.795462, 0.782918, 1.0, 1.0, 0.99989], [209, \"hsa04520\", \"Adherens junction\", \"  8\", 7.22373, 0.434986, 0.727643, 0.782918, 1.0, 1.0, 0.99989], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"  4\", 3.35459, 0.438786, 0.764072, 0.782918, 1.0, 1.0, 0.99989], [134, \"hsa03410\", \"Base excision repair\", \"  1\", 0.56762, 0.439266, 0.891811, 0.782918, 1.0, 1.0, 0.99989], [105, \"hsa02044\", \"Secretion system\", \"  1\", 0.57089, 0.443296, 0.891021, 0.782918, 1.0, 1.0, 0.99989], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  6\", 5.33362, 0.446006, 0.724243, 0.782918, 1.0, 1.0, 0.99989], [237, \"hsa04714\", \"Thermogenesis\", \" 10\", 9.33838, 0.458835, 0.680173, 0.789197, 1.0, 1.0, 0.99989], [342, \"hsa05210\", \"Colorectal cancer\", \"  6\", 5.45122, 0.465265, 0.711793, 0.796172, 1.0, 1.0, 0.99989], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"  1\", 0.55588, 0.466825, 0.917611, 0.796172, 1.0, 1.0, 0.99989], [249, \"hsa04742\", \"Taste transduction\", \"  5\", 4.47536, 0.472845, 0.724833, 0.800155, 1.0, 1.0, 0.99989], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  7\", 6.50163, 0.480455, 0.680353, 0.81687, 1.0, 1.0, 0.99989], [330, \"hsa05165\", \"Human papillomavirus infection\", \" 19\", 18.45758, 0.483355, 0.618074, 0.81687, 1.0, 1.0, 0.99989], [17, \"hsa00220\", \"Arginine biosynthesis\", \"  1\", 0.64392, 0.489765, 0.869221, 0.82265, 1.0, 1.0, 0.99989], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"  1\", 0.65298, 0.503985, 0.872181, 0.839805, 1.0, 1.0, 0.99989], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  7\", 6.62596, 0.504075, 0.664883, 0.839805, 1.0, 1.0, 0.99989], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"  1\", 0.68369, 0.504175, 0.853281, 0.839805, 1.0, 1.0, 0.99989], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  9\", 8.63891, 0.505255, 0.643224, 0.839805, 1.0, 1.0, 0.99989], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  6\", 5.64286, 0.510095, 0.675793, 0.842934, 1.0, 1.0, 0.99989], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"  1\", 0.6937, 0.512775, 0.851311, 0.846875, 1.0, 1.0, 0.99989], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \" 11\", 10.68606, 0.513055, 0.625964, 0.846875, 1.0, 1.0, 0.99989], [153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  7\", 6.7276, 0.514335, 0.640324, 0.846875, 1.0, 1.0, 0.99989], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"  1\", 0.6863, 0.517175, 0.856621, 0.847113, 1.0, 1.0, 0.99989], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"  1\", 0.70998, 0.517405, 0.844092, 0.847113, 1.0, 1.0, 0.99989], [345, \"hsa05213\", \"Endometrial cancer\", \"  4\", 3.70113, 0.519025, 0.699013, 0.847113, 1.0, 1.0, 0.99989], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \"  8\", 7.73167, 0.519945, 0.636204, 0.847113, 1.0, 1.0, 0.99989], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  9\", 8.76154, 0.524065, 0.625974, 0.847113, 1.0, 1.0, 0.99989], [53, \"hsa00535\", \"Proteoglycans\", \"  5\", 4.73589, 0.537555, 0.693543, 0.866678, 1.0, 1.0, 0.99989], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"  3\", 2.84332, 0.557044, 0.686833, 0.888297, 1.0, 1.0, 0.99989], [94, \"hsa01006\", \"Prenyltransferases\", \"  1\", 0.76295, 0.559274, 0.830672, 0.888297, 1.0, 1.0, 0.99989], [336, \"hsa05200\", \"Pathways in cancer\", \" 29\", 29.35584, 0.562974, 0.520775, 0.888297, 1.0, 1.0, 0.99989], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"  2\", 1.86996, 0.569204, 0.714323, 0.89359, 1.0, 1.0, 0.99989], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  6\", 5.90782, 0.570944, 0.634384, 0.894046, 1.0, 1.0, 0.99989], [211, \"hsa04540\", \"Gap junction\", \"  8\", 8.031, 0.574624, 0.594024, 0.895122, 1.0, 1.0, 0.99989], [138, \"hsa03450\", \"Non-homologous end-joining\", \"  1\", 0.80297, 0.577184, 0.815892, 0.895122, 1.0, 1.0, 0.99989], [36, \"hsa00450\", \"Selenocompound metabolism\", \"  1\", 0.82666, 0.578814, 0.801242, 0.895122, 1.0, 1.0, 0.99989], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  7\", 7.12524, 0.584664, 0.579824, 0.895122, 1.0, 1.0, 0.99989], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"  3\", 2.97088, 0.591414, 0.656723, 0.901549, 1.0, 1.0, 0.99989], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"  4\", 4.02313, 0.593924, 0.625594, 0.901549, 1.0, 1.0, 0.99989], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  8\", 8.17326, 0.597404, 0.571174, 0.901549, 1.0, 1.0, 0.99989], [196, \"hsa04330\", \"Notch signaling pathway\", \"  2\", 1.98226, 0.607654, 0.683163, 0.914247, 1.0, 1.0, 0.99989], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"  1\", 0.89385, 0.609864, 0.777922, 0.914247, 1.0, 1.0, 0.99989], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  7\", 7.25103, 0.613874, 0.556574, 0.917926, 1.0, 1.0, 0.99989], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"  1\", 0.92183, 0.617674, 0.765722, 0.923202, 1.0, 1.0, 0.99989], [354, \"hsa05222\", \"Small cell lung cancer\", \"  6\", 6.29242, 0.623224, 0.554634, 0.927613, 1.0, 1.0, 0.99989], [260, \"hsa04916\", \"Melanogenesis\", \"  6\", 6.30922, 0.624344, 0.552304, 0.927613, 1.0, 1.0, 0.99989], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"  2\", 2.04318, 0.624884, 0.664463, 0.927613, 1.0, 1.0, 0.99989], [373, \"hsa05416\", \"Viral myocarditis\", \"  3\", 3.07969, 0.626784, 0.632474, 0.927613, 1.0, 1.0, 0.99989], [155, \"hsa04062\", \"Chemokine signaling pathway\", \" 10\", 10.53104, 0.629864, 0.510575, 0.927613, 1.0, 1.0, 0.99989], [350, \"hsa05218\", \"Melanoma\", \"  4\", 4.22416, 0.630674, 0.583464, 0.927613, 1.0, 1.0, 0.99989], [29, \"hsa00350\", \"Tyrosine metabolism\", \"  1\", 0.95608, 0.633084, 0.752842, 0.927613, 1.0, 1.0, 0.99989], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"  3\", 3.20036, 0.638014, 0.601454, 0.927613, 1.0, 1.0, 0.99989], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"  1\", 1.01797, 0.640754, 0.729693, 0.927613, 1.0, 1.0, 0.99989], [253, \"hsa04812\", \"Cytoskeleton proteins\", \" 27\", 28.3092, 0.641904, 0.439606, 0.927613, 0.921782, 1.0, 0.99989], [151, \"hsa04052\", \"Cytokines and growth factors\", \"  7\", 7.46083, 0.645174, 0.525735, 0.927613, 1.0, 1.0, 0.99989], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  5\", 5.40421, 0.649734, 0.538295, 0.927613, 1.0, 1.0, 0.99989], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"  1\", 0.96133, 0.649764, 0.754612, 0.927613, 1.0, 1.0, 0.99989], [215, \"hsa04612\", \"Antigen processing and presentation\", \"  1\", 1.04005, 0.650763, 0.720773, 0.927613, 1.0, 1.0, 0.99989], [5, \"hsa00052\", \"Galactose metabolism\", \"  1\", 1.02242, 0.653353, 0.728393, 0.927613, 1.0, 1.0, 0.99989], [72, \"hsa00670\", \"One carbon pool by folate\", \"  1\", 0.98813, 0.655153, 0.742343, 0.927613, 1.0, 1.0, 0.99989], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"  1\", 1.03923, 0.663693, 0.722323, 0.93264, 1.0, 1.0, 0.99989], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  9\", 9.73588, 0.670433, 0.478425, 0.945165, 0.955513, 1.0, 0.99989], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"  1\", 1.09858, 0.672543, 0.699533, 0.945165, 1.0, 1.0, 0.99989], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"  1\", 1.04275, 0.676383, 0.722343, 0.947269, 1.0, 1.0, 0.99989], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"  2\", 2.29881, 0.689493, 0.592404, 0.957717, 1.0, 1.0, 0.99989], [80, \"hsa00790\", \"Folate biosynthesis\", \"  1\", 1.05138, 0.695033, 0.722393, 0.967204, 1.0, 1.0, 0.99989], [60, \"hsa00565\", \"Ether lipid metabolism\", \"  2\", 2.34885, 0.698623, 0.578644, 0.971666, 1.0, 1.0, 0.99989], [71, \"hsa00650\", \"Butanoate metabolism\", \"  1\", 1.14433, 0.698873, 0.682563, 0.971666, 1.0, 1.0, 0.99989], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"  2\", 2.28389, 0.702843, 0.599694, 0.973164, 1.0, 1.0, 0.99989], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \"  8\", 8.96537, 0.723343, 0.435796, 0.992755, 0.921782, 1.0, 0.99989], [268, \"hsa04924\", \"Renin secretion\", \"  5\", 5.85935, 0.734893, 0.448826, 1.0, 0.921782, 1.0, 0.99989], [245, \"hsa04727\", \"GABAergic synapse\", \"  7\", 8.13337, 0.739823, 0.411176, 1.0, 0.875354, 1.0, 0.99989], [343, \"hsa05211\", \"Renal cell carcinoma\", \"  3\", 3.75975, 0.745673, 0.470945, 1.0, 0.955513, 1.0, 0.99989], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  9\", 10.44752, 0.747103, 0.382386, 1.0, 0.851227, 1.0, 0.99989], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"  1\", 1.17946, 0.749213, 0.671393, 1.0, 1.0, 1.0, 0.99989], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"  1\", 1.3544, 0.752472, 0.606434, 1.0, 1.0, 1.0, 0.99989], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \" 11\", 12.65058, 0.753162, 0.364036, 1.0, 0.831052, 1.0, 0.99989], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"  4\", 4.93772, 0.753272, 0.435786, 1.0, 0.921782, 1.0, 0.99989], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"  1\", 1.37658, 0.760142, 0.595184, 1.0, 1.0, 1.0, 0.99989], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \"  7\", 8.35261, 0.770812, 0.374676, 1.0, 0.842267, 1.0, 0.99989], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  7\", 8.51319, 0.772882, 0.362826, 1.0, 0.83074, 1.0, 0.99989], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  5\", 6.23839, 0.777852, 0.386006, 1.0, 0.85442, 1.0, 0.99989], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  4\", 5.21938, 0.779902, 0.391026, 1.0, 0.85442, 1.0, 0.99989], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"  1\", 1.31485, 0.784282, 0.620564, 1.0, 1.0, 1.0, 0.99989], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  6\", 7.44181, 0.791142, 0.357376, 1.0, 0.821614, 1.0, 0.99989], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"  1\", 1.5569, 0.795112, 0.535135, 1.0, 1.0, 1.0, 0.99989], [341, \"hsa05206\", \"MicroRNAs in cancer\", \"  9\", 10.93242, 0.796742, 0.321297, 1.0, 0.759447, 1.0, 0.99989], [175, \"hsa04140\", \"Autophagy - animal\", \"  6\", 7.60802, 0.796752, 0.342357, 1.0, 0.775629, 1.0, 0.99989], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \" 10\", 11.93718, 0.797812, 0.318697, 1.0, 0.759447, 1.0, 0.99989], [190, \"hsa04217\", \"Necroptosis\", \"  3\", 4.14745, 0.799442, 0.393286, 1.0, 0.85442, 1.0, 0.99989], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  4\", 5.24307, 0.801012, 0.376096, 1.0, 0.84447, 1.0, 0.99989], [180, \"hsa04146\", \"Peroxisome\", \"  2\", 2.9331, 0.806182, 0.427506, 1.0, 0.905742, 1.0, 0.99989], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  8\", 9.69519, 0.809232, 0.324077, 1.0, 0.761544, 1.0, 0.99989], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"  1\", 1.51271, 0.813012, 0.540585, 1.0, 1.0, 1.0, 0.99989], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"  3\", 4.09001, 0.816652, 0.388656, 1.0, 0.85442, 1.0, 0.99989], [346, \"hsa05214\", \"Glioma\", \"  4\", 5.43745, 0.830332, 0.335077, 1.0, 0.766467, 1.0, 0.99989], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  5\", 6.66867, 0.830612, 0.313837, 1.0, 0.759447, 1.0, 0.99989], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"  4\", 5.44733, 0.833332, 0.333097, 1.0, 0.76573, 1.0, 0.99989], [348, \"hsa05216\", \"Thyroid cancer\", \"  1\", 1.72332, 0.837612, 0.476475, 1.0, 0.955513, 1.0, 0.99989], [247, \"hsa04730\", \"Long-term depression\", \"  6\", 7.7791, 0.839642, 0.296117, 1.0, 0.716288, 1.0, 0.99989], [289, \"hsa04972\", \"Pancreatic secretion\", \"  5\", 6.71031, 0.842392, 0.302977, 1.0, 0.742854, 1.0, 0.99989], [142, \"hsa04014\", \"Ras signaling pathway\", \" 13\", 16.22717, 0.853641, 0.226028, 1.0, 0.569494, 1.0, 0.99989], [293, \"hsa04976\", \"Bile secretion\", \"  3\", 4.56821, 0.860411, 0.305327, 1.0, 0.747182, 1.0, 0.99989], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  6\", 8.1762, 0.861141, 0.256317, 1.0, 0.639344, 1.0, 0.99989], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"  2\", 3.2772, 0.866631, 0.338377, 1.0, 0.775629, 1.0, 0.99989], [303, \"hsa05030\", \"Cocaine addiction\", \"  2\", 3.2915, 0.872641, 0.332687, 1.0, 0.76573, 1.0, 0.99989], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"  1\", 1.8169, 0.874291, 0.437266, 1.0, 0.921782, 1.0, 0.99989], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \" 29\", 33.99745, 0.874881, 0.175118, 1.0, 0.502219, 1.0, 0.97894], [131, \"hsa03310\", \"Nuclear receptors\", \"  2\", 3.32742, 0.875081, 0.326757, 1.0, 0.761544, 1.0, 0.99989], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  3\", 4.76017, 0.883761, 0.269447, 1.0, 0.683927, 1.0, 0.99989], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \"  8\", 11.06686, 0.896541, 0.187588, 1.0, 0.515503, 1.0, 0.97894], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  5\", 7.39595, 0.898001, 0.211878, 1.0, 0.545539, 1.0, 0.99989], [173, \"hsa04136\", \"Autophagy - other\", \"  1\", 2.02205, 0.899561, 0.367486, 1.0, 0.834944, 1.0, 0.99989], [166, \"hsa04114\", \"Oocyte meiosis\", \"  4\", 6.35698, 0.903631, 0.211568, 1.0, 0.545539, 1.0, 0.99989], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"  2\", 3.53651, 0.905251, 0.273197, 1.0, 0.683927, 1.0, 0.99989], [238, \"hsa04720\", \"Long-term potentiation\", \"  5\", 7.42747, 0.905291, 0.202898, 1.0, 0.532225, 1.0, 0.99989], [70, \"hsa00640\", \"Propanoate metabolism\", \"  1\", 2.1805, 0.914131, 0.329897, 1.0, 0.76573, 1.0, 0.99989], [205, \"hsa04510\", \"Focal adhesion\", \" 13\", 17.35403, 0.914251, 0.143699, 1.0, 0.430125, 1.0, 0.876805], [214, \"hsa04611\", \"Platelet activation\", \"  6\", 9.20183, 0.926961, 0.151558, 1.0, 0.446501, 1.0, 0.909351], [307, \"hsa05034\", \"Alcoholism\", \"  4\", 6.7598, 0.929331, 0.164078, 1.0, 0.477082, 1.0, 0.952713], [273, \"hsa04929\", \"GnRH secretion\", \"  4\", 6.62909, 0.934541, 0.161788, 1.0, 0.477082, 1.0, 0.952713], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  8\", 11.81425, 0.934711, 0.128979, 1.0, 0.399075, 1.0, 0.800558], [201, \"hsa04371\", \"Apelin signaling pathway\", \"  7\", 10.66717, 0.938211, 0.126839, 1.0, 0.399075, 1.0, 0.800558], [306, \"hsa05033\", \"Nicotine addiction\", \"  2\", 4.09033, 0.938391, 0.190738, 1.0, 0.515503, 1.0, 0.97894], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"  1\", 2.69198, 0.938811, 0.241178, 1.0, 0.588084, 1.0, 0.99989], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  7\", 10.61028, 0.938821, 0.126609, 1.0, 0.399075, 1.0, 0.800558], [319, \"hsa05143\", \"African trypanosomiasis\", \"  1\", 2.35207, 0.939341, 0.270467, 1.0, 0.683927, 1.0, 0.99989], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"  1\", 2.75921, 0.943431, 0.225928, 1.0, 0.569494, 1.0, 0.99989], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"  1\", 2.64616, 0.946271, 0.229748, 1.0, 0.571019, 1.0, 0.99989], [146, \"hsa04024\", \"cAMP signaling pathway\", \" 11\", 15.90401, 0.947871, 0.096069, 1.0, 0.329737, 1.0, 0.751845], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \"  6\", 9.61589, 0.948671, 0.113999, 1.0, 0.365211, 1.0, 0.800558], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \"  6\", 9.4392, 0.949821, 0.115759, 1.0, 0.366235, 1.0, 0.800558], [288, \"hsa04971\", \"Gastric acid secretion\", \"  3\", 5.87722, 0.95596, 0.126339, 1.0, 0.399075, 1.0, 0.800558], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  5\", 8.69184, 0.95736, 0.101099, 1.0, 0.338275, 1.0, 0.774375], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"  1\", 2.92824, 0.96172, 0.176908, 1.0, 0.502219, 1.0, 0.97894], [304, \"hsa05031\", \"Amphetamine addiction\", \"  3\", 5.93922, 0.9622, 0.112569, 1.0, 0.364694, 1.0, 0.800558], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"  1\", 2.79716, 0.96414, 0.183078, 1.0, 0.511155, 1.0, 0.97894], [144, \"hsa04020\", \"Calcium signaling pathway\", \" 12\", 17.70606, 0.96502, 0.067179, 1.0, 0.24775, 1.0, 0.620117], [147, \"hsa04030\", \"G protein-coupled receptors\", \" 10\", 15.66625, 0.96745, 0.064199, 1.0, 0.24775, 1.0, 0.609625], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  8\", 12.89406, 0.96767, 0.069379, 1.0, 0.249957, 1.0, 0.624414], [244, \"hsa04726\", \"Serotonergic synapse\", \"  5\", 9.22064, 0.97088, 0.071669, 1.0, 0.256762, 1.0, 0.629291], [91, \"hsa01002\", \"Peptidases and inhibitors\", \" 25\", 33.8963, 0.97142, 0.04535, 1.0, 0.198204, 1.0, 0.52664], [143, \"hsa04015\", \"Rap1 signaling pathway\", \" 11\", 17.37042, 0.97836, 0.04473, 1.0, 0.198204, 1.0, 0.52664], [150, \"hsa04050\", \"Cytokine receptors\", \"  1\", 3.67778, 0.97883, 0.107619, 1.0, 0.356497, 1.0, 0.800558], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  4\", 8.27548, 0.97997, 0.059229, 1.0, 0.227365, 1.0, 0.592294], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \"  5\", 9.66476, 0.98056, 0.052589, 1.0, 0.213256, 1.0, 0.55683], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \"  7\", 12.6012, 0.98177, 0.04326, 1.0, 0.197842, 1.0, 0.52664], [103, \"hsa02010\", \"ABC transporters\", \"  1\", 3.6309, 0.98319, 0.095149, 1.0, 0.329737, 1.0, 0.751845], [242, \"hsa04724\", \"Glutamatergic synapse\", \"  8\", 13.86134, 0.98417, 0.03641, 1.0, 0.177982, 1.0, 0.488309], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \" 15\", 23.09575, 0.98508, 0.02882, 1.0, 0.172273, 1.0, 0.482395], [18, \"hsa00230\", \"Purine metabolism\", \"  4\", 9.03617, 0.98779, 0.03665, 1.0, 0.177982, 1.0, 0.488309], [243, \"hsa04725\", \"Cholinergic synapse\", \"  5\", 10.40872, 0.98884, 0.03187, 1.0, 0.17235, 1.0, 0.482395], [322, \"hsa05146\", \"Amoebiasis\", \"  3\", 7.62889, 0.99022, 0.03545, 1.0, 0.177982, 1.0, 0.488309], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \" 10\", 17.60414, 0.99138, 0.01987, 1.0, 0.124649, 1.0, 0.397396], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"  1\", 3.47251, 0.99226, 0.073939, 1.0, 0.264151, 1.0, 0.633765], [305, \"hsa05032\", \"Morphine addiction\", \"  4\", 9.74728, 0.99428, 0.01921, 1.0, 0.124649, 1.0, 0.397396], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"  1\", 4.11166, 0.99492, 0.04783, 1.0, 0.203854, 1.0, 0.538082], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"  1\", 4.72951, 0.99607, 0.03089, 1.0, 0.172273, 1.0, 0.482395], [163, \"hsa04090\", \"CD molecules\", \"  7\", 15.25732, 0.99609, 0.01058, 1.0, 0.0718, 1.0, 0.253917], [172, \"hsa04131\", \"Membrane trafficking\", \" 70\", 90.91827, 0.997, 0.00433, 1.0, 0.029109, 1.0, 0.129899], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"  1\", 4.49355, 0.99729, 0.02762, 1.0, 0.172273, 1.0, 0.482395], [102, \"hsa02000\", \"Transporters\", \" 20\", 32.72526, 0.99752, 0.0053, 1.0, 0.034942, 1.0, 0.146768], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"  1\", 6.07252, 0.99921, 0.00801, 1.0, 0.053951, 1.0, 0.205969], [199, \"hsa04360\", \"Axon guidance\", \"  8\", 17.91703, 0.9993, 0.0019, 1.0, 0.018875, 1.0, 0.070919], [149, \"hsa04040\", \"Ion channels\", \" 15\", 28.17748, 0.99949, 0.00121, 1.0, 0.016527, 1.0, 0.062228], [287, \"hsa04970\", \"Salivary secretion\", \"  1\", 6.91181, 0.99981, 0.00197, 1.0, 0.018875, 1.0, 0.070919], [236, \"hsa04713\", \"Circadian entrainment\", \"  3\", 11.28416, 0.99988, 0.00082, 1.0, 0.016527, 1.0, 0.062228], [255, \"hsa04911\", \"Insulin secretion\", \"  1\", 7.62642, 0.99989, 0.00119, 1.0, 0.016527, 1.0, 0.062228], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  1\", 8.21815, 0.99991, 0.00106, 1.0, 0.016527, 1.0, 0.062228], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"  0\", 1.57795, 1.0, 0.185498, 1.0, 0.513372, 1.0, 0.97894], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"  0\", 3.10802, 1.0, 0.03216, 1.0, 0.17235, 1.0, 0.482395], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"  0\", 2.94492, 1.0, 0.03798, 1.0, 0.177982, 1.0, 0.488309], [85, \"hsa00920\", \"Sulfur metabolism\", \"  0\", 0.35955, 1.0, 0.687813, 1.0, 1.0, 1.0, 0.99989], [84, \"hsa00910\", \"Nitrogen metabolism\", \"  0\", 0.58914, 1.0, 0.539285, 1.0, 1.0, 1.0, 0.99989], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"  0\", 0.68407, 1.0, 0.493025, 1.0, 1.0, 1.0, 0.99989], [81, \"hsa00830\", \"Retinol metabolism\", \"  0\", 1.15145, 1.0, 0.306807, 1.0, 0.747182, 1.0, 0.99989], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"  0\", 1.69777, 1.0, 0.121239, 1.0, 0.390275, 1.0, 0.800558], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"  0\", 1.40571, 1.0, 0.180578, 1.0, 0.50585, 1.0, 0.97894], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"  0\", 1.80333, 1.0, 0.122769, 1.0, 0.390275, 1.0, 0.800558], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"  0\", 0.66003, 1.0, 0.480425, 1.0, 0.955513, 1.0, 0.99989], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"  0\", 2.71801, 1.0, 0.03174, 1.0, 0.17235, 1.0, 0.482395], [73, \"hsa00730\", \"Thiamine metabolism\", \"  0\", 1.07293, 1.0, 0.292177, 1.0, 0.712879, 1.0, 0.99989], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"  0\", 3.94424, 1.0, 0.00271, 1.0, 0.018875, 1.0, 0.08869], [362, \"hsa05310\", \"Asthma\", \"  0\", 0.36009, 1.0, 0.695013, 1.0, 1.0, 1.0, 0.99989], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"  0\", 0.87541, 1.0, 0.403736, 1.0, 0.863776, 1.0, 0.99989], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"  0\", 0.5797, 1.0, 0.544115, 1.0, 1.0, 1.0, 0.99989], [92, \"hsa01003\", \"Glycosyltransferases\", \"  3\", 15.24621, 1.0, 6e-05, 1.0, 0.00179, 1.0, 0.0162], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"  0\", 1.5878, 1.0, 0.195788, 1.0, 0.518374, 1.0, 0.97894], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"  0\", 1.44257, 1.0, 0.214678, 1.0, 0.545858, 1.0, 0.99989], [291, \"hsa04974\", \"Protein digestion and absorption\", \"  0\", 5.68177, 1.0, 0.00186, 1.0, 0.018875, 1.0, 0.070919], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"  0\", 0.6818, 1.0, 0.471915, 1.0, 0.955513, 1.0, 0.99989], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"  0\", 2.16698, 1.0, 0.090289, 1.0, 0.320948, 1.0, 0.738729], [295, \"hsa04978\", \"Mineral absorption\", \"  0\", 1.89413, 1.0, 0.127989, 1.0, 0.399075, 1.0, 0.800558], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"  0\", 0.72095, 1.0, 0.468505, 1.0, 0.955159, 1.0, 0.99989], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"  0\", 0.43558, 1.0, 0.636774, 1.0, 1.0, 1.0, 0.99989], [302, \"hsa05020\", \"Prion diseases\", \"  0\", 2.06659, 1.0, 0.084659, 1.0, 0.303746, 1.0, 0.708774], [250, \"hsa04744\", \"Phototransduction\", \"  0\", 0.67162, 1.0, 0.499325, 1.0, 1.0, 1.0, 0.99989], [248, \"hsa04740\", \"Olfactory transduction\", \"  0\", 5.62303, 1.0, 0.00084, 1.0, 0.016527, 1.0, 0.062228], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"  0\", 0.2089, 1.0, 0.809242, 1.0, 1.0, 1.0, 0.99989], [216, \"hsa04614\", \"Renin-angiotensin system\", \"  0\", 0.93218, 1.0, 0.376996, 1.0, 0.84447, 1.0, 0.99989], [208, \"hsa04515\", \"Cell adhesion molecules\", \"  7\", 19.78274, 1.0, 9e-05, 1.0, 0.00179, 1.0, 0.0162], [164, \"hsa04091\", \"Lectins\", \"  0\", 2.81003, 1.0, 0.054889, 1.0, 0.213256, 1.0, 0.564577], [152, \"hsa04054\", \"Pattern recognition receptors\", \"  0\", 1.61975, 1.0, 0.188398, 1.0, 0.515503, 1.0, 0.97894], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"  0\", 0.71716, 1.0, 0.471775, 1.0, 0.955513, 1.0, 0.99989], [136, \"hsa03430\", \"Mismatch repair\", \"  0\", 0.89473, 1.0, 0.388916, 1.0, 0.85442, 1.0, 0.99989], [132, \"hsa03320\", \"PPAR signaling pathway\", \"  0\", 2.79602, 1.0, 0.051309, 1.0, 0.213256, 1.0, 0.55683], [129, \"hsa03060\", \"Protein export\", \"  0\", 1.15817, 1.0, 0.206538, 1.0, 0.539872, 1.0, 0.99989], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"  0\", 1.57911, 1.0, 0.195638, 1.0, 0.518374, 1.0, 0.97894], [118, \"hsa03020\", \"RNA polymerase\", \"  0\", 0.69164, 1.0, 0.493555, 1.0, 1.0, 1.0, 0.99989], [116, \"hsa03018\", \"RNA degradation\", \"  0\", 2.60734, 1.0, 0.064349, 1.0, 0.24775, 1.0, 0.609625], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"  0\", 3.84843, 1.0, 0.01617, 1.0, 0.113334, 1.0, 0.363821], [39, \"hsa00480\", \"Glutathione metabolism\", \"  0\", 0.89962, 1.0, 0.401016, 1.0, 0.859119, 1.0, 0.99989]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#dfa9f3f6-0d67-45ee-acdf-6c70c70cfa7f').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#dfa9f3f6-0d67-45ee-acdf-6c70c70cfa7f').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                            FunctionName  n_candidates  \\\n",
       "124  hsa03036      Chromosome and associated proteins            84   \n",
       "119  hsa03021                 Transcription machinery            21   \n",
       "26   hsa00310                      Lysine degradation             9   \n",
       "113  hsa03013                           RNA transport            11   \n",
       "374  hsa05418  Fluid shear stress and atherosclerosis            12   \n",
       "..        ...                                     ...           ...   \n",
       "23   hsa00270      Cysteine and methionine metabolism             0   \n",
       "118  hsa03020                          RNA polymerase             0   \n",
       "116  hsa03018                         RNA degradation             0   \n",
       "93   hsa01004             Lipid biosynthesis proteins             0   \n",
       "39   hsa00480                  Glutathione metabolism             0   \n",
       "\n",
       "     mean_n_resample  emp_p_e   emp_p_d     fdr_e     fdr_d  BH_fdr_e  \\\n",
       "124         57.93256  0.00015  0.999890  0.024820  1.000000  0.053999   \n",
       "119         10.08338  0.00058  0.999800  0.050705  1.000000  0.104399   \n",
       "26           3.03488  0.00139  0.999780  0.088307  1.000000  0.148499   \n",
       "113          3.97442  0.00165  0.999540  0.088307  1.000000  0.148499   \n",
       "374          4.99547  0.00244  0.999290  0.092488  1.000000  0.175678   \n",
       "..               ...      ...       ...       ...       ...       ...   \n",
       "23           1.57911  1.00000  0.195638  1.000000  0.518374  1.000000   \n",
       "118          0.69164  1.00000  0.493555  1.000000  1.000000  1.000000   \n",
       "116          2.60734  1.00000  0.064349  1.000000  0.247750  1.000000   \n",
       "93           3.84843  1.00000  0.016170  1.000000  0.113334  1.000000   \n",
       "39           0.89962  1.00000  0.401016  1.000000  0.859119  1.000000   \n",
       "\n",
       "     BH_fdr_d  \n",
       "124  0.999890  \n",
       "119  0.999890  \n",
       "26   0.999890  \n",
       "113  0.999890  \n",
       "374  0.999890  \n",
       "..        ...  \n",
       "23   0.978940  \n",
       "118  0.999890  \n",
       "116  0.609625  \n",
       "93   0.363821  \n",
       "39   0.999890  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "i_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "5b3d5ea6",
   "metadata": {},
   "outputs": [],
   "source": [
    "# join objects\n",
    "# test objs\n",
    "ce_test_obj = psp.TestObject.add_objects(c_test_obj,e_test_obj)\n",
    "ci_test_obj = psp.TestObject.add_objects(c_test_obj,i_test_obj)\n",
    "ei_test_obj = psp.TestObject.add_objects(e_test_obj,i_test_obj)\n",
    "cei_test_obj = psp.TestObject.add_objects(ce_test_obj,i_test_obj)\n",
    "\n",
    "# n per permuation objs\n",
    "ce_per_set=psp.SetPerPerm.join_objects(c_per_set,e_per_set)\n",
    "ci_per_set=psp.SetPerPerm.join_objects(c_per_set,i_per_set)\n",
    "ei_per_set=psp.SetPerPerm.join_objects(e_per_set,i_per_set)\n",
    "cei_per_set=psp.SetPerPerm.join_objects(ce_per_set,i_per_set)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "ae3b1da2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# joint results\n",
    "ce_results = make_results_table(ce_test_obj, function_sets, ce_per_set)\n",
    "ci_results = make_results_table(ci_test_obj, function_sets, ci_per_set)\n",
    "ei_results = make_results_table(ei_test_obj, function_sets, ei_per_set)\n",
    "cei_results = make_results_table(cei_test_obj, function_sets, cei_per_set)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "af241aa7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"9c3dc905-fa25-4c65-a99a-379c4de9708e\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  31\", 12.92409, 1e-05, 1.0, 0.0, 1.0, 0.0018, 1.0], [317, \"hsa05140\", \"Leishmaniasis\", \"  14\", 4.02017, 1e-05, 1.0, 0.0, 1.0, 0.0018, 1.0], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"  11\", 2.87772, 2e-05, 1.0, 0.000483, 1.0, 0.0018, 1.0], [226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  20\", 7.42084, 2e-05, 1.0, 0.000483, 1.0, 0.0018, 1.0], [369, \"hsa05340\", \"Primary immunodeficiency\", \"   8\", 1.4759, 7e-05, 1.0, 0.002486, 1.0, 0.00504, 1.0], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"  12\", 3.80137, 0.00016, 0.99996, 0.005252, 1.0, 0.0096, 1.0], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \"  27\", 13.30778, 0.00023, 0.99993, 0.006706, 1.0, 0.011828, 1.0], [84, \"hsa00910\", \"Nitrogen metabolism\", \"   6\", 1.17815, 0.00057, 0.99991, 0.015043, 1.0, 0.02565, 1.0], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"   7\", 1.67071, 0.00125, 0.9998, 0.030163, 1.0, 0.05, 1.0], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  19\", 9.37795, 0.00198, 0.99931, 0.043807, 1.0, 0.071279, 1.0], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"   9\", 2.97091, 0.00299, 0.99928, 0.060611, 1.0, 0.097854, 1.0], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"   7\", 2.21997, 0.00361, 0.99945, 0.067224, 1.0, 0.104159, 1.0], [150, \"hsa04050\", \"Cytokine receptors\", \"  15\", 7.01875, 0.00402, 0.99844, 0.071652, 1.0, 0.104159, 1.0], [321, \"hsa05145\", \"Toxoplasmosis\", \"  19\", 10.22211, 0.00422, 0.99822, 0.071652, 1.0, 0.104159, 1.0], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \"  23\", 13.147, 0.00434, 0.99814, 0.071652, 1.0, 0.104159, 1.0], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"   9\", 3.34962, 0.006, 0.99826, 0.0852, 1.0, 0.134999, 1.0], [151, \"hsa04052\", \"Cytokines and growth factors\", \"  23\", 13.82302, 0.00709, 0.9967, 0.094723, 1.0, 0.15014, 1.0], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  17\", 9.41461, 0.00891, 0.99642, 0.114529, 1.0, 0.178198, 1.0], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  15\", 8.06076, 0.01112, 0.99554, 0.138148, 1.0, 0.210693, 1.0], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  19\", 11.5975, 0.0118, 0.9947, 0.14059, 1.0, 0.212398, 1.0], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  22\", 13.46836, 0.01321, 0.99319, 0.153345, 1.0, 0.226455, 1.0], [362, \"hsa05310\", \"Asthma\", \"   3\", 0.52288, 0.01623, 0.99827, 0.175679, 1.0, 0.262647, 1.0], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  23\", 14.80452, 0.01713, 0.99103, 0.175738, 1.0, 0.262647, 1.0], [132, \"hsa03320\", \"PPAR signaling pathway\", \"  11\", 5.42494, 0.01751, 0.99316, 0.175738, 1.0, 0.262647, 1.0], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  18\", 11.66576, 0.01957, 0.99156, 0.186703, 1.0, 0.272797, 1.0], [125, \"hsa03040\", \"Spliceosome\", \"  11\", 5.41238, 0.0201, 0.99218, 0.186703, 1.0, 0.272797, 1.0], [215, \"hsa04612\", \"Antigen processing and presentation\", \"   6\", 2.16737, 0.02046, 0.99448, 0.186703, 1.0, 0.272797, 1.0], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  11\", 5.64732, 0.0216, 0.99136, 0.186703, 1.0, 0.277712, 1.0], [338, \"hsa05203\", \"Viral carcinogenesis\", \"  24\", 15.94467, 0.02267, 0.98775, 0.188562, 1.0, 0.281418, 1.0], [5, \"hsa00052\", \"Galactose metabolism\", \"   6\", 2.31164, 0.0252, 0.99305, 0.20439, 1.0, 0.302397, 1.0], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"  10\", 5.04016, 0.0292, 0.98791, 0.227562, 1.0, 0.339093, 1.0], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"   9\", 4.45862, 0.03025, 0.98842, 0.231475, 1.0, 0.340309, 1.0], [307, \"hsa05034\", \"Alcoholism\", \"  20\", 13.44765, 0.03757, 0.98018, 0.277272, 1.0, 0.393436, 1.0], [85, \"hsa00920\", \"Sulfur metabolism\", \"   3\", 0.77573, 0.04004, 0.99367, 0.290229, 1.0, 0.393436, 1.0], [134, \"hsa03410\", \"Base excision repair\", \"   4\", 1.30948, 0.04038, 0.99128, 0.290229, 1.0, 0.393436, 1.0], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \"  24\", 17.27584, 0.04082, 0.97751, 0.290229, 1.0, 0.393436, 1.0], [26, \"hsa00310\", \"Lysine degradation\", \"  11\", 6.35057, 0.04265, 0.98162, 0.291181, 1.0, 0.393436, 1.0], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  12\", 7.07304, 0.04283, 0.98104, 0.291181, 1.0, 0.393436, 1.0], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \"  26\", 18.9913, 0.04338, 0.97553, 0.291181, 1.0, 0.393436, 1.0], [306, \"hsa05033\", \"Nicotine addiction\", \"  13\", 8.04552, 0.04391, 0.98108, 0.291181, 1.0, 0.393436, 1.0], [123, \"hsa03032\", \"DNA replication proteins\", \"  13\", 7.74478, 0.04594, 0.97712, 0.291181, 1.0, 0.393436, 1.0], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \"  19\", 12.86708, 0.04721, 0.97443, 0.291181, 1.0, 0.393436, 1.0], [237, \"hsa04714\", \"Thermogenesis\", \"  26\", 18.88752, 0.04779, 0.9718, 0.291181, 1.0, 0.393436, 1.0], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"   7\", 3.35521, 0.04885, 0.98153, 0.291181, 1.0, 0.393436, 1.0], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"   5\", 1.9975, 0.04918, 0.98552, 0.291181, 1.0, 0.393436, 1.0], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  17\", 11.22737, 0.051779, 0.97214, 0.291181, 1.0, 0.405231, 1.0], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \"  26\", 18.86913, 0.054979, 0.96586, 0.298281, 1.0, 0.419246, 1.0], [275, \"hsa04931\", \"Insulin resistance\", \"  18\", 12.29854, 0.055899, 0.96893, 0.298281, 1.0, 0.419246, 1.0], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"   3\", 0.92436, 0.059639, 0.98903, 0.306282, 1.0, 0.428579, 1.0], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"   7\", 3.58306, 0.062639, 0.9762, 0.31905, 1.0, 0.428579, 1.0], [107, \"hsa03000\", \"Transcription factors\", \"  92\", 79.12351, 0.063309, 0.95032, 0.31905, 1.0, 0.428579, 1.0], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \"  31\", 24.06948, 0.063309, 0.95977, 0.31905, 1.0, 0.428579, 1.0], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"   6\", 2.86716, 0.064589, 0.97695, 0.31905, 1.0, 0.428579, 1.0], [291, \"hsa04974\", \"Protein digestion and absorption\", \"  16\", 10.84033, 0.067519, 0.96339, 0.319105, 1.0, 0.428579, 1.0], [295, \"hsa04978\", \"Mineral absorption\", \"   7\", 3.71545, 0.068469, 0.97397, 0.319105, 1.0, 0.428579, 1.0], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \"  23\", 17.36025, 0.068889, 0.96102, 0.319105, 1.0, 0.428579, 1.0], [68, \"hsa00620\", \"Pyruvate metabolism\", \"   6\", 2.95656, 0.069369, 0.97569, 0.319105, 1.0, 0.428579, 1.0], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \"  27\", 20.3244, 0.070159, 0.95554, 0.319105, 1.0, 0.428579, 1.0], [42, \"hsa00511\", \"Other glycan degradation\", \"   3\", 0.97878, 0.070239, 0.98675, 0.319105, 1.0, 0.428579, 1.0], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  14\", 9.4293, 0.074079, 0.96185, 0.319105, 1.0, 0.435421, 1.0], [303, \"hsa05030\", \"Cocaine addiction\", \"  10\", 6.19146, 0.074299, 0.9665, 0.319105, 1.0, 0.435421, 1.0], [327, \"hsa05162\", \"Measles\", \"  13\", 8.42078, 0.074989, 0.96094, 0.319105, 1.0, 0.435421, 1.0], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"   8\", 4.55738, 0.078019, 0.96762, 0.319105, 1.0, 0.445343, 1.0], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"  12\", 8.31587, 0.079579, 0.96437, 0.319703, 1.0, 0.445343, 1.0], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"  15\", 10.35832, 0.080409, 0.95589, 0.319703, 1.0, 0.445343, 1.0], [292, \"hsa04975\", \"Fat digestion and absorption\", \"   5\", 2.33947, 0.083129, 0.97231, 0.323386, 1.0, 0.453432, 1.0], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  18\", 13.08839, 0.085679, 0.9518, 0.329069, 1.0, 0.45979, 1.0], [190, \"hsa04217\", \"Necroptosis\", \"  13\", 8.63487, 0.086849, 0.95277, 0.329069, 1.0, 0.45979, 1.0], [140, \"hsa04010\", \"MAPK signaling pathway\", \"  48\", 40.0907, 0.093009, 0.932741, 0.346806, 1.0, 0.481432, 1.0], [296, \"hsa04979\", \"Cholesterol metabolism\", \"   8\", 4.77901, 0.093699, 0.95968, 0.346941, 1.0, 0.481432, 1.0], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"  16\", 11.58724, 0.094949, 0.947831, 0.348315, 1.0, 0.481432, 1.0], [179, \"hsa04145\", \"Phagosome\", \"  13\", 8.80364, 0.100219, 0.945341, 0.365617, 1.0, 0.501095, 1.0], [29, \"hsa00350\", \"Tyrosine metabolism\", \"   4\", 1.82733, 0.106129, 0.96771, 0.379019, 1.0, 0.514132, 1.0], [326, \"hsa05161\", \"Hepatitis B\", \"  19\", 14.17202, 0.107679, 0.933791, 0.382483, 1.0, 0.514132, 1.0], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"  11\", 7.55977, 0.107949, 0.947541, 0.382483, 1.0, 0.514132, 1.0], [216, \"hsa04614\", \"Renin-angiotensin system\", \"   4\", 1.85196, 0.108539, 0.9668, 0.382483, 1.0, 0.514132, 1.0], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"   4\", 1.89835, 0.118099, 0.96144, 0.406128, 1.0, 0.546456, 1.0], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \"  23\", 18.31086, 0.118399, 0.926851, 0.406128, 1.0, 0.546456, 1.0], [163, \"hsa04090\", \"CD molecules\", \"  36\", 29.86684, 0.133909, 0.901791, 0.437704, 1.0, 0.610217, 1.0], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  18\", 13.82257, 0.140799, 0.912601, 0.457878, 1.0, 0.630991, 1.0], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"   8\", 5.23618, 0.143969, 0.930721, 0.463819, 1.0, 0.630991, 1.0], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \"  13\", 9.51855, 0.144269, 0.916721, 0.463819, 1.0, 0.630991, 1.0], [155, \"hsa04062\", \"Chemokine signaling pathway\", \"  26\", 21.19972, 0.145479, 0.902141, 0.463819, 1.0, 0.630991, 1.0], [302, \"hsa05020\", \"Prion diseases\", \"   6\", 3.73036, 0.148289, 0.939191, 0.46474, 1.0, 0.635522, 1.0], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  14\", 10.40288, 0.154548, 0.906551, 0.484384, 1.0, 0.635967, 1.0], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"   2\", 0.70923, 0.155608, 0.97003, 0.484384, 1.0, 0.635967, 1.0], [314, \"hsa05133\", \"Pertussis\", \"   6\", 3.68333, 0.158018, 0.928991, 0.488271, 1.0, 0.635967, 1.0], [278, \"hsa04934\", \"Cushing syndrome\", \"  25\", 20.47652, 0.158098, 0.892631, 0.488271, 1.0, 0.635967, 1.0], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"   3\", 1.39537, 0.159388, 0.95295, 0.488271, 1.0, 0.635967, 1.0], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"   8\", 5.30788, 0.160248, 0.916961, 0.488271, 1.0, 0.635967, 1.0], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"   9\", 6.27441, 0.160758, 0.918231, 0.488271, 1.0, 0.635967, 1.0], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  23\", 19.07266, 0.164188, 0.893911, 0.488271, 1.0, 0.638742, 1.0], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \"  20\", 16.03979, 0.165008, 0.890451, 0.488271, 1.0, 0.638742, 1.0], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"   4\", 2.17722, 0.171198, 0.935231, 0.50439, 1.0, 0.655653, 1.0], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \"  17\", 13.32261, 0.175288, 0.885711, 0.508642, 1.0, 0.657931, 1.0], [312, \"hsa05131\", \"Shigellosis\", \"  29\", 24.43378, 0.175448, 0.874701, 0.508642, 1.0, 0.657931, 1.0], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \"  24\", 19.62359, 0.183648, 0.868801, 0.525875, 1.0, 0.676059, 1.0], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"   7\", 4.67907, 0.184038, 0.907061, 0.525875, 1.0, 0.676059, 1.0], [120, \"hsa03022\", \"Basal transcription factors\", \"   5\", 3.07959, 0.188898, 0.919351, 0.531655, 1.0, 0.682661, 1.0], [232, \"hsa04668\", \"TNF signaling pathway\", \"  12\", 9.1027, 0.189628, 0.886061, 0.531655, 1.0, 0.682661, 1.0], [181, \"hsa04147\", \"Exosome\", \"  75\", 68.05226, 0.196628, 0.836802, 0.532179, 1.0, 0.700852, 1.0], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"   3\", 1.58559, 0.209428, 0.927121, 0.562448, 1.0, 0.739157, 1.0], [166, \"hsa04114\", \"Oocyte meiosis\", \"  16\", 12.9597, 0.212228, 0.861731, 0.566177, 1.0, 0.739673, 1.0], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"   5\", 3.22768, 0.215408, 0.902561, 0.569352, 1.0, 0.739673, 1.0], [126, \"hsa03041\", \"Spliceosome\", \"  29\", 25.0175, 0.215738, 0.842182, 0.569352, 1.0, 0.739673, 1.0], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"   9\", 6.69138, 0.219528, 0.875471, 0.570335, 1.0, 0.745566, 1.0], [138, \"hsa03450\", \"Non-homologous end-joining\", \"   3\", 1.67447, 0.227628, 0.924711, 0.588398, 1.0, 0.75514, 1.0], [99, \"hsa01522\", \"Endocrine resistance\", \"  15\", 12.25904, 0.231648, 0.850201, 0.588398, 1.0, 0.75514, 1.0], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \"  23\", 19.72315, 0.232858, 0.836022, 0.588398, 1.0, 0.75514, 1.0], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"   8\", 5.95334, 0.235078, 0.871711, 0.589177, 1.0, 0.75514, 1.0], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"   4\", 2.49954, 0.237638, 0.900061, 0.589519, 1.0, 0.75514, 1.0], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  15\", 12.33544, 0.238608, 0.846892, 0.589519, 1.0, 0.75514, 1.0], [18, \"hsa00230\", \"Purine metabolism\", \"  21\", 17.84083, 0.238898, 0.832012, 0.589519, 1.0, 0.75514, 1.0], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"   4\", 2.54162, 0.239128, 0.905341, 0.589519, 1.0, 0.75514, 1.0], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"   6\", 4.25233, 0.245698, 0.875631, 0.593739, 1.0, 0.76914, 1.0], [180, \"hsa04146\", \"Peroxisome\", \"   8\", 6.04108, 0.256057, 0.851021, 0.61356, 1.0, 0.781251, 1.0], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"   9\", 6.98134, 0.256597, 0.850451, 0.61356, 1.0, 0.781251, 1.0], [100, \"hsa01523\", \"Antifolate resistance\", \"   3\", 1.78872, 0.260737, 0.906421, 0.616646, 1.0, 0.781251, 1.0], [196, \"hsa04330\", \"Notch signaling pathway\", \"   6\", 4.35057, 0.262447, 0.865201, 0.616646, 1.0, 0.781251, 1.0], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  15\", 12.48962, 0.262987, 0.822872, 0.616646, 1.0, 0.781251, 1.0], [152, \"hsa04054\", \"Pattern recognition receptors\", \"   5\", 3.46622, 0.264247, 0.868341, 0.616646, 1.0, 0.781251, 1.0], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \"  25\", 22.00301, 0.264757, 0.806022, 0.616646, 1.0, 0.781251, 1.0], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \"  22\", 19.20275, 0.275527, 0.797602, 0.621819, 1.0, 0.792564, 1.0], [39, \"hsa00480\", \"Glutathione metabolism\", \"   3\", 1.8286, 0.276367, 0.888501, 0.621819, 1.0, 0.792564, 1.0], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  15\", 12.70561, 0.276407, 0.813612, 0.621819, 1.0, 0.792564, 1.0], [329, \"hsa05164\", \"Influenza A\", \"  13\", 10.77576, 0.277397, 0.816532, 0.621819, 1.0, 0.792564, 1.0], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"   4\", 2.7173, 0.286647, 0.871591, 0.634164, 1.0, 0.812543, 1.0], [236, \"hsa04713\", \"Circadian entrainment\", \"  25\", 22.39856, 0.290457, 0.790432, 0.639721, 1.0, 0.816911, 1.0], [135, \"hsa03420\", \"Nucleotide excision repair\", \"   4\", 2.75505, 0.295377, 0.864491, 0.646435, 1.0, 0.824308, 1.0], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  12\", 10.07146, 0.303367, 0.798252, 0.657633, 1.0, 0.840093, 1.0], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"   7\", 5.5766, 0.312867, 0.826522, 0.673529, 1.0, 0.859787, 1.0], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 127\", 121.86412, 0.316347, 0.718453, 0.673529, 1.0, 0.862764, 1.0], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  11\", 9.31747, 0.320817, 0.791822, 0.673612, 1.0, 0.868376, 1.0], [367, \"hsa05330\", \"Allograft rejection\", \"   2\", 1.1666, 0.327277, 0.891451, 0.689194, 1.0, 0.873911, 1.0], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  16\", 14.06648, 0.327717, 0.766392, 0.689194, 1.0, 0.873911, 1.0], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  20\", 17.97177, 0.332557, 0.756012, 0.693427, 1.0, 0.880297, 1.0], [273, \"hsa04929\", \"GnRH secretion\", \"  15\", 13.317, 0.342867, 0.765682, 0.71512, 1.0, 0.890978, 1.0], [200, \"hsa04370\", \"VEGF signaling pathway\", \"   9\", 7.59968, 0.343637, 0.785502, 0.71512, 1.0, 0.890978, 1.0], [53, \"hsa00535\", \"Proteoglycans\", \"  11\", 9.61465, 0.344017, 0.789812, 0.71512, 1.0, 0.890978, 1.0], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \"  30\", 27.7615, 0.348387, 0.723693, 0.71512, 1.0, 0.895851, 1.0], [347, \"hsa05215\", \"Prostate cancer\", \"  14\", 12.43327, 0.359166, 0.746233, 0.730184, 1.0, 0.904562, 1.0], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"   1\", 0.44194, 0.361146, 0.929201, 0.731641, 1.0, 0.904562, 1.0], [313, \"hsa05132\", \"Salmonella infection\", \"  21\", 19.19052, 0.362206, 0.723203, 0.731641, 1.0, 0.904562, 1.0], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"   6\", 4.93195, 0.364406, 0.803572, 0.731641, 1.0, 0.904562, 1.0], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"   7\", 5.86413, 0.368346, 0.782272, 0.733275, 1.0, 0.904562, 1.0], [201, \"hsa04371\", \"Apelin signaling pathway\", \"  23\", 21.29874, 0.372116, 0.717293, 0.736837, 1.0, 0.904562, 1.0], [305, \"hsa05032\", \"Morphine addiction\", \"  21\", 19.38317, 0.376146, 0.714863, 0.738676, 1.0, 0.904562, 1.0], [102, \"hsa02000\", \"Transporters\", \"  66\", 63.38799, 0.378606, 0.672883, 0.738676, 1.0, 0.904562, 1.0], [315, \"hsa05134\", \"Legionellosis\", \"   3\", 2.20201, 0.378766, 0.822482, 0.738676, 1.0, 0.904562, 1.0], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"   3\", 2.20032, 0.380296, 0.830892, 0.738676, 1.0, 0.904562, 1.0], [324, \"hsa05152\", \"Tuberculosis\", \"  13\", 11.66529, 0.380906, 0.728293, 0.738676, 1.0, 0.904562, 1.0], [182, \"hsa04150\", \"mTOR signaling pathway\", \"  18\", 16.50213, 0.381926, 0.713843, 0.738676, 1.0, 0.904562, 1.0], [172, \"hsa04131\", \"Membrane trafficking\", \" 187\", 183.38036, 0.390426, 0.643044, 0.738676, 1.0, 0.916962, 1.0], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"   4\", 3.1701, 0.392256, 0.791992, 0.738676, 1.0, 0.916962, 1.0], [129, \"hsa03060\", \"Protein export\", \"   3\", 2.28132, 0.395616, 0.853971, 0.738676, 1.0, 0.91885, 1.0], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"   8\", 6.98617, 0.400016, 0.741903, 0.740732, 1.0, 0.923104, 1.0], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"   2\", 1.35784, 0.402576, 0.860861, 0.741251, 1.0, 0.923104, 1.0], [293, \"hsa04976\", \"Bile secretion\", \"  10\", 8.96032, 0.405766, 0.723523, 0.742164, 1.0, 0.92453, 1.0], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"   2\", 1.38251, 0.410006, 0.851671, 0.74697, 1.0, 0.926864, 1.0], [373, \"hsa05416\", \"Viral myocarditis\", \"   7\", 6.14587, 0.417466, 0.743943, 0.760977, 1.0, 0.926864, 1.0], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"   2\", 1.40506, 0.418876, 0.842822, 0.760977, 1.0, 0.926864, 1.0], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"   2\", 1.43246, 0.424266, 0.830232, 0.763242, 1.0, 0.926864, 1.0], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"   2\", 1.43536, 0.428526, 0.836432, 0.772022, 1.0, 0.926864, 1.0], [316, \"hsa05135\", \"Yersinia infection\", \"  16\", 14.97929, 0.428626, 0.678033, 0.772022, 1.0, 0.926864, 1.0], [36, \"hsa00450\", \"Selenocompound metabolism\", \"   2\", 1.45191, 0.429936, 0.826302, 0.772022, 1.0, 0.926864, 1.0], [142, \"hsa04014\", \"Ras signaling pathway\", \"  33\", 31.78896, 0.434996, 0.639874, 0.772022, 1.0, 0.926864, 1.0], [341, \"hsa05206\", \"MicroRNAs in cancer\", \"  23\", 21.94391, 0.435066, 0.655273, 0.772022, 1.0, 0.926864, 1.0], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"   5\", 4.31854, 0.435226, 0.746963, 0.772022, 1.0, 0.926864, 1.0], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  13\", 12.11677, 0.437166, 0.676283, 0.772022, 1.0, 0.926864, 1.0], [9, \"hsa00071\", \"Fatty acid degradation\", \"   3\", 2.41655, 0.437686, 0.777882, 0.772022, 1.0, 0.926864, 1.0], [191, \"hsa04218\", \"Cellular senescence\", \"  16\", 15.07906, 0.440826, 0.665703, 0.772022, 1.0, 0.928054, 1.0], [94, \"hsa01006\", \"Prenyltransferases\", \"   2\", 1.47592, 0.444326, 0.826252, 0.772022, 1.0, 0.929984, 1.0], [164, \"hsa04091\", \"Lectins\", \"   6\", 5.36495, 0.447186, 0.710323, 0.772022, 1.0, 0.930559, 1.0], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  25\", 24.08791, 0.452035, 0.638514, 0.772022, 1.0, 0.931506, 1.0], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  11\", 10.26987, 0.452815, 0.677673, 0.772022, 1.0, 0.931506, 1.0], [320, \"hsa05144\", \"Malaria\", \"   3\", 2.49566, 0.458955, 0.761942, 0.772497, 1.0, 0.938772, 1.0], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \"  22\", 21.27225, 0.469725, 0.627304, 0.791303, 1.0, 0.953343, 1.0], [137, \"hsa03440\", \"Homologous recombination\", \"   4\", 3.51397, 0.471375, 0.728543, 0.79377, 1.0, 0.953343, 1.0], [71, \"hsa00650\", \"Butanoate metabolism\", \"   3\", 2.55064, 0.474795, 0.750792, 0.795854, 1.0, 0.95483, 1.0], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  12\", 11.43997, 0.477415, 0.647544, 0.795854, 1.0, 0.95483, 1.0], [177, \"hsa04142\", \"Lysosome\", \"  10\", 9.6033, 0.496635, 0.638574, 0.820317, 1.0, 0.967362, 1.0], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  19\", 18.60831, 0.500145, 0.604694, 0.821764, 1.0, 0.967362, 1.0], [304, \"hsa05031\", \"Amphetamine addiction\", \"  12\", 11.58429, 0.500315, 0.632754, 0.821764, 1.0, 0.967362, 1.0], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \"  26\", 25.63522, 0.500885, 0.587994, 0.821764, 1.0, 0.967362, 1.0], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  17\", 16.6475, 0.503235, 0.603554, 0.821764, 1.0, 0.967362, 1.0], [148, \"hsa04031\", \"GTP-binding proteins\", \"  14\", 13.67299, 0.505035, 0.609764, 0.821764, 1.0, 0.967362, 1.0], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  10\", 9.65862, 0.505305, 0.631054, 0.821764, 1.0, 0.967362, 1.0], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  15\", 14.65144, 0.505395, 0.611354, 0.821764, 1.0, 0.967362, 1.0], [244, \"hsa04726\", \"Serotonergic synapse\", \"  19\", 18.67133, 0.507865, 0.597754, 0.821764, 1.0, 0.967362, 1.0], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \"  25\", 24.80662, 0.516075, 0.571524, 0.821764, 1.0, 0.974427, 1.0], [238, \"hsa04720\", \"Long-term potentiation\", \"  15\", 14.74336, 0.520295, 0.601364, 0.822405, 1.0, 0.974427, 1.0], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"   8\", 7.75218, 0.523015, 0.635354, 0.822405, 1.0, 0.974427, 1.0], [185, \"hsa04210\", \"Apoptosis\", \"  11\", 10.8054, 0.524765, 0.605794, 0.822564, 1.0, 0.974427, 1.0], [90, \"hsa01001\", \"Protein kinases\", \"  80\", 80.10418, 0.525635, 0.526875, 0.822564, 1.0, 0.974427, 1.0], [243, \"hsa04725\", \"Cholinergic synapse\", \"  21\", 20.88814, 0.527815, 0.571934, 0.822564, 1.0, 0.974427, 1.0], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  10\", 9.89756, 0.536205, 0.597004, 0.8248, 1.0, 0.984866, 1.0], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"   3\", 2.82647, 0.539025, 0.686413, 0.82676, 1.0, 0.98502, 1.0], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \"  17\", 17.03362, 0.544625, 0.560744, 0.831819, 1.0, 0.990226, 1.0], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"   8\", 7.93243, 0.553814, 0.603174, 0.844721, 1.0, 0.998515, 1.0], [325, \"hsa05160\", \"Hepatitis C\", \"  12\", 12.09739, 0.557074, 0.565074, 0.844835, 1.0, 0.998515, 1.0], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  15\", 15.10207, 0.557504, 0.558144, 0.844835, 1.0, 0.998515, 1.0], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"   9\", 9.03174, 0.568364, 0.585654, 0.85652, 1.0, 1.0, 1.0], [72, \"hsa00670\", \"One carbon pool by folate\", \"   2\", 1.8777, 0.574734, 0.712803, 0.864545, 1.0, 1.0, 1.0], [289, \"hsa04972\", \"Pancreatic secretion\", \"  13\", 13.20016, 0.577254, 0.550564, 0.864545, 1.0, 1.0, 1.0], [165, \"hsa04110\", \"Cell cycle\", \"  10\", 10.22492, 0.580454, 0.555364, 0.867153, 1.0, 1.0, 1.0], [11, \"hsa00100\", \"Steroid biosynthesis\", \"   1\", 0.85767, 0.583774, 0.789122, 0.867153, 1.0, 1.0, 1.0], [136, \"hsa03430\", \"Mismatch repair\", \"   2\", 1.9014, 0.584574, 0.705913, 0.867153, 1.0, 1.0, 1.0], [122, \"hsa03030\", \"DNA replication\", \"   2\", 1.94007, 0.586854, 0.693503, 0.867153, 1.0, 1.0, 1.0], [248, \"hsa04740\", \"Olfactory transduction\", \"  11\", 11.24028, 0.590284, 0.549825, 0.867153, 1.0, 1.0, 1.0], [103, \"hsa02010\", \"ABC transporters\", \"   7\", 7.17524, 0.592974, 0.571944, 0.867153, 1.0, 1.0, 1.0], [146, \"hsa04024\", \"cAMP signaling pathway\", \"  31\", 31.7813, 0.595384, 0.484255, 0.867153, 1.0, 1.0, 1.0], [70, \"hsa00640\", \"Propanoate metabolism\", \"   4\", 4.08552, 0.599314, 0.612964, 0.867464, 1.0, 1.0, 1.0], [214, \"hsa04611\", \"Platelet activation\", \"  18\", 18.68784, 0.612514, 0.491865, 0.876232, 1.0, 1.0, 1.0], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  24\", 24.88114, 0.617754, 0.474155, 0.879731, 1.0, 1.0, 1.0], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"   2\", 2.01962, 0.621614, 0.675083, 0.882851, 1.0, 1.0, 1.0], [287, \"hsa04970\", \"Salivary secretion\", \"  13\", 13.55252, 0.626174, 0.504805, 0.885287, 1.0, 1.0, 1.0], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"   5\", 5.30053, 0.628634, 0.560624, 0.887667, 1.0, 1.0, 1.0], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  10\", 10.59659, 0.632084, 0.501835, 0.889428, 1.0, 1.0, 1.0], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \"  23\", 24.05613, 0.633294, 0.457625, 0.889428, 1.0, 1.0, 1.0], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"   2\", 2.11942, 0.638564, 0.643414, 0.891, 1.0, 1.0, 1.0], [128, \"hsa03051\", \"Proteasome\", \"   3\", 3.26247, 0.638904, 0.587564, 0.891, 1.0, 1.0, 1.0], [127, \"hsa03050\", \"Proteasome\", \"   2\", 2.15402, 0.642004, 0.634434, 0.891381, 1.0, 1.0, 1.0], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"   3\", 3.29203, 0.644624, 0.582964, 0.891381, 1.0, 1.0, 1.0], [80, \"hsa00790\", \"Folate biosynthesis\", \"   2\", 2.09226, 0.645834, 0.654213, 0.891381, 1.0, 1.0, 1.0], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"   6\", 6.52917, 0.649964, 0.516795, 0.893303, 1.0, 1.0, 1.0], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"   4\", 4.36239, 0.652843, 0.556504, 0.893413, 1.0, 1.0, 1.0], [16, \"hsa00199\", \"Cytochrome P450\", \"   3\", 3.34917, 0.659443, 0.567024, 0.899607, 1.0, 1.0, 1.0], [105, \"hsa02044\", \"Secretion system\", \"   1\", 1.0716, 0.664103, 0.708463, 0.907567, 1.0, 1.0, 1.0], [28, \"hsa00340\", \"Histidine metabolism\", \"   1\", 1.07345, 0.665263, 0.707793, 0.907567, 1.0, 1.0, 1.0], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  16\", 17.1709, 0.667843, 0.439186, 0.907817, 1.0, 1.0, 1.0], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  12\", 13.02513, 0.671283, 0.447656, 0.909337, 1.0, 1.0, 1.0], [91, \"hsa01002\", \"Peptidases and inhibitors\", \"  65\", 67.95877, 0.678883, 0.372966, 0.913322, 1.0, 1.0, 1.0], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"   2\", 2.27483, 0.679773, 0.600274, 0.913322, 1.0, 1.0, 1.0], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  15\", 16.22589, 0.681003, 0.428266, 0.913322, 1.0, 1.0, 1.0], [8, \"hsa00062\", \"Fatty acid elongation\", \"   2\", 2.33045, 0.688793, 0.584564, 0.919105, 1.0, 1.0, 1.0], [340, \"hsa05205\", \"Proteoglycans in cancer\", \"  25\", 26.79084, 0.688913, 0.394386, 0.919105, 1.0, 1.0, 1.0], [245, \"hsa04727\", \"GABAergic synapse\", \"  15\", 16.29927, 0.689783, 0.419616, 0.919105, 1.0, 1.0, 1.0], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"   6\", 6.58322, 0.695053, 0.498525, 0.919105, 1.0, 1.0, 1.0], [110, \"hsa03010\", \"Ribosome\", \"   2\", 2.42242, 0.700353, 0.561234, 0.919105, 1.0, 1.0, 1.0], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  11\", 12.2588, 0.701953, 0.420316, 0.919105, 1.0, 1.0, 1.0], [149, \"hsa04040\", \"Ion channels\", \"  52\", 54.91809, 0.703753, 0.354696, 0.919105, 1.0, 1.0, 1.0], [368, \"hsa05332\", \"Graft-versus-host disease\", \"   1\", 1.18502, 0.704633, 0.665953, 0.919105, 1.0, 1.0, 1.0], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  12\", 13.30045, 0.706363, 0.414026, 0.919105, 1.0, 1.0, 1.0], [143, \"hsa04015\", \"Rap1 signaling pathway\", \"  32\", 34.3453, 0.707553, 0.363806, 0.919105, 1.0, 1.0, 1.0], [319, \"hsa05143\", \"African trypanosomiasis\", \"   4\", 4.55496, 0.708303, 0.506475, 0.919105, 1.0, 1.0, 1.0], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  16\", 17.62371, 0.710223, 0.390236, 0.919105, 1.0, 1.0, 1.0], [300, \"hsa05016\", \"Huntington disease\", \"  22\", 24.10466, 0.713183, 0.368676, 0.919105, 1.0, 1.0, 1.0], [111, \"hsa03011\", \"Ribosome\", \"   3\", 3.67458, 0.713983, 0.495845, 0.919105, 1.0, 1.0, 1.0], [95, \"hsa01007\", \"Amino acid related enzymes\", \"   5\", 5.83927, 0.714113, 0.462855, 0.919105, 1.0, 1.0, 1.0], [348, \"hsa05216\", \"Thyroid cancer\", \"   3\", 3.61243, 0.716523, 0.505985, 0.919105, 1.0, 1.0, 1.0], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"   2\", 2.52155, 0.723673, 0.535495, 0.919105, 1.0, 1.0, 1.0], [167, \"hsa04115\", \"p53 signaling pathway\", \"   4\", 4.83454, 0.724283, 0.461395, 0.919105, 1.0, 1.0, 1.0], [247, \"hsa04730\", \"Long-term depression\", \"  14\", 15.57993, 0.731273, 0.380906, 0.919105, 1.0, 1.0, 1.0], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  11\", 12.62977, 0.735263, 0.378816, 0.919105, 1.0, 1.0, 1.0], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"   4\", 4.80259, 0.736753, 0.462885, 0.919105, 1.0, 1.0, 1.0], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"   4\", 4.97348, 0.739453, 0.439816, 0.919105, 1.0, 1.0, 1.0], [250, \"hsa04744\", \"Phototransduction\", \"   1\", 1.34008, 0.749563, 0.609654, 0.927287, 1.0, 1.0, 1.0], [144, \"hsa04020\", \"Calcium signaling pathway\", \"  32\", 34.91067, 0.749753, 0.319217, 0.927287, 1.0, 1.0, 1.0], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"   4\", 4.8885, 0.752642, 0.444576, 0.927287, 1.0, 1.0, 1.0], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"   3\", 3.86914, 0.756252, 0.452565, 0.929584, 1.0, 1.0, 1.0], [298, \"hsa05012\", \"Parkinson disease\", \"  15\", 17.15218, 0.762332, 0.335177, 0.933636, 1.0, 1.0, 1.0], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"   6\", 7.43793, 0.765532, 0.376446, 0.936166, 1.0, 1.0, 1.0], [189, \"hsa04216\", \"Ferroptosis\", \"   2\", 2.69216, 0.766402, 0.488515, 0.936166, 1.0, 1.0, 1.0], [178, \"hsa04144\", \"Endocytosis\", \"  26\", 29.15255, 0.769722, 0.298487, 0.936166, 1.0, 1.0, 1.0], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"   2\", 2.66534, 0.770912, 0.490205, 0.936166, 1.0, 1.0, 1.0], [350, \"hsa05218\", \"Melanoma\", \"   7\", 8.55263, 0.771422, 0.361486, 0.936166, 1.0, 1.0, 1.0], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"   9\", 10.8007, 0.776452, 0.342277, 0.938218, 1.0, 1.0, 1.0], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"   1\", 1.43429, 0.777882, 0.572424, 0.939483, 1.0, 1.0, 1.0], [322, \"hsa05146\", \"Amoebiasis\", \"  12\", 14.1961, 0.788322, 0.314017, 0.951072, 1.0, 1.0, 1.0], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  10\", 12.07857, 0.791852, 0.318207, 0.952498, 1.0, 1.0, 1.0], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"   7\", 8.5618, 0.800062, 0.340337, 0.958061, 1.0, 1.0, 1.0], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"   1\", 1.57056, 0.804362, 0.528875, 0.963326, 1.0, 1.0, 1.0], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"   9\", 10.95386, 0.806352, 0.311757, 0.963326, 1.0, 1.0, 1.0], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"   1\", 1.59463, 0.807602, 0.520225, 0.963326, 1.0, 1.0, 1.0], [92, \"hsa01003\", \"Glycosyltransferases\", \"  26\", 29.60893, 0.808542, 0.255917, 0.963326, 1.0, 1.0, 1.0], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  13\", 15.63658, 0.809192, 0.281987, 0.963326, 1.0, 1.0, 1.0], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"   1\", 1.62635, 0.811842, 0.511975, 0.963326, 1.0, 1.0, 1.0], [119, \"hsa03021\", \"Transcription machinery\", \"  18\", 21.30182, 0.813092, 0.260517, 0.963326, 1.0, 1.0, 1.0], [208, \"hsa04515\", \"Cell adhesion molecules\", \"  34\", 38.22991, 0.813712, 0.245168, 0.963326, 1.0, 1.0, 1.0], [209, \"hsa04520\", \"Adherens junction\", \"  12\", 14.40226, 0.813872, 0.285437, 0.963326, 1.0, 1.0, 1.0], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \"  26\", 29.69512, 0.819352, 0.245288, 0.963326, 1.0, 1.0, 1.0], [297, \"hsa05010\", \"Alzheimer disease\", \"  27\", 31.13528, 0.821612, 0.237318, 0.963326, 1.0, 1.0, 1.0], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  16\", 19.22149, 0.824532, 0.251537, 0.963326, 1.0, 1.0, 1.0], [101, \"hsa01524\", \"Platinum drug resistance\", \"   4\", 5.58943, 0.827092, 0.329647, 0.963326, 1.0, 1.0, 1.0], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \"  22\", 26.0614, 0.829902, 0.232118, 0.963326, 1.0, 1.0, 1.0], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \"  40\", 45.11572, 0.830952, 0.217588, 0.963326, 1.0, 1.0, 1.0], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"   4\", 5.64831, 0.833692, 0.317277, 0.963326, 1.0, 1.0, 1.0], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \"  23\", 27.06086, 0.834732, 0.227168, 0.963326, 1.0, 1.0, 1.0], [211, \"hsa04540\", \"Gap junction\", \"  13\", 15.79352, 0.835872, 0.253017, 0.963326, 1.0, 1.0, 1.0], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"   4\", 5.63696, 0.836812, 0.313947, 0.963326, 1.0, 1.0, 1.0], [205, \"hsa04510\", \"Focal adhesion\", \"  29\", 33.5041, 0.837352, 0.217148, 0.963326, 1.0, 1.0, 1.0], [345, \"hsa05213\", \"Endometrial cancer\", \"   6\", 7.9529, 0.837662, 0.290707, 0.963326, 1.0, 1.0, 1.0], [60, \"hsa00565\", \"Ether lipid metabolism\", \"   3\", 4.49785, 0.840472, 0.329527, 0.963326, 1.0, 1.0, 1.0], [249, \"hsa04742\", \"Taste transduction\", \"   7\", 9.10871, 0.842402, 0.276027, 0.963326, 1.0, 1.0, 1.0], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  12\", 14.92713, 0.847302, 0.240248, 0.963326, 1.0, 1.0, 1.0], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"   2\", 3.02662, 0.853971, 0.383426, 0.963326, 1.0, 1.0, 1.0], [169, \"hsa04121\", \"Ubiquitin system\", \"  66\", 73.68237, 0.854701, 0.177308, 0.963326, 1.0, 1.0, 1.0], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"   1\", 1.83252, 0.855051, 0.441856, 0.963326, 1.0, 1.0, 1.0], [255, \"hsa04911\", \"Insulin secretion\", \"  12\", 14.96701, 0.858041, 0.228188, 0.963326, 1.0, 1.0, 1.0], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"   5\", 7.18647, 0.867631, 0.253527, 0.963326, 1.0, 1.0, 1.0], [242, \"hsa04724\", \"Glutamatergic synapse\", \"  23\", 27.38543, 0.868841, 0.189338, 0.963326, 1.0, 1.0, 1.0], [343, \"hsa05211\", \"Renal cell carcinoma\", \"   5\", 7.46104, 0.882681, 0.226568, 0.971203, 1.0, 1.0, 1.0], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"   8\", 10.96623, 0.888591, 0.198838, 0.973553, 1.0, 1.0, 1.0], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"   1\", 2.12983, 0.892701, 0.359226, 0.978667, 1.0, 1.0, 1.0], [346, \"hsa05214\", \"Glioma\", \"   8\", 11.2353, 0.901531, 0.178068, 0.983929, 1.0, 1.0, 1.0], [351, \"hsa05219\", \"Bladder cancer\", \"   2\", 3.81447, 0.908061, 0.248178, 0.991166, 1.0, 1.0, 1.0], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"   1\", 2.41361, 0.910761, 0.305557, 0.993559, 1.0, 1.0, 1.0], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \"  27\", 33.223, 0.913211, 0.126549, 0.995003, 0.820048, 1.0, 1.0], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  11\", 14.98769, 0.914611, 0.147919, 0.995003, 0.900353, 1.0, 1.0], [235, \"hsa04710\", \"Circadian rhythm\", \"   2\", 3.91739, 0.919201, 0.228188, 0.997674, 1.0, 1.0, 1.0], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"   2\", 3.75568, 0.926371, 0.233988, 1.0, 1.0, 1.0, 1.0], [175, \"hsa04140\", \"Autophagy - animal\", \"  11\", 15.61153, 0.927411, 0.125609, 1.0, 0.820048, 1.0, 1.0], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \"  26\", 33.21605, 0.928091, 0.103069, 1.0, 0.774219, 1.0, 1.0], [73, \"hsa00730\", \"Thiamine metabolism\", \"   1\", 2.3184, 0.928451, 0.287677, 1.0, 1.0, 1.0, 1.0], [147, \"hsa04030\", \"G protein-coupled receptors\", \"  24\", 30.63731, 0.929191, 0.105389, 1.0, 0.774219, 1.0, 1.0], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  10\", 14.39366, 0.931871, 0.121379, 1.0, 0.820048, 1.0, 1.0], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"   5\", 7.96474, 0.934211, 0.150478, 1.0, 0.900353, 1.0, 1.0], [113, \"hsa03013\", \"RNA transport\", \"   5\", 8.53352, 0.935321, 0.136379, 1.0, 0.853856, 1.0, 1.0], [344, \"hsa05212\", \"Pancreatic cancer\", \"   5\", 8.42101, 0.935961, 0.137509, 1.0, 0.853856, 1.0, 1.0], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"   1\", 2.34432, 0.936761, 0.277257, 1.0, 1.0, 1.0, 1.0], [268, \"hsa04924\", \"Renin secretion\", \"   8\", 11.92098, 0.939231, 0.118829, 1.0, 0.820048, 1.0, 1.0], [330, \"hsa05165\", \"Human papillomavirus infection\", \"  30\", 37.8228, 0.939351, 0.087759, 1.0, 0.710983, 1.0, 1.0], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"   3\", 5.75165, 0.939361, 0.153648, 1.0, 0.900353, 1.0, 1.0], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"   1\", 2.69465, 0.940741, 0.235398, 1.0, 1.0, 1.0, 1.0], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"   1\", 2.60693, 0.941161, 0.242238, 1.0, 1.0, 1.0, 1.0], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  16\", 21.51588, 0.941381, 0.098259, 1.0, 0.774219, 1.0, 1.0], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"   2\", 4.36784, 0.945051, 0.168358, 1.0, 0.972938, 1.0, 1.0], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \"  58\", 68.54873, 0.945181, 0.072889, 1.0, 0.699443, 1.0, 1.0], [31, \"hsa00380\", \"Tryptophan metabolism\", \"   1\", 2.99777, 0.95516, 0.189398, 1.0, 1.0, 1.0, 1.0], [253, \"hsa04812\", \"Cytoskeleton proteins\", \"  46\", 57.14127, 0.96194, 0.053249, 1.0, 0.619264, 1.0, 1.0], [210, \"hsa04530\", \"Tight junction\", \"  16\", 22.68768, 0.96387, 0.063169, 1.0, 0.674612, 1.0, 1.0], [356, \"hsa05224\", \"Breast cancer\", \"   9\", 14.79663, 0.96884, 0.061519, 1.0, 0.674612, 1.0, 1.0], [116, \"hsa03018\", \"RNA degradation\", \"   2\", 5.12419, 0.96902, 0.103339, 1.0, 0.774219, 1.0, 1.0], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"   4\", 8.1276, 0.97002, 0.078419, 1.0, 0.700413, 1.0, 1.0], [131, \"hsa03310\", \"Nuclear receptors\", \"   3\", 6.60289, 0.97241, 0.081969, 1.0, 0.700413, 1.0, 1.0], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"   3\", 6.7149, 0.97248, 0.080589, 1.0, 0.700413, 1.0, 1.0], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  10\", 16.13064, 0.97944, 0.04386, 1.0, 0.560563, 1.0, 1.0], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"   1\", 3.55779, 0.98351, 0.096319, 1.0, 0.774219, 1.0, 1.0], [288, \"hsa04971\", \"Gastric acid secretion\", \"   6\", 11.56658, 0.98532, 0.03729, 1.0, 0.534492, 1.0, 1.0], [199, \"hsa04360\", \"Axon guidance\", \"  25\", 35.07378, 0.98598, 0.02506, 1.0, 0.37697, 1.0, 0.751792], [173, \"hsa04136\", \"Autophagy - other\", \"   1\", 3.94887, 0.98891, 0.070969, 1.0, 0.699443, 1.0, 1.0], [112, \"hsa03012\", \"Translation factors\", \"   1\", 4.44926, 0.99089, 0.053829, 1.0, 0.619264, 1.0, 1.0], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"   1\", 4.55255, 0.99179, 0.051029, 1.0, 0.618861, 1.0, 1.0], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  12\", 20.87107, 0.99392, 0.01368, 1.0, 0.37697, 1.0, 0.615594], [336, \"hsa05200\", \"Pathways in cancer\", \"  43\", 59.27648, 0.99425, 0.0089, 1.0, 0.37697, 1.0, 0.615594], [342, \"hsa05210\", \"Colorectal cancer\", \"   5\", 11.26832, 0.99453, 0.01691, 1.0, 0.37697, 1.0, 0.627048], [260, \"hsa04916\", \"Melanogenesis\", \"   6\", 13.33051, 0.9954, 0.01262, 1.0, 0.37697, 1.0, 0.615594], [354, \"hsa05222\", \"Small cell lung cancer\", \"   5\", 11.94553, 0.99611, 0.01276, 1.0, 0.37697, 1.0, 0.615594], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  11\", 20.77755, 0.99647, 0.00797, 1.0, 0.37697, 1.0, 0.615594], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"   9\", 18.28936, 0.9967, 0.0083, 1.0, 0.37697, 1.0, 0.615594], [174, \"hsa04137\", \"Mitophagy - animal\", \"   2\", 6.45875, 0.9971, 0.01916, 1.0, 0.37697, 1.0, 0.627048], [358, \"hsa05226\", \"Gastric cancer\", \"   6\", 16.69864, 0.99962, 0.00122, 1.0, 0.14268, 1.0, 0.439196], [17, \"hsa00220\", \"Arginine biosynthesis\", \"   0\", 1.31708, 1.0, 0.255857, 1.0, 1.0, 1.0, 1.0], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"   0\", 0.94251, 1.0, 0.359616, 1.0, 1.0, 1.0, 1.0], [349, \"hsa05217\", \"Basal cell carcinoma\", \"   0\", 5.4806, 1.0, 0.00284, 1.0, 0.181, 1.0, 0.511195], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"   0\", 1.68613, 1.0, 0.178048, 1.0, 1.0, 1.0, 1.0], [81, \"hsa00830\", \"Retinol metabolism\", \"   0\", 2.5752, 1.0, 0.070379, 1.0, 0.699443, 1.0, 1.0], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"   0\", 0.74644, 1.0, 0.466915, 1.0, 1.0, 1.0, 1.0], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"   0\", 3.20339, 1.0, 0.01874, 1.0, 0.37697, 1.0, 0.627048], [118, \"hsa03020\", \"RNA polymerase\", \"   0\", 1.37035, 1.0, 0.244548, 1.0, 1.0, 1.0, 1.0]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#9c3dc905-fa25-4c65-a99a-379c4de9708e').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#9c3dc905-fa25-4c65-a99a-379c4de9708e').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                            FunctionName  n_candidates  \\\n",
       "153  hsa04060  Cytokine-cytokine receptor interaction            31   \n",
       "317  hsa05140                           Leishmaniasis            14   \n",
       "4    hsa00051         Fructose and mannose metabolism            11   \n",
       "226  hsa04658        Th1 and Th2 cell differentiation            20   \n",
       "369  hsa05340                Primary immunodeficiency             8   \n",
       "..        ...                                     ...           ...   \n",
       "82   hsa00860    Porphyrin and chlorophyll metabolism             0   \n",
       "81   hsa00830                      Retinol metabolism             0   \n",
       "6    hsa00053       Ascorbate and aldarate metabolism             0   \n",
       "77   hsa00770       Pantothenate and CoA biosynthesis             0   \n",
       "118  hsa03020                          RNA polymerase             0   \n",
       "\n",
       "     mean_n_resample  emp_p_e   emp_p_d     fdr_e     fdr_d  BH_fdr_e  \\\n",
       "153         12.92409  0.00001  1.000000  0.000000  1.000000   0.00180   \n",
       "317          4.02017  0.00001  1.000000  0.000000  1.000000   0.00180   \n",
       "4            2.87772  0.00002  1.000000  0.000483  1.000000   0.00180   \n",
       "226          7.42084  0.00002  1.000000  0.000483  1.000000   0.00180   \n",
       "369          1.47590  0.00007  1.000000  0.002486  1.000000   0.00504   \n",
       "..               ...      ...       ...       ...       ...       ...   \n",
       "82           1.68613  1.00000  0.178048  1.000000  1.000000   1.00000   \n",
       "81           2.57520  1.00000  0.070379  1.000000  0.699443   1.00000   \n",
       "6            0.74644  1.00000  0.466915  1.000000  1.000000   1.00000   \n",
       "77           3.20339  1.00000  0.018740  1.000000  0.376970   1.00000   \n",
       "118          1.37035  1.00000  0.244548  1.000000  1.000000   1.00000   \n",
       "\n",
       "     BH_fdr_d  \n",
       "153  1.000000  \n",
       "317  1.000000  \n",
       "4    1.000000  \n",
       "226  1.000000  \n",
       "369  1.000000  \n",
       "..        ...  \n",
       "82   1.000000  \n",
       "81   1.000000  \n",
       "6    1.000000  \n",
       "77   0.627048  \n",
       "118  1.000000  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ce_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "00ac9401",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"9ede0138-85d5-4de7-8b06-c6528342feef\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  29\", 13.18629, 5e-05, 0.99999, 0.0083, 1.0, 0.0144, 0.99999], [369, \"hsa05340\", \"Primary immunodeficiency\", \"   8\", 1.48048, 0.0001, 0.99998, 0.00917, 1.0, 0.0144, 0.99999], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \"  21\", 9.35499, 0.00014, 0.99994, 0.00917, 1.0, 0.0144, 0.99999], [317, \"hsa05140\", \"Leishmaniasis\", \"  13\", 4.05193, 0.00016, 0.99998, 0.00917, 1.0, 0.0144, 0.99999], [226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  17\", 7.29916, 0.00072, 0.99978, 0.030566, 1.0, 0.051839, 0.99999], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  17\", 8.00632, 0.00149, 0.99944, 0.055467, 1.0, 0.089399, 0.99999], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \"  24\", 12.85206, 0.00202, 0.99915, 0.064067, 1.0, 0.101879, 0.99999], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  13\", 5.4839, 0.00237, 0.99922, 0.064067, 1.0, 0.101879, 0.99999], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \"  42\", 27.34249, 0.00262, 0.9986, 0.064067, 1.0, 0.101879, 0.99999], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  18\", 9.25053, 0.00283, 0.99897, 0.064067, 1.0, 0.101879, 0.99999], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  19\", 10.02529, 0.00399, 0.99832, 0.084581, 1.0, 0.130581, 0.99999], [99, \"hsa01522\", \"Endocrine resistance\", \"  21\", 12.04005, 0.00524, 0.99782, 0.098203, 1.0, 0.155906, 0.99999], [26, \"hsa00310\", \"Lysine degradation\", \"  13\", 6.2166, 0.00563, 0.99817, 0.098203, 1.0, 0.155906, 0.99999], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  10\", 4.26377, 0.00825, 0.99723, 0.138864, 1.0, 0.195523, 0.99999], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"   6\", 1.78896, 0.00862, 0.99814, 0.138864, 1.0, 0.195523, 0.99999], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 143\", 118.89178, 0.00869, 0.99329, 0.138864, 1.0, 0.195523, 0.99999], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  13\", 6.54985, 0.01155, 0.99577, 0.161273, 1.0, 0.244586, 0.99999], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  19\", 11.29985, 0.0145, 0.99282, 0.191937, 1.0, 0.261925, 0.99999], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  16\", 9.1343, 0.01473, 0.99369, 0.191937, 1.0, 0.261925, 0.99999], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"   8\", 3.26798, 0.01624, 0.99476, 0.196582, 1.0, 0.261925, 0.99999], [113, \"hsa03013\", \"RNA transport\", \"  15\", 8.24783, 0.01749, 0.99195, 0.203031, 1.0, 0.261925, 0.99999], [125, \"hsa03040\", \"Spliceosome\", \"  11\", 5.30354, 0.01754, 0.99285, 0.203031, 1.0, 0.261925, 0.99999], [278, \"hsa04934\", \"Cushing syndrome\", \"  29\", 19.93897, 0.01888, 0.98963, 0.203031, 1.0, 0.261925, 0.99999], [28, \"hsa00340\", \"Histidine metabolism\", \"   4\", 1.05665, 0.02019, 0.99638, 0.203031, 1.0, 0.261925, 0.99999], [312, \"hsa05131\", \"Shigellosis\", \"  34\", 24.36798, 0.0219, 0.98666, 0.206447, 1.0, 0.261925, 0.99999], [119, \"hsa03021\", \"Transcription machinery\", \"  30\", 20.7398, 0.02218, 0.987, 0.206447, 1.0, 0.261925, 0.99999], [314, \"hsa05133\", \"Pertussis\", \"   8\", 3.54401, 0.02231, 0.99257, 0.206447, 1.0, 0.261925, 0.99999], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \"  20\", 12.74127, 0.02335, 0.98811, 0.206447, 1.0, 0.261925, 0.99999], [321, \"hsa05145\", \"Toxoplasmosis\", \"  17\", 10.34363, 0.02353, 0.98869, 0.206447, 1.0, 0.261925, 0.99999], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \"  28\", 18.71304, 0.02373, 0.98577, 0.206447, 1.0, 0.261925, 0.99999], [100, \"hsa01523\", \"Antifolate resistance\", \"   5\", 1.7446, 0.02389, 0.99464, 0.206447, 1.0, 0.261925, 0.99999], [126, \"hsa03041\", \"Spliceosome\", \"  34\", 24.35085, 0.0239, 0.98527, 0.206447, 1.0, 0.261925, 0.99999], [351, \"hsa05219\", \"Bladder cancer\", \"   8\", 3.63413, 0.02401, 0.99238, 0.206447, 1.0, 0.261925, 0.99999], [68, \"hsa00620\", \"Pyruvate metabolism\", \"   7\", 3.04597, 0.02641, 0.99186, 0.206447, 1.0, 0.279632, 0.99999], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"   3\", 0.70763, 0.02925, 0.99616, 0.206447, 1.0, 0.300854, 0.99999], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"  12\", 6.8357, 0.03164, 0.98647, 0.211668, 1.0, 0.31164, 0.99999], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  12\", 6.82486, 0.03203, 0.98617, 0.211668, 1.0, 0.31164, 0.99999], [16, \"hsa00199\", \"Cytochrome P450\", \"   7\", 3.09144, 0.03336, 0.98902, 0.213538, 1.0, 0.316039, 0.99999], [29, \"hsa00350\", \"Tyrosine metabolism\", \"   5\", 1.87546, 0.035, 0.9911, 0.222097, 1.0, 0.323074, 0.99999], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"   6\", 2.75287, 0.03856, 0.98938, 0.24272, 1.0, 0.346821, 0.99999], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  15\", 9.43691, 0.04059, 0.98052, 0.249315, 1.0, 0.346821, 0.99999], [107, \"hsa03000\", \"Transcription factors\", \"  92\", 77.66448, 0.04181, 0.96716, 0.249315, 1.0, 0.346821, 0.99999], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \"  20\", 13.32238, 0.04271, 0.97613, 0.249315, 1.0, 0.346821, 0.99999], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  15\", 9.34587, 0.04299, 0.97859, 0.249315, 1.0, 0.346821, 0.99999], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  12\", 7.11715, 0.04428, 0.97976, 0.249315, 1.0, 0.346821, 0.99999], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  21\", 14.52509, 0.0465, 0.97374, 0.252265, 1.0, 0.346821, 0.99999], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  17\", 11.45074, 0.04662, 0.97669, 0.252265, 1.0, 0.346821, 0.99999], [338, \"hsa05203\", \"Viral carcinogenesis\", \"  22\", 15.34565, 0.04675, 0.97306, 0.252265, 1.0, 0.346821, 0.99999], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \"  19\", 12.79153, 0.0475, 0.97398, 0.252265, 1.0, 0.346821, 0.99999], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"   5\", 1.99961, 0.04817, 0.98599, 0.252265, 1.0, 0.346821, 0.99999], [137, \"hsa03440\", \"Homologous recombination\", \"   7\", 3.41489, 0.051999, 0.98084, 0.254135, 1.0, 0.364496, 0.99999], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \"  32\", 24.19553, 0.052649, 0.96636, 0.254135, 1.0, 0.364496, 0.99999], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"   7\", 3.4863, 0.054559, 0.97962, 0.260298, 1.0, 0.36633, 0.99999], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"   5\", 2.06964, 0.054949, 0.9833, 0.260298, 1.0, 0.36633, 0.99999], [297, \"hsa05010\", \"Alzheimer disease\", \"  39\", 30.67973, 0.061179, 0.95865, 0.280829, 1.0, 0.399537, 0.99999], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"   7\", 3.54195, 0.062559, 0.97543, 0.285093, 1.0, 0.399537, 0.99999], [329, \"hsa05164\", \"Influenza A\", \"  16\", 10.72269, 0.064129, 0.96521, 0.288711, 1.0, 0.399537, 0.99999], [151, \"hsa04052\", \"Cytokines and growth factors\", \"  20\", 14.37116, 0.064749, 0.96266, 0.288711, 1.0, 0.399537, 0.99999], [315, \"hsa05134\", \"Legionellosis\", \"   5\", 2.17065, 0.065569, 0.97922, 0.288711, 1.0, 0.399537, 0.99999], [327, \"hsa05162\", \"Measles\", \"  13\", 8.26654, 0.067159, 0.96513, 0.288711, 1.0, 0.399537, 0.99999], [123, \"hsa03032\", \"DNA replication proteins\", \"  12\", 7.42155, 0.067699, 0.96535, 0.288711, 1.0, 0.399537, 0.99999], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"   8\", 4.41522, 0.070149, 0.97097, 0.291956, 1.0, 0.407319, 0.99999], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  17\", 11.68106, 0.071329, 0.95951, 0.291956, 1.0, 0.407596, 0.99999], [292, \"hsa04975\", \"Fat digestion and absorption\", \"   5\", 2.25896, 0.073179, 0.97671, 0.293961, 1.0, 0.411633, 0.99999], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \"  25\", 18.62494, 0.074509, 0.95387, 0.293961, 1.0, 0.412667, 0.99999], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"   5\", 2.33573, 0.078939, 0.97426, 0.30951, 1.0, 0.430578, 0.99999], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"   6\", 3.0759, 0.087329, 0.96642, 0.336231, 1.0, 0.461995, 0.99999], [148, \"hsa04031\", \"GTP-binding proteins\", \"  19\", 13.79031, 0.089599, 0.946181, 0.339405, 1.0, 0.461995, 0.99999], [9, \"hsa00071\", \"Fatty acid degradation\", \"   5\", 2.39349, 0.091759, 0.96723, 0.344644, 1.0, 0.461995, 0.99999], [179, \"hsa04145\", \"Phagosome\", \"  13\", 8.70278, 0.092309, 0.9501, 0.344644, 1.0, 0.461995, 0.99999], [296, \"hsa04979\", \"Cholesterol metabolism\", \"   8\", 4.78289, 0.092319, 0.96045, 0.344644, 1.0, 0.461995, 0.99999], [191, \"hsa04218\", \"Cellular senescence\", \"  20\", 14.71563, 0.092399, 0.943491, 0.344644, 1.0, 0.461995, 0.99999], [150, \"hsa04050\", \"Cytokine receptors\", \"  11\", 7.18696, 0.101949, 0.947081, 0.360509, 1.0, 0.501564, 0.99999], [320, \"hsa05144\", \"Malaria\", \"   5\", 2.5295, 0.104099, 0.9627, 0.36202, 1.0, 0.501564, 0.99999], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"   8\", 4.82966, 0.106949, 0.95034, 0.364003, 1.0, 0.501564, 0.99999], [84, \"hsa00910\", \"Nitrogen metabolism\", \"   3\", 1.17885, 0.107149, 0.97479, 0.364003, 1.0, 0.501564, 0.99999], [53, \"hsa00535\", \"Proteoglycans\", \"  13\", 9.54833, 0.107279, 0.949261, 0.364003, 1.0, 0.501564, 0.99999], [324, \"hsa05152\", \"Tuberculosis\", \"  16\", 11.61354, 0.114429, 0.931251, 0.379711, 1.0, 0.528133, 0.99999], [356, \"hsa05224\", \"Breast cancer\", \"  19\", 14.33052, 0.118339, 0.926061, 0.387471, 1.0, 0.535297, 0.99999], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"   2\", 0.60349, 0.120709, 0.97923, 0.391178, 1.0, 0.535297, 0.99999], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"  14\", 10.12149, 0.120899, 0.930581, 0.391178, 1.0, 0.535297, 0.99999], [134, \"hsa03410\", \"Base excision repair\", \"   3\", 1.22352, 0.121929, 0.96679, 0.391178, 1.0, 0.535297, 0.99999], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \"  25\", 19.86495, 0.127029, 0.915281, 0.399985, 1.0, 0.545737, 0.99999], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \"  39\", 32.39421, 0.127339, 0.906821, 0.399985, 1.0, 0.545737, 0.99999], [90, \"hsa01001\", \"Protein kinases\", \"  89\", 80.05178, 0.136069, 0.890131, 0.421789, 1.0, 0.55651, 0.99999], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  18\", 13.76328, 0.138079, 0.914511, 0.424658, 1.0, 0.55651, 0.99999], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"   7\", 4.42166, 0.140269, 0.935921, 0.428511, 1.0, 0.55651, 0.99999], [155, \"hsa04062\", \"Chemokine signaling pathway\", \"  26\", 21.13989, 0.141629, 0.904921, 0.428511, 1.0, 0.55651, 0.99999], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  10\", 6.9354, 0.147419, 0.921701, 0.436609, 1.0, 0.55651, 0.99999], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  16\", 12.25714, 0.147419, 0.911551, 0.436609, 1.0, 0.55651, 0.99999], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \"  21\", 16.56049, 0.147539, 0.902371, 0.436609, 1.0, 0.55651, 0.99999], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"   5\", 2.81226, 0.148119, 0.940651, 0.436609, 1.0, 0.55651, 0.99999], [300, \"hsa05016\", \"Huntington disease\", \"  29\", 23.86866, 0.148579, 0.894411, 0.436609, 1.0, 0.55651, 0.99999], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"   6\", 3.7842, 0.148879, 0.940171, 0.436609, 1.0, 0.55651, 0.99999], [340, \"hsa05205\", \"Proteoglycans in cancer\", \"  32\", 26.7994, 0.149019, 0.894021, 0.436609, 1.0, 0.55651, 0.99999], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"   8\", 5.19782, 0.149289, 0.925141, 0.436609, 1.0, 0.55651, 0.99999], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"   6\", 3.71697, 0.149949, 0.937661, 0.436609, 1.0, 0.55651, 0.99999], [326, \"hsa05161\", \"Hepatitis B\", \"  18\", 14.00635, 0.154468, 0.901561, 0.436609, 1.0, 0.567435, 0.99999], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"   4\", 2.15294, 0.158808, 0.946461, 0.436609, 1.0, 0.577485, 0.99999], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  17\", 13.24432, 0.165158, 0.892931, 0.442817, 1.0, 0.578487, 0.99999], [111, \"hsa03011\", \"Ribosome\", \"   6\", 3.68634, 0.165428, 0.922661, 0.442817, 1.0, 0.578487, 0.99999], [140, \"hsa04010\", \"MAPK signaling pathway\", \"  46\", 40.14173, 0.165778, 0.874091, 0.442817, 1.0, 0.578487, 0.99999], [237, \"hsa04714\", \"Thermogenesis\", \"  23\", 18.79196, 0.165928, 0.887981, 0.442817, 1.0, 0.578487, 0.99999], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"   7\", 4.6042, 0.167118, 0.920501, 0.442817, 1.0, 0.578487, 0.99999], [85, \"hsa00920\", \"Sulfur metabolism\", \"   2\", 0.74747, 0.169828, 0.9652, 0.442817, 1.0, 0.582268, 0.99999], [303, \"hsa05030\", \"Cocaine addiction\", \"   9\", 6.39387, 0.173398, 0.910291, 0.443402, 1.0, 0.5889, 0.99999], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  16\", 12.48787, 0.175688, 0.887791, 0.443402, 1.0, 0.591101, 0.99999], [169, \"hsa04121\", \"Ubiquitin system\", \"  80\", 72.79296, 0.189528, 0.843122, 0.481517, 1.0, 0.62897, 0.99999], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"   3\", 1.50607, 0.190438, 0.936951, 0.481517, 1.0, 0.62897, 0.99999], [31, \"hsa00380\", \"Tryptophan metabolism\", \"   5\", 3.11843, 0.197858, 0.913381, 0.492403, 1.0, 0.647535, 0.99999], [316, \"hsa05135\", \"Yersinia infection\", \"  18\", 14.6341, 0.200818, 0.867251, 0.498516, 1.0, 0.651302, 0.99999], [232, \"hsa04668\", \"TNF signaling pathway\", \"  12\", 9.22175, 0.204998, 0.874691, 0.503923, 1.0, 0.658922, 0.99999], [275, \"hsa04931\", \"Insulin resistance\", \"  15\", 12.01643, 0.208758, 0.866891, 0.507236, 1.0, 0.664793, 0.99999], [344, \"hsa05212\", \"Pancreatic cancer\", \"  11\", 8.37349, 0.210518, 0.875051, 0.507902, 1.0, 0.664793, 0.99999], [138, \"hsa03450\", \"Non-homologous end-joining\", \"   3\", 1.64309, 0.221228, 0.927871, 0.533543, 1.0, 0.689423, 0.99999], [177, \"hsa04142\", \"Lysosome\", \"  12\", 9.45889, 0.227538, 0.857591, 0.54267, 1.0, 0.689423, 0.99999], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  16\", 13.17054, 0.228788, 0.850481, 0.54267, 1.0, 0.689423, 0.99999], [347, \"hsa05215\", \"Prostate cancer\", \"  15\", 12.21613, 0.229128, 0.850221, 0.54267, 1.0, 0.689423, 0.99999], [95, \"hsa01007\", \"Amino acid related enzymes\", \"   8\", 5.92035, 0.231078, 0.874421, 0.54267, 1.0, 0.689423, 0.99999], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"   8\", 5.95242, 0.232868, 0.873081, 0.54267, 1.0, 0.689423, 0.99999], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"   4\", 2.52139, 0.233218, 0.908691, 0.54267, 1.0, 0.689423, 0.99999], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \"  20\", 17.00226, 0.233638, 0.842672, 0.54267, 1.0, 0.689423, 0.99999], [313, \"hsa05132\", \"Salmonella infection\", \"  22\", 18.73139, 0.237738, 0.828882, 0.54267, 1.0, 0.695817, 0.99999], [180, \"hsa04146\", \"Peroxisome\", \"   8\", 5.96153, 0.242628, 0.861891, 0.54267, 1.0, 0.704403, 0.99999], [182, \"hsa04150\", \"mTOR signaling pathway\", \"  19\", 16.15436, 0.255237, 0.820332, 0.562382, 1.0, 0.735084, 0.99999], [165, \"hsa04110\", \"Cell cycle\", \"  12\", 9.6824, 0.258167, 0.834962, 0.563994, 1.0, 0.737621, 0.99999], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  16\", 13.42134, 0.261047, 0.822922, 0.563994, 1.0, 0.739977, 0.99999], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"   7\", 5.20943, 0.265117, 0.849482, 0.56535, 1.0, 0.745643, 0.99999], [135, \"hsa03420\", \"Nucleotide excision repair\", \"   4\", 2.63384, 0.267617, 0.880561, 0.569339, 1.0, 0.746839, 0.99999], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  12\", 9.78279, 0.269847, 0.825822, 0.571589, 1.0, 0.747269, 0.99999], [42, \"hsa00511\", \"Other glycan degradation\", \"   2\", 1.02677, 0.273137, 0.922171, 0.576431, 1.0, 0.750606, 0.99999], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \"  29\", 25.81605, 0.278437, 0.785292, 0.590293, 1.0, 0.759374, 0.99999], [216, \"hsa04614\", \"Renin-angiotensin system\", \"   3\", 1.85882, 0.281597, 0.890261, 0.592607, 1.0, 0.762218, 0.99999], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  22\", 19.32721, 0.284817, 0.790512, 0.594154, 1.0, 0.76518, 0.99999], [122, \"hsa03030\", \"DNA replication\", \"   3\", 1.87769, 0.288367, 0.884551, 0.59786, 1.0, 0.768979, 0.99999], [166, \"hsa04114\", \"Oocyte meiosis\", \"  15\", 12.84168, 0.294667, 0.796792, 0.602075, 1.0, 0.780001, 0.99999], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \"  18\", 15.75618, 0.301847, 0.785072, 0.613391, 1.0, 0.793166, 0.99999], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"   8\", 6.41327, 0.304047, 0.822812, 0.613958, 1.0, 0.793166, 0.99999], [367, \"hsa05330\", \"Allograft rejection\", \"   2\", 1.11389, 0.307577, 0.901121, 0.619536, 1.0, 0.796602, 0.99999], [295, \"hsa04978\", \"Mineral absorption\", \"   5\", 3.74845, 0.316287, 0.837622, 0.645722, 1.0, 0.813309, 0.99999], [200, \"hsa04370\", \"VEGF signaling pathway\", \"   9\", 7.49968, 0.328427, 0.797852, 0.657978, 1.0, 0.825112, 0.99999], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"   5\", 3.80269, 0.329037, 0.823902, 0.657978, 1.0, 0.825112, 0.99999], [210, \"hsa04530\", \"Tight junction\", \"  25\", 22.78285, 0.330257, 0.750232, 0.657978, 1.0, 0.825112, 0.99999], [120, \"hsa03022\", \"Basal transcription factors\", \"   4\", 2.91148, 0.331377, 0.838622, 0.657978, 1.0, 0.825112, 0.99999], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \"  21\", 18.85356, 0.332337, 0.749333, 0.657978, 1.0, 0.825112, 0.99999], [190, \"hsa04217\", \"Necroptosis\", \"  10\", 8.46915, 0.340087, 0.778022, 0.664263, 1.0, 0.831989, 0.99999], [289, \"hsa04972\", \"Pancreatic secretion\", \"  15\", 13.31861, 0.344237, 0.762522, 0.669473, 1.0, 0.831989, 0.99999], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  12\", 10.42175, 0.348727, 0.759312, 0.676715, 1.0, 0.831989, 0.99999], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \"  26\", 23.97967, 0.350156, 0.733103, 0.676715, 1.0, 0.831989, 0.99999], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"   3\", 2.0992, 0.350486, 0.848012, 0.676715, 1.0, 0.831989, 0.99999], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  14\", 12.36667, 0.350526, 0.754222, 0.676715, 1.0, 0.831989, 0.99999], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"   4\", 3.00111, 0.353436, 0.820712, 0.676715, 1.0, 0.831989, 0.99999], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"   1\", 0.43111, 0.354066, 0.931971, 0.676715, 1.0, 0.831989, 0.99999], [215, \"hsa04612\", \"Antigen processing and presentation\", \"   3\", 2.12084, 0.355906, 0.836582, 0.676715, 1.0, 0.831989, 0.99999], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"   3\", 2.14724, 0.363906, 0.839302, 0.676715, 1.0, 0.843524, 0.99999], [307, \"hsa05034\", \"Alcoholism\", \"  15\", 13.49445, 0.369506, 0.736283, 0.676715, 1.0, 0.843524, 0.99999], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  12\", 10.63276, 0.370806, 0.744933, 0.676715, 1.0, 0.843524, 0.99999], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"   3\", 2.1718, 0.372336, 0.837652, 0.676715, 1.0, 0.843524, 0.99999], [5, \"hsa00052\", \"Galactose metabolism\", \"   3\", 2.1791, 0.372556, 0.828632, 0.676715, 1.0, 0.843524, 0.99999], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  14\", 12.59582, 0.375286, 0.734803, 0.676715, 1.0, 0.844394, 0.99999], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  13\", 11.74772, 0.380846, 0.745203, 0.680262, 1.0, 0.848969, 0.99999], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"   6\", 4.99745, 0.382036, 0.773022, 0.680262, 1.0, 0.848969, 0.99999], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  19\", 17.57821, 0.391836, 0.704273, 0.691206, 1.0, 0.862147, 0.99999], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \"  19\", 17.6475, 0.392756, 0.711613, 0.691881, 1.0, 0.862147, 0.99999], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \"  27\", 25.47991, 0.399526, 0.685373, 0.698363, 1.0, 0.868663, 0.99999], [196, \"hsa04330\", \"Notch signaling pathway\", \"   5\", 4.15445, 0.400696, 0.771412, 0.699668, 1.0, 0.868663, 0.99999], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"   2\", 1.36876, 0.403606, 0.852121, 0.699668, 1.0, 0.868663, 0.99999], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"   9\", 7.99238, 0.405376, 0.734293, 0.699668, 1.0, 0.868663, 0.99999], [8, \"hsa00062\", \"Fatty acid elongation\", \"   3\", 2.3092, 0.408686, 0.805032, 0.7015, 1.0, 0.870574, 0.99999], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"   2\", 1.3874, 0.412816, 0.846862, 0.703371, 1.0, 0.873739, 0.99999], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \"  31\", 29.60366, 0.415026, 0.667833, 0.703371, 1.0, 0.873739, 0.99999], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  18\", 16.84716, 0.418486, 0.680463, 0.709203, 1.0, 0.875901, 0.99999], [306, \"hsa05033\", \"Nicotine addiction\", \"   9\", 8.11116, 0.423396, 0.717153, 0.716067, 1.0, 0.876284, 0.99999], [112, \"hsa03012\", \"Translation factors\", \"   5\", 4.2674, 0.423876, 0.748563, 0.716164, 1.0, 0.876284, 0.99999], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  13\", 12.04722, 0.427436, 0.689443, 0.718294, 1.0, 0.876284, 0.99999], [110, \"hsa03010\", \"Ribosome\", \"   3\", 2.38534, 0.428406, 0.783922, 0.719263, 1.0, 0.876284, 0.99999], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  13\", 12.12956, 0.438706, 0.679243, 0.732104, 1.0, 0.882571, 0.99999], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"   2\", 1.48018, 0.440576, 0.818212, 0.732753, 1.0, 0.882571, 0.99999], [71, \"hsa00650\", \"Butanoate metabolism\", \"   3\", 2.42211, 0.440746, 0.780022, 0.732753, 1.0, 0.882571, 0.99999], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  12\", 11.17471, 0.441286, 0.689243, 0.732753, 1.0, 0.882571, 0.99999], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \"  23\", 22.07879, 0.451515, 0.643334, 0.742968, 1.0, 0.898042, 0.99999], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"   5\", 4.42103, 0.456385, 0.725383, 0.747331, 1.0, 0.902681, 0.99999], [142, \"hsa04014\", \"Ras signaling pathway\", \"  33\", 32.13532, 0.462055, 0.613824, 0.751182, 1.0, 0.902681, 0.99999], [362, \"hsa05310\", \"Asthma\", \"   1\", 0.62076, 0.463725, 0.871601, 0.75394, 1.0, 0.902681, 0.99999], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  11\", 10.38861, 0.466095, 0.664783, 0.755181, 1.0, 0.902681, 0.99999], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  17\", 16.29057, 0.466385, 0.643294, 0.755181, 1.0, 0.902681, 0.99999], [348, \"hsa05216\", \"Thyroid cancer\", \"   4\", 3.52863, 0.475145, 0.725203, 0.764218, 1.0, 0.914718, 0.99999], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"   3\", 2.54865, 0.479345, 0.756342, 0.769302, 1.0, 0.917895, 0.99999], [350, \"hsa05218\", \"Melanoma\", \"   9\", 8.50496, 0.483595, 0.659363, 0.77156, 1.0, 0.921134, 0.99999], [214, \"hsa04611\", \"Platelet activation\", \"  19\", 18.54728, 0.493955, 0.611594, 0.776558, 1.0, 0.935915, 0.99999], [247, \"hsa04730\", \"Long-term depression\", \"  16\", 15.57102, 0.498395, 0.620364, 0.781016, 1.0, 0.939383, 0.99999], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"   3\", 2.66327, 0.504275, 0.726693, 0.788045, 1.0, 0.945516, 0.99999], [185, \"hsa04210\", \"Apoptosis\", \"  11\", 10.76104, 0.518775, 0.610264, 0.80578, 1.0, 0.967663, 0.99999], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  24\", 23.86556, 0.526715, 0.567724, 0.815684, 1.0, 0.977409, 0.99999], [181, \"hsa04147\", \"Exosome\", \"  68\", 68.17486, 0.529585, 0.522135, 0.815684, 1.0, 0.977695, 0.99999], [268, \"hsa04924\", \"Renin secretion\", \"  12\", 11.82653, 0.532585, 0.601664, 0.815684, 1.0, 0.978217, 0.99999], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"  12\", 11.87389, 0.538835, 0.594994, 0.825114, 1.0, 0.982894, 0.99999], [211, \"hsa04540\", \"Gap junction\", \"  16\", 15.93517, 0.541685, 0.575154, 0.825114, 1.0, 0.982894, 0.99999], [39, \"hsa00480\", \"Glutathione metabolism\", \"   2\", 1.8142, 0.545375, 0.726783, 0.825425, 1.0, 0.982894, 0.99999], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"   5\", 4.85959, 0.548695, 0.651393, 0.827164, 1.0, 0.982894, 0.99999], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"   2\", 1.80933, 0.551494, 0.730863, 0.827164, 1.0, 0.982894, 0.99999], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  13\", 13.02656, 0.553144, 0.569574, 0.827164, 1.0, 0.982894, 0.99999], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \"  19\", 19.11912, 0.557284, 0.551634, 0.827164, 1.0, 0.982894, 0.99999], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"   3\", 2.84951, 0.558794, 0.687413, 0.827164, 1.0, 0.982894, 0.99999], [293, \"hsa04976\", \"Bile secretion\", \"   9\", 9.05209, 0.562404, 0.581924, 0.827164, 1.0, 0.982894, 0.99999], [291, \"hsa04974\", \"Protein digestion and absorption\", \"  11\", 11.10797, 0.564564, 0.566054, 0.827164, 1.0, 0.982894, 0.99999], [249, \"hsa04742\", \"Taste transduction\", \"   9\", 9.03491, 0.566384, 0.584904, 0.827164, 1.0, 0.982894, 0.99999], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"   2\", 1.87382, 0.567894, 0.713343, 0.827164, 1.0, 0.982894, 0.99999], [298, \"hsa05012\", \"Parkinson disease\", \"  17\", 17.26199, 0.572424, 0.538705, 0.829591, 1.0, 0.984179, 0.99999], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"   3\", 2.96883, 0.574104, 0.654623, 0.829591, 1.0, 0.984179, 0.99999], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  20\", 20.51275, 0.588614, 0.512215, 0.843677, 1.0, 1.0, 0.99999], [209, \"hsa04520\", \"Adherens junction\", \"  14\", 14.43675, 0.602764, 0.521355, 0.865828, 1.0, 1.0, 0.99999], [373, \"hsa05416\", \"Viral myocarditis\", \"   6\", 6.15699, 0.603704, 0.580714, 0.865828, 1.0, 1.0, 0.99999], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"   1\", 0.89776, 0.606884, 0.776802, 0.866063, 1.0, 1.0, 0.99999], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  17\", 17.62319, 0.609334, 0.499025, 0.867986, 1.0, 1.0, 0.99999], [11, \"hsa00100\", \"Steroid biosynthesis\", \"   1\", 0.91881, 0.610354, 0.766752, 0.867986, 1.0, 1.0, 0.99999], [349, \"hsa05217\", \"Basal cell carcinoma\", \"   5\", 5.22777, 0.610914, 0.574794, 0.867986, 1.0, 1.0, 0.99999], [127, \"hsa03050\", \"Proteasome\", \"   2\", 2.03837, 0.611344, 0.667143, 0.867986, 1.0, 1.0, 0.99999], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \"  18\", 18.59972, 0.613474, 0.498415, 0.867986, 1.0, 1.0, 0.99999], [341, \"hsa05206\", \"MicroRNAs in cancer\", \"  21\", 21.90982, 0.622254, 0.472385, 0.868381, 1.0, 1.0, 0.99999], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"   2\", 2.0688, 0.623194, 0.657313, 0.868381, 1.0, 1.0, 0.99999], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"   9\", 9.47161, 0.624144, 0.520065, 0.868381, 1.0, 1.0, 0.99999], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"   7\", 7.3189, 0.624634, 0.548615, 0.868381, 1.0, 1.0, 0.99999], [70, \"hsa00640\", \"Propanoate metabolism\", \"   4\", 4.22414, 0.630844, 0.583324, 0.869729, 1.0, 1.0, 0.99999], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"   3\", 3.19402, 0.634744, 0.601614, 0.873958, 1.0, 1.0, 0.99999], [128, \"hsa03051\", \"Proteasome\", \"   3\", 3.26867, 0.641874, 0.586414, 0.878544, 1.0, 1.0, 0.99999], [238, \"hsa04720\", \"Long-term potentiation\", \"  14\", 14.80254, 0.647474, 0.472695, 0.881616, 1.0, 1.0, 0.99999], [80, \"hsa00790\", \"Folate biosynthesis\", \"   2\", 2.09945, 0.650993, 0.651333, 0.883783, 1.0, 1.0, 0.99999], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  18\", 19.04229, 0.652503, 0.453405, 0.883783, 1.0, 1.0, 0.99999], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"   2\", 2.22373, 0.652933, 0.616544, 0.883783, 1.0, 1.0, 0.99999], [132, \"hsa03320\", \"PPAR signaling pathway\", \"   5\", 5.50802, 0.656083, 0.524165, 0.883817, 1.0, 1.0, 0.99999], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  10\", 10.88057, 0.666343, 0.466455, 0.893375, 1.0, 1.0, 0.99999], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \"  20\", 21.32029, 0.669583, 0.428886, 0.893681, 1.0, 1.0, 0.99999], [101, \"hsa01524\", \"Platinum drug resistance\", \"   5\", 5.58737, 0.670593, 0.508155, 0.893681, 1.0, 1.0, 0.99999], [345, \"hsa05213\", \"Endometrial cancer\", \"   7\", 7.68332, 0.670613, 0.488455, 0.893681, 1.0, 1.0, 0.99999], [105, \"hsa02044\", \"Secretion system\", \"   1\", 1.10749, 0.678703, 0.695313, 0.894635, 1.0, 1.0, 0.99999], [368, \"hsa05332\", \"Graft-versus-host disease\", \"   1\", 1.11657, 0.679273, 0.691623, 0.894635, 1.0, 1.0, 0.99999], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"   1\", 1.02611, 0.679903, 0.730293, 0.894635, 1.0, 1.0, 0.99999], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"   6\", 6.71671, 0.682033, 0.483315, 0.894635, 1.0, 1.0, 0.99999], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"   5\", 5.67181, 0.687703, 0.491635, 0.894635, 1.0, 1.0, 0.99999], [245, \"hsa04727\", \"GABAergic synapse\", \"  15\", 16.29078, 0.688563, 0.421906, 0.894635, 1.0, 1.0, 0.99999], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"   2\", 2.36091, 0.688723, 0.578314, 0.894635, 1.0, 1.0, 0.99999], [167, \"hsa04115\", \"p53 signaling pathway\", \"   4\", 4.64486, 0.692893, 0.499395, 0.896173, 1.0, 1.0, 0.99999], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \"  18\", 19.53858, 0.695923, 0.404006, 0.89768, 1.0, 1.0, 0.99999], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  10\", 11.12686, 0.696753, 0.431726, 0.89768, 1.0, 1.0, 0.99999], [102, \"hsa02000\", \"Transporters\", \"  61\", 64.45308, 0.706143, 0.344147, 0.903926, 1.0, 1.0, 0.99999], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"   7\", 8.07258, 0.712153, 0.432906, 0.910298, 1.0, 1.0, 0.99999], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"  16\", 17.89306, 0.725333, 0.368696, 0.926539, 1.0, 1.0, 0.99999], [18, \"hsa00230\", \"Purine metabolism\", \"  16\", 17.9712, 0.735973, 0.358486, 0.937672, 1.0, 1.0, 0.99999], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"   1\", 1.29323, 0.738853, 0.624284, 0.938901, 1.0, 1.0, 0.99999], [17, \"hsa00220\", \"Arginine biosynthesis\", \"   1\", 1.30302, 0.740943, 0.621404, 0.938901, 1.0, 1.0, 0.99999], [250, \"hsa04744\", \"Phototransduction\", \"   1\", 1.34274, 0.749143, 0.607854, 0.948755, 1.0, 1.0, 0.99999], [201, \"hsa04371\", \"Apelin signaling pathway\", \"  19\", 21.32865, 0.755392, 0.331487, 0.952085, 1.0, 1.0, 0.99999], [178, \"hsa04144\", \"Endocytosis\", \"  26\", 28.94868, 0.758322, 0.311747, 0.953039, 0.998621, 1.0, 0.99999], [330, \"hsa05165\", \"Human papillomavirus infection\", \"  34\", 37.36723, 0.759352, 0.302077, 0.953039, 0.979792, 1.0, 0.99999], [189, \"hsa04216\", \"Ferroptosis\", \"   2\", 2.69512, 0.766492, 0.486495, 0.956646, 1.0, 1.0, 0.99999], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"   1\", 1.4133, 0.769582, 0.581054, 0.956646, 1.0, 1.0, 0.99999], [325, \"hsa05160\", \"Hepatitis C\", \"  10\", 11.96358, 0.773652, 0.336017, 0.961299, 1.0, 1.0, 0.99999], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  15\", 17.28427, 0.774282, 0.319077, 0.961299, 0.998621, 1.0, 0.99999], [343, \"hsa05211\", \"Renal cell carcinoma\", \"   6\", 7.48863, 0.776292, 0.366926, 0.961299, 1.0, 1.0, 0.99999], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"   1\", 1.37262, 0.776712, 0.592544, 0.961299, 1.0, 1.0, 0.99999], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  17\", 19.23835, 0.779622, 0.317377, 0.961299, 0.998621, 1.0, 0.99999], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \"  24\", 27.14517, 0.779932, 0.290837, 0.961299, 0.94737, 1.0, 0.99999], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  12\", 14.13511, 0.780352, 0.322907, 0.961299, 0.999211, 1.0, 0.99999], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"   1\", 1.48044, 0.783992, 0.558404, 0.961299, 1.0, 1.0, 0.99999], [336, \"hsa05200\", \"Pathways in cancer\", \"  54\", 59.02333, 0.789722, 0.255667, 0.961299, 0.899098, 1.0, 0.99999], [302, \"hsa05020\", \"Prion diseases\", \"   3\", 3.93121, 0.790632, 0.425966, 0.961299, 1.0, 1.0, 0.99999], [235, \"hsa04710\", \"Circadian rhythm\", \"   3\", 4.10588, 0.800622, 0.395636, 0.967301, 1.0, 1.0, 0.99999], [94, \"hsa01006\", \"Prenyltransferases\", \"   1\", 1.49766, 0.800842, 0.547885, 0.967301, 1.0, 1.0, 0.99999], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"   4\", 5.30259, 0.801472, 0.371826, 0.967301, 1.0, 1.0, 0.99999], [36, \"hsa00450\", \"Selenocompound metabolism\", \"   1\", 1.55353, 0.802652, 0.533035, 0.967301, 1.0, 1.0, 0.99999], [174, \"hsa04137\", \"Mitophagy - animal\", \"   5\", 6.34225, 0.807392, 0.360776, 0.967301, 1.0, 1.0, 0.99999], [346, \"hsa05214\", \"Glioma\", \"   9\", 11.06439, 0.808322, 0.304357, 0.967301, 0.979792, 1.0, 0.99999], [146, \"hsa04024\", \"cAMP signaling pathway\", \"  28\", 31.80292, 0.808582, 0.252817, 0.967301, 0.899098, 1.0, 0.99999], [91, \"hsa01002\", \"Peptidases and inhibitors\", \"  62\", 67.88064, 0.809932, 0.230958, 0.967301, 0.889464, 1.0, 0.99999], [342, \"hsa05210\", \"Colorectal cancer\", \"   9\", 11.08913, 0.811232, 0.302137, 0.967301, 0.979792, 1.0, 0.99999], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"   3\", 4.22892, 0.813292, 0.372636, 0.967301, 1.0, 1.0, 0.99999], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"   4\", 5.1843, 0.813442, 0.372356, 0.967301, 1.0, 1.0, 0.99999], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  12\", 14.57756, 0.822812, 0.270517, 0.967301, 0.935144, 1.0, 0.99999], [144, \"hsa04020\", \"Calcium signaling pathway\", \"  31\", 35.18527, 0.823442, 0.234608, 0.967301, 0.889464, 1.0, 0.99999], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"   1\", 1.68941, 0.825832, 0.491815, 0.967301, 1.0, 1.0, 0.99999], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"   2\", 3.16378, 0.833142, 0.378616, 0.967301, 1.0, 1.0, 0.99999], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  12\", 14.89994, 0.847262, 0.239728, 0.983261, 0.889464, 1.0, 0.99999], [305, \"hsa05032\", \"Morphine addiction\", \"  16\", 19.44837, 0.847362, 0.226108, 0.983261, 0.889464, 1.0, 0.99999], [60, \"hsa00565\", \"Ether lipid metabolism\", \"   3\", 4.59541, 0.852531, 0.311647, 0.984005, 0.998621, 1.0, 0.99999], [136, \"hsa03430\", \"Mismatch repair\", \"   1\", 1.84399, 0.858121, 0.436666, 0.991009, 1.0, 1.0, 0.99999], [260, \"hsa04916\", \"Melanogenesis\", \"  10\", 12.98181, 0.858821, 0.226278, 0.991009, 0.889464, 1.0, 0.99999], [244, \"hsa04726\", \"Serotonergic synapse\", \"  15\", 18.57228, 0.864971, 0.207248, 0.993779, 0.869521, 1.0, 0.99999], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"   4\", 5.86068, 0.865751, 0.273617, 0.993779, 0.935144, 1.0, 0.99999], [243, \"hsa04725\", \"Cholinergic synapse\", \"  17\", 20.86658, 0.866431, 0.199028, 0.993779, 0.865299, 1.0, 0.99999], [304, \"hsa05031\", \"Amphetamine addiction\", \"   9\", 11.73654, 0.868471, 0.225318, 0.993779, 0.889464, 1.0, 0.99999], [163, \"hsa04090\", \"CD molecules\", \"  25\", 30.20047, 0.870491, 0.178968, 0.993779, 0.848138, 1.0, 0.99999], [72, \"hsa00670\", \"One carbon pool by folate\", \"   1\", 1.92702, 0.873471, 0.409146, 0.993779, 1.0, 1.0, 0.99999], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"   3\", 4.68649, 0.881671, 0.280667, 0.995783, 0.935144, 1.0, 0.99999], [319, \"hsa05143\", \"African trypanosomiasis\", \"   3\", 4.63161, 0.884081, 0.277387, 0.995783, 0.935144, 1.0, 0.99999], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"   1\", 1.9722, 0.884501, 0.391176, 0.995783, 1.0, 1.0, 0.99999], [354, \"hsa05222\", \"Small cell lung cancer\", \"   9\", 12.27249, 0.888681, 0.191368, 0.995783, 0.853615, 1.0, 0.99999], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  10\", 13.32466, 0.888781, 0.188818, 0.995783, 0.853615, 1.0, 0.99999], [273, \"hsa04929\", \"GnRH secretion\", \"  10\", 13.28751, 0.894701, 0.182128, 0.998369, 0.848138, 1.0, 0.99999], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  17\", 21.37367, 0.896401, 0.160708, 0.998369, 0.788633, 1.0, 0.99999], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"   4\", 6.46582, 0.902481, 0.207598, 1.0, 0.869521, 1.0, 0.99999], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"   3\", 5.24597, 0.904241, 0.220178, 1.0, 0.889464, 1.0, 0.99999], [358, \"hsa05226\", \"Gastric cancer\", \"  12\", 16.42346, 0.912771, 0.143099, 1.0, 0.788633, 1.0, 0.99999], [164, \"hsa04091\", \"Lectins\", \"   3\", 5.50134, 0.917941, 0.193478, 1.0, 0.853615, 1.0, 0.99999], [131, \"hsa03310\", \"Nuclear receptors\", \"   4\", 6.63152, 0.919261, 0.180658, 1.0, 0.848138, 1.0, 0.99999], [287, \"hsa04970\", \"Salivary secretion\", \"  10\", 13.69161, 0.920951, 0.146109, 1.0, 0.788633, 1.0, 0.99999], [175, \"hsa04140\", \"Autophagy - animal\", \"  11\", 15.41562, 0.921481, 0.134699, 1.0, 0.737907, 1.0, 0.99999], [143, \"hsa04015\", \"Rap1 signaling pathway\", \"  28\", 34.54724, 0.921561, 0.114199, 1.0, 0.667901, 1.0, 0.99999], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  12\", 16.24926, 0.924541, 0.131999, 1.0, 0.737907, 1.0, 0.99999], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"   5\", 7.97179, 0.929751, 0.156658, 1.0, 0.788633, 1.0, 0.99999], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"   6\", 9.25376, 0.930781, 0.145099, 1.0, 0.788633, 1.0, 0.99999], [173, \"hsa04136\", \"Autophagy - other\", \"   2\", 3.99769, 0.932961, 0.203978, 1.0, 0.868536, 1.0, 0.99999], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"   1\", 2.35405, 0.938151, 0.273067, 1.0, 0.935144, 1.0, 0.99999], [147, \"hsa04030\", \"G protein-coupled receptors\", \"  24\", 30.99336, 0.939781, 0.091079, 1.0, 0.603238, 1.0, 0.988084], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"   3\", 5.58166, 0.944601, 0.152988, 1.0, 0.788633, 1.0, 0.99999], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"   7\", 10.93969, 0.945241, 0.112829, 1.0, 0.667901, 1.0, 0.99999], [322, \"hsa05146\", \"Amoebiasis\", \"  10\", 14.72919, 0.945911, 0.101479, 1.0, 0.620472, 1.0, 0.99999], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"   2\", 4.33224, 0.947321, 0.166818, 1.0, 0.803653, 1.0, 0.99999], [103, \"hsa02010\", \"ABC transporters\", \"   4\", 7.22188, 0.948111, 0.126529, 1.0, 0.711949, 1.0, 0.99999], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"   1\", 2.80071, 0.948491, 0.211828, 1.0, 0.869521, 1.0, 0.99999], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  10\", 14.903, 0.95187, 0.091069, 1.0, 0.603238, 1.0, 0.988084], [129, \"hsa03060\", \"Protein export\", \"   1\", 2.29894, 0.95375, 0.253317, 1.0, 0.899098, 1.0, 0.99999], [205, \"hsa04510\", \"Focal adhesion\", \"  26\", 34.10657, 0.95719, 0.065079, 1.0, 0.465379, 1.0, 0.836734], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \"  57\", 68.30198, 0.95781, 0.057609, 1.0, 0.465379, 1.0, 0.789859], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"   5\", 8.10101, 0.96362, 0.106529, 1.0, 0.639071, 1.0, 0.99999], [288, \"hsa04971\", \"Gastric acid secretion\", \"   7\", 11.66418, 0.96529, 0.074889, 1.0, 0.512395, 1.0, 0.92966], [152, \"hsa04054\", \"Pattern recognition receptors\", \"   1\", 3.35297, 0.96799, 0.143699, 1.0, 0.788633, 1.0, 0.99999], [236, \"hsa04713\", \"Circadian entrainment\", \"  16\", 22.49999, 0.96832, 0.057659, 1.0, 0.465379, 1.0, 0.789859], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  10\", 15.76491, 0.97047, 0.059239, 1.0, 0.465379, 1.0, 0.789859], [242, \"hsa04724\", \"Glutamatergic synapse\", \"  20\", 27.57084, 0.97054, 0.050549, 1.0, 0.428402, 1.0, 0.789859], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  14\", 20.84312, 0.971, 0.051969, 1.0, 0.428402, 1.0, 0.789859], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \"  35\", 45.65662, 0.97422, 0.0386, 1.0, 0.391452, 1.0, 0.756182], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \"  17\", 24.64559, 0.97428, 0.04566, 1.0, 0.413951, 1.0, 0.789859], [172, \"hsa04131\", \"Membrane trafficking\", \" 161\", 182.65008, 0.97558, 0.03003, 1.0, 0.338019, 1.0, 0.641005], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"   4\", 8.09701, 0.98107, 0.058129, 1.0, 0.465379, 1.0, 0.789859], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  17\", 25.34792, 0.98372, 0.03027, 1.0, 0.338019, 1.0, 0.641005], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"   1\", 3.58156, 0.98378, 0.093319, 1.0, 0.603238, 1.0, 0.988084], [248, \"hsa04740\", \"Olfactory transduction\", \"   6\", 11.24911, 0.98505, 0.03991, 1.0, 0.391452, 1.0, 0.756182], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"   3\", 7.56963, 0.98511, 0.04647, 1.0, 0.413951, 1.0, 0.789859], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \"  24\", 34.21855, 0.98591, 0.02436, 1.0, 0.302312, 1.0, 0.632051], [253, \"hsa04812\", \"Cytoskeleton proteins\", \"  43\", 56.89361, 0.98696, 0.01967, 1.0, 0.261013, 1.0, 0.590094], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"   9\", 16.10068, 0.98913, 0.02458, 1.0, 0.302312, 1.0, 0.632051], [149, \"hsa04040\", \"Ion channels\", \"  40\", 55.64988, 0.99596, 0.00665, 1.0, 0.094538, 1.0, 0.239398], [255, \"hsa04911\", \"Insulin secretion\", \"   7\", 15.11688, 0.99818, 0.00622, 1.0, 0.094538, 1.0, 0.239398], [199, \"hsa04360\", \"Axon guidance\", \"  21\", 35.45997, 0.99926, 0.00165, 1.0, 0.078985, 1.0, 0.095142], [208, \"hsa04515\", \"Cell adhesion molecules\", \"  24\", 38.90478, 0.99941, 0.00141, 1.0, 0.078985, 1.0, 0.095142], [92, \"hsa01003\", \"Glycosyltransferases\", \"  15\", 30.06002, 0.9998, 0.00058, 1.0, 0.06585, 1.0, 0.095142], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"   2\", 8.78289, 0.99986, 0.00157, 1.0, 0.078985, 1.0, 0.095142], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"   1\", 6.76869, 0.99993, 0.00141, 1.0, 0.078985, 1.0, 0.095142], [81, \"hsa00830\", \"Retinol metabolism\", \"   0\", 2.44146, 1.0, 0.080109, 1.0, 0.527591, 1.0, 0.9303], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"   0\", 1.33736, 1.0, 0.228868, 1.0, 0.889464, 1.0, 0.99999], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"   0\", 3.30053, 1.0, 0.01588, 1.0, 0.232355, 1.0, 0.519704], [116, \"hsa03018\", \"RNA degradation\", \"   0\", 5.17244, 1.0, 0.00413, 1.0, 0.078985, 1.0, 0.185848], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"   0\", 2.91716, 1.0, 0.02925, 1.0, 0.338019, 1.0, 0.641005], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"   0\", 5.7594, 1.0, 0.00185, 1.0, 0.078985, 1.0, 0.095142], [73, \"hsa00730\", \"Thiamine metabolism\", \"   0\", 2.23624, 1.0, 0.077669, 1.0, 0.51937, 1.0, 0.9303], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"   0\", 5.98277, 1.0, 0.00137, 1.0, 0.078985, 1.0, 0.095142], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"   0\", 1.43935, 1.0, 0.221348, 1.0, 0.889464, 1.0, 0.99999], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"   0\", 1.52663, 1.0, 0.208158, 1.0, 0.869521, 1.0, 0.99999], [118, \"hsa03020\", \"RNA polymerase\", \"   0\", 1.37691, 1.0, 0.243268, 1.0, 0.889464, 1.0, 0.99999]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#9ede0138-85d5-4de7-8b06-c6528342feef').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#9ede0138-85d5-4de7-8b06-c6528342feef').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                            FunctionName  n_candidates  \\\n",
       "153  hsa04060  Cytokine-cytokine receptor interaction            29   \n",
       "369  hsa05340                Primary immunodeficiency             8   \n",
       "198  hsa04350              TGF-beta signaling pathway            21   \n",
       "317  hsa05140                           Leishmaniasis            13   \n",
       "226  hsa04658        Th1 and Th2 cell differentiation            17   \n",
       "..        ...                                     ...           ...   \n",
       "73   hsa00730                     Thiamine metabolism             0   \n",
       "41   hsa00510                   N-Glycan biosynthesis             0   \n",
       "12   hsa00120          Primary bile acid biosynthesis             0   \n",
       "82   hsa00860    Porphyrin and chlorophyll metabolism             0   \n",
       "118  hsa03020                          RNA polymerase             0   \n",
       "\n",
       "     mean_n_resample  emp_p_e   emp_p_d     fdr_e     fdr_d  BH_fdr_e  \\\n",
       "153         13.18629  0.00005  0.999990  0.008300  1.000000  0.014400   \n",
       "369          1.48048  0.00010  0.999980  0.009170  1.000000  0.014400   \n",
       "198          9.35499  0.00014  0.999940  0.009170  1.000000  0.014400   \n",
       "317          4.05193  0.00016  0.999980  0.009170  1.000000  0.014400   \n",
       "226          7.29916  0.00072  0.999780  0.030566  1.000000  0.051839   \n",
       "..               ...      ...       ...       ...       ...       ...   \n",
       "73           2.23624  1.00000  0.077669  1.000000  0.519370  1.000000   \n",
       "41           5.98277  1.00000  0.001370  1.000000  0.078985  1.000000   \n",
       "12           1.43935  1.00000  0.221348  1.000000  0.889464  1.000000   \n",
       "82           1.52663  1.00000  0.208158  1.000000  0.869521  1.000000   \n",
       "118          1.37691  1.00000  0.243268  1.000000  0.889464  1.000000   \n",
       "\n",
       "     BH_fdr_d  \n",
       "153  0.999990  \n",
       "369  0.999990  \n",
       "198  0.999990  \n",
       "317  0.999990  \n",
       "226  0.999990  \n",
       "..        ...  \n",
       "73   0.930300  \n",
       "41   0.095142  \n",
       "12   0.999990  \n",
       "82   0.999990  \n",
       "118  0.999990  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ci_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "346ddbfe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"a3b81c42-d505-46ef-974e-0aceb5ff7d96\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  19\", 7.3041, 6e-05, 0.99999, 0.01024, 1.0, 0.0216, 0.99999], [26, \"hsa00310\", \"Lysine degradation\", \"  16\", 6.20373, 0.00019, 0.99995, 0.017975, 1.0, 0.0264, 0.99999], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \"  27\", 12.84532, 0.00022, 0.99993, 0.017975, 1.0, 0.0264, 0.99999], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 152\", 118.83746, 0.00048, 0.99964, 0.025065, 1.0, 0.0432, 0.99999], [327, \"hsa05162\", \"Measles\", \"  18\", 8.26746, 0.00106, 0.99963, 0.044538, 1.0, 0.068399, 0.99999], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  19\", 9.2515, 0.00114, 0.99956, 0.044538, 1.0, 0.068399, 0.99999], [317, \"hsa05140\", \"Leishmaniasis\", \"  11\", 4.05298, 0.00172, 0.99957, 0.054009, 1.0, 0.080999, 0.99999], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"   7\", 1.79297, 0.0018, 0.99954, 0.054009, 1.0, 0.080999, 0.99999], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \"  23\", 12.75617, 0.00248, 0.99902, 0.061144, 1.0, 0.092879, 0.99999], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  11\", 4.25889, 0.00258, 0.99929, 0.061144, 1.0, 0.092879, 0.99999], [100, \"hsa01523\", \"Antifolate resistance\", \"   6\", 1.73882, 0.00473, 0.99918, 0.09676, 1.0, 0.154798, 0.99999], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"   9\", 3.26641, 0.00533, 0.99848, 0.099341, 1.0, 0.159506, 0.99999], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  23\", 13.23432, 0.00576, 0.99719, 0.099404, 1.0, 0.159506, 0.99999], [123, \"hsa03032\", \"DNA replication proteins\", \"  15\", 7.41567, 0.00701, 0.99716, 0.111548, 1.0, 0.168478, 0.99999], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  12\", 5.48802, 0.00702, 0.99752, 0.111548, 1.0, 0.168478, 0.99999], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  14\", 7.12583, 0.00845, 0.99684, 0.123867, 1.0, 0.190123, 0.99999], [329, \"hsa05164\", \"Influenza A\", \"  19\", 10.73293, 0.00898, 0.99588, 0.125295, 1.0, 0.190163, 0.99999], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"   7\", 2.75455, 0.01082, 0.99742, 0.140389, 1.0, 0.216398, 0.99999], [321, \"hsa05145\", \"Toxoplasmosis\", \"  18\", 10.33978, 0.01163, 0.99494, 0.144063, 1.0, 0.220356, 0.99999], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"   6\", 1.98871, 0.01468, 0.99652, 0.17451, 1.0, 0.254397, 0.99999], [126, \"hsa03041\", \"Spliceosome\", \"  35\", 24.36771, 0.01484, 0.9911, 0.17451, 1.0, 0.254397, 0.99999], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  17\", 10.03711, 0.01869, 0.99113, 0.20401, 1.0, 0.276152, 0.99999], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"   8\", 3.48824, 0.02044, 0.99345, 0.210141, 1.0, 0.276152, 0.99999], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  16\", 9.34654, 0.0219, 0.98962, 0.216175, 1.0, 0.276152, 0.99999], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"  10\", 5.00149, 0.02208, 0.99189, 0.216175, 1.0, 0.276152, 0.99999], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"   8\", 3.7182, 0.02224, 0.99269, 0.216175, 1.0, 0.276152, 0.99999], [119, \"hsa03021\", \"Transcription machinery\", \"  30\", 20.72878, 0.02253, 0.98668, 0.216175, 1.0, 0.276152, 0.99999], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"   8\", 3.53997, 0.02349, 0.99227, 0.216175, 1.0, 0.276152, 0.99999], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \"  28\", 18.71123, 0.02358, 0.98552, 0.216175, 1.0, 0.276152, 0.99999], [275, \"hsa04931\", \"Insulin resistance\", \"  19\", 12.00937, 0.02362, 0.98835, 0.216175, 1.0, 0.276152, 0.99999], [367, \"hsa05330\", \"Allograft rejection\", \"   4\", 1.11447, 0.02378, 0.99546, 0.216175, 1.0, 0.276152, 0.99999], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"   9\", 4.41789, 0.02455, 0.99136, 0.216175, 1.0, 0.276185, 0.99999], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \"  27\", 18.60413, 0.0288, 0.98308, 0.216175, 1.0, 0.314179, 0.99999], [9, \"hsa00071\", \"Fatty acid degradation\", \"   6\", 2.38534, 0.03108, 0.99088, 0.220143, 1.0, 0.329079, 0.99999], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \"  28\", 19.86167, 0.03363, 0.98025, 0.233993, 1.0, 0.340397, 0.99999], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"   9\", 4.59646, 0.03404, 0.98731, 0.233993, 1.0, 0.340397, 0.99999], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  19\", 12.48224, 0.0379, 0.97894, 0.257033, 1.0, 0.365681, 0.99999], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  12\", 6.92903, 0.0386, 0.98267, 0.257033, 1.0, 0.365681, 0.99999], [125, \"hsa03040\", \"Spliceosome\", \"  10\", 5.30974, 0.04008, 0.98259, 0.259069, 1.0, 0.366386, 0.99999], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  15\", 9.43779, 0.04071, 0.98041, 0.259069, 1.0, 0.366386, 0.99999], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  17\", 11.73368, 0.04355, 0.98023, 0.262092, 1.0, 0.379368, 0.99999], [135, \"hsa03420\", \"Nucleotide excision repair\", \"   6\", 2.63783, 0.04426, 0.98601, 0.262235, 1.0, 0.379368, 0.99999], [338, \"hsa05203\", \"Viral carcinogenesis\", \"  22\", 15.36068, 0.04754, 0.97261, 0.274427, 1.0, 0.398005, 0.99999], [169, \"hsa04121\", \"Ubiquitin system\", \"  86\", 72.73343, 0.051069, 0.96047, 0.28866, 1.0, 0.415436, 0.99999], [137, \"hsa03440\", \"Homologous recombination\", \"   7\", 3.41532, 0.051929, 0.98106, 0.28866, 1.0, 0.415436, 0.99999], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"   5\", 2.15253, 0.053649, 0.98585, 0.293557, 1.0, 0.418438, 0.99999], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"   5\", 2.07514, 0.054629, 0.98345, 0.293678, 1.0, 0.418438, 0.99999], [369, \"hsa05340\", \"Primary immunodeficiency\", \"   4\", 1.48374, 0.057919, 0.98553, 0.304083, 1.0, 0.434396, 0.99999], [215, \"hsa04612\", \"Antigen processing and presentation\", \"   5\", 2.12663, 0.061789, 0.97981, 0.320983, 1.0, 0.443996, 0.99999], [185, \"hsa04210\", \"Apoptosis\", \"  16\", 10.75304, 0.062729, 0.96583, 0.320983, 1.0, 0.443996, 0.99999], [5, \"hsa00052\", \"Galactose metabolism\", \"   5\", 2.17738, 0.062899, 0.98043, 0.320983, 1.0, 0.443996, 0.99999], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  11\", 6.82326, 0.069499, 0.96725, 0.342944, 1.0, 0.481149, 0.99999], [313, \"hsa05132\", \"Salmonella infection\", \"  25\", 18.69709, 0.076929, 0.95052, 0.367001, 1.0, 0.500452, 0.99999], [42, \"hsa00511\", \"Other glycan degradation\", \"   3\", 1.02481, 0.077219, 0.98357, 0.367001, 1.0, 0.500452, 0.99999], [111, \"hsa03011\", \"Ribosome\", \"   7\", 3.68796, 0.077659, 0.96779, 0.367001, 1.0, 0.500452, 0.99999], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \"  31\", 24.17741, 0.078939, 0.947911, 0.367001, 1.0, 0.500452, 0.99999], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \"  18\", 12.78489, 0.079699, 0.95327, 0.367001, 1.0, 0.500452, 0.99999], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \"  25\", 18.83633, 0.080989, 0.948381, 0.367001, 1.0, 0.500452, 0.99999], [316, \"hsa05135\", \"Yersinia infection\", \"  20\", 14.62973, 0.082469, 0.951, 0.367001, 1.0, 0.500452, 0.99999], [312, \"hsa05131\", \"Shigellosis\", \"  31\", 24.3571, 0.083679, 0.944621, 0.367001, 1.0, 0.500452, 0.99999], [16, \"hsa00199\", \"Cytochrome P450\", \"   6\", 3.08511, 0.086109, 0.96679, 0.367001, 1.0, 0.500452, 0.99999], [28, \"hsa00340\", \"Histidine metabolism\", \"   3\", 1.05568, 0.086799, 0.9795, 0.367001, 1.0, 0.500452, 0.99999], [181, \"hsa04147\", \"Exosome\", \"  79\", 68.13272, 0.087579, 0.931171, 0.367001, 1.0, 0.500452, 0.99999], [110, \"hsa03010\", \"Ribosome\", \"   5\", 2.38246, 0.090489, 0.96651, 0.367001, 1.0, 0.509001, 0.99999], [140, \"hsa04010\", \"MAPK signaling pathway\", \"  48\", 40.11999, 0.093339, 0.932711, 0.374146, 1.0, 0.516955, 0.99999], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  12\", 8.0191, 0.095089, 0.9515, 0.375684, 1.0, 0.518668, 0.99999], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  14\", 9.78031, 0.103769, 0.942531, 0.398417, 1.0, 0.552594, 0.99999], [107, \"hsa03000\", \"Transcription factors\", \"  88\", 77.58421, 0.105949, 0.914211, 0.401815, 1.0, 0.552594, 0.99999], [128, \"hsa03051\", \"Proteasome\", \"   6\", 3.27518, 0.107499, 0.95572, 0.401815, 1.0, 0.552594, 0.99999], [84, \"hsa00910\", \"Nitrogen metabolism\", \"   3\", 1.17758, 0.107689, 0.97583, 0.401815, 1.0, 0.552594, 0.99999], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  10\", 6.52829, 0.109169, 0.944041, 0.401815, 1.0, 0.552594, 0.99999], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  13\", 9.12371, 0.110519, 0.940011, 0.401815, 1.0, 0.552594, 0.99999], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"   4\", 1.86819, 0.112189, 0.96442, 0.401815, 1.0, 0.55326, 0.99999], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  16\", 11.68155, 0.116819, 0.929061, 0.406819, 1.0, 0.560289, 0.99999], [113, \"hsa03013\", \"RNA transport\", \"  12\", 8.23453, 0.119479, 0.932771, 0.411228, 1.0, 0.560289, 0.99999], [182, \"hsa04150\", \"mTOR signaling pathway\", \"  21\", 16.15043, 0.119869, 0.924521, 0.411228, 1.0, 0.560289, 0.99999], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"   2\", 0.60467, 0.121559, 0.97924, 0.411228, 1.0, 0.560289, 0.99999], [134, \"hsa03410\", \"Base excision repair\", \"   3\", 1.2212, 0.122699, 0.96735, 0.411228, 1.0, 0.560289, 0.99999], [344, \"hsa05212\", \"Pancreatic cancer\", \"  12\", 8.36654, 0.123739, 0.932671, 0.411228, 1.0, 0.560289, 0.99999], [95, \"hsa01007\", \"Amino acid related enzymes\", \"   9\", 5.91404, 0.124509, 0.938981, 0.411228, 1.0, 0.560289, 0.99999], [362, \"hsa05310\", \"Asthma\", \"   2\", 0.6223, 0.129359, 0.97627, 0.417652, 1.0, 0.574928, 0.99999], [325, \"hsa05160\", \"Hepatitis C\", \"  16\", 11.96181, 0.137279, 0.916141, 0.443672, 1.0, 0.602687, 0.99999], [127, \"hsa03050\", \"Proteasome\", \"   4\", 2.04269, 0.145409, 0.947921, 0.466905, 1.0, 0.62518, 0.99999], [351, \"hsa05219\", \"Bladder cancer\", \"   6\", 3.62316, 0.146719, 0.936841, 0.467938, 1.0, 0.62518, 0.99999], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"   8\", 5.18986, 0.147809, 0.924761, 0.468494, 1.0, 0.62518, 0.99999], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"   7\", 4.41847, 0.149349, 0.929021, 0.472727, 1.0, 0.62518, 0.99999], [179, \"hsa04145\", \"Phagosome\", \"  12\", 8.69122, 0.156748, 0.907911, 0.487437, 1.0, 0.646514, 0.99999], [120, \"hsa03022\", \"Basal transcription factors\", \"   5\", 2.90851, 0.158588, 0.935071, 0.487568, 1.0, 0.646514, 0.99999], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \"  31\", 25.80799, 0.159838, 0.883991, 0.487568, 1.0, 0.646514, 0.99999], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"   4\", 2.17142, 0.161628, 0.944811, 0.487568, 1.0, 0.646514, 0.99999], [237, \"hsa04714\", \"Thermogenesis\", \"  23\", 18.77232, 0.163598, 0.889681, 0.487568, 1.0, 0.647202, 0.99999], [297, \"hsa05010\", \"Alzheimer disease\", \"  36\", 30.66591, 0.166178, 0.876701, 0.487568, 1.0, 0.650263, 0.99999], [315, \"hsa05134\", \"Legionellosis\", \"   4\", 2.16718, 0.169228, 0.936051, 0.492621, 1.0, 0.650483, 0.99999], [178, \"hsa04144\", \"Endocytosis\", \"  34\", 28.91027, 0.169848, 0.875331, 0.492621, 1.0, 0.650483, 0.99999], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \"  17\", 13.31509, 0.175808, 0.885441, 0.500683, 1.0, 0.666221, 0.99999], [278, \"hsa04934\", \"Cushing syndrome\", \"  24\", 19.91161, 0.180188, 0.875271, 0.512471, 1.0, 0.670218, 0.99999], [94, \"hsa01006\", \"Prenyltransferases\", \"   3\", 1.50416, 0.182008, 0.946871, 0.513084, 1.0, 0.670218, 0.99999], [68, \"hsa00620\", \"Pyruvate metabolism\", \"   5\", 3.04671, 0.182448, 0.922891, 0.513084, 1.0, 0.670218, 0.99999], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \"  32\", 27.34153, 0.187338, 0.861721, 0.520702, 1.0, 0.674885, 0.99999], [292, \"hsa04975\", \"Fat digestion and absorption\", \"   4\", 2.26083, 0.187468, 0.926461, 0.520702, 1.0, 0.674885, 0.99999], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"   7\", 4.85889, 0.193348, 0.906441, 0.526322, 1.0, 0.689161, 0.99999], [36, \"hsa00450\", \"Selenocompound metabolism\", \"   3\", 1.5517, 0.199468, 0.936741, 0.540228, 1.0, 0.698804, 0.99999], [200, \"hsa04370\", \"VEGF signaling pathway\", \"  10\", 7.50068, 0.201068, 0.887681, 0.540228, 1.0, 0.698804, 0.99999], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"   7\", 4.82207, 0.203468, 0.895251, 0.540228, 1.0, 0.698804, 0.99999], [232, \"hsa04668\", \"TNF signaling pathway\", \"  12\", 9.21783, 0.203818, 0.876301, 0.540228, 1.0, 0.698804, 0.99999], [191, \"hsa04218\", \"Cellular senescence\", \"  18\", 14.69411, 0.209818, 0.858941, 0.547942, 1.0, 0.709294, 0.99999], [148, \"hsa04031\", \"GTP-binding proteins\", \"  17\", 13.7811, 0.210818, 0.859521, 0.547942, 1.0, 0.709294, 0.99999], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \"  12\", 9.35586, 0.214778, 0.870331, 0.548559, 1.0, 0.714378, 0.99999], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  21\", 17.6264, 0.216298, 0.851101, 0.550468, 1.0, 0.714378, 0.99999], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"   2\", 0.89776, 0.225138, 0.945431, 0.566437, 1.0, 0.726208, 0.99999], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  16\", 13.16977, 0.226408, 0.852821, 0.566437, 1.0, 0.726208, 0.99999], [326, \"hsa05161\", \"Hepatitis B\", \"  17\", 14.00001, 0.227578, 0.846862, 0.566437, 1.0, 0.726208, 0.99999], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"   4\", 2.51825, 0.233148, 0.909121, 0.569584, 1.0, 0.726208, 0.99999], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  14\", 11.43248, 0.233368, 0.854181, 0.569584, 1.0, 0.726208, 0.99999], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  14\", 11.3035, 0.234588, 0.847422, 0.569584, 1.0, 0.726208, 0.99999], [11, \"hsa00100\", \"Steroid biosynthesis\", \"   2\", 0.92224, 0.235778, 0.938101, 0.569584, 1.0, 0.726208, 0.99999], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"   9\", 6.83769, 0.236018, 0.865801, 0.569584, 1.0, 0.726208, 0.99999], [320, \"hsa05144\", \"Malaria\", \"   4\", 2.52476, 0.243218, 0.896131, 0.569584, 1.0, 0.74202, 0.99999], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  15\", 12.34519, 0.246978, 0.835752, 0.569584, 1.0, 0.742193, 0.99999], [153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  16\", 13.193, 0.247398, 0.828392, 0.569584, 1.0, 0.742193, 0.99999], [151, \"hsa04052\", \"Cytokines and growth factors\", \"  17\", 14.37352, 0.252217, 0.831192, 0.574637, 1.0, 0.746343, 0.99999], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  22\", 19.22469, 0.252927, 0.825352, 0.574637, 1.0, 0.746343, 0.99999], [165, \"hsa04110\", \"Cell cycle\", \"  12\", 9.6636, 0.255067, 0.837482, 0.574637, 1.0, 0.746539, 0.99999], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  16\", 13.40449, 0.259177, 0.825172, 0.574637, 1.0, 0.752451, 0.99999], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  17\", 14.57594, 0.274087, 0.812982, 0.607632, 1.0, 0.789371, 0.99999], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  13\", 10.86441, 0.280327, 0.816092, 0.619894, 1.0, 0.79579, 0.99999], [189, \"hsa04216\", \"Ferroptosis\", \"   4\", 2.69794, 0.280737, 0.872931, 0.619894, 1.0, 0.79579, 0.99999], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \"  24\", 21.32408, 0.285117, 0.791032, 0.621917, 1.0, 0.800783, 0.99999], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \"  20\", 17.64349, 0.286947, 0.802462, 0.623246, 1.0, 0.800783, 0.99999], [122, \"hsa03030\", \"DNA replication\", \"   3\", 1.87856, 0.289347, 0.885181, 0.623246, 1.0, 0.801269, 0.99999], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  16\", 13.74516, 0.294167, 0.796132, 0.626345, 1.0, 0.808398, 0.99999], [72, \"hsa00670\", \"One carbon pool by folate\", \"   3\", 1.92694, 0.300517, 0.883771, 0.634185, 1.0, 0.809022, 0.99999], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \"  18\", 15.74695, 0.301407, 0.786152, 0.634185, 1.0, 0.809022, 0.99999], [99, \"hsa01522\", \"Endocrine resistance\", \"  14\", 12.01761, 0.304677, 0.794222, 0.634185, 1.0, 0.809022, 0.99999], [105, \"hsa02044\", \"Secretion system\", \"   2\", 1.10589, 0.304737, 0.902971, 0.634185, 1.0, 0.809022, 0.99999], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  13\", 11.14707, 0.307877, 0.800352, 0.636411, 1.0, 0.809022, 0.99999], [368, \"hsa05332\", \"Graft-versus-host disease\", \"   2\", 1.11761, 0.309517, 0.900581, 0.638673, 1.0, 0.809022, 0.99999], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"   3\", 1.97008, 0.312287, 0.878791, 0.643738, 1.0, 0.809022, 0.99999], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  15\", 13.01293, 0.313547, 0.784222, 0.643738, 1.0, 0.809022, 0.99999], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"   8\", 6.46407, 0.314747, 0.809182, 0.643738, 1.0, 0.809022, 0.99999], [167, \"hsa04115\", \"p53 signaling pathway\", \"   6\", 4.63944, 0.316867, 0.821842, 0.643738, 1.0, 0.809022, 0.99999], [101, \"hsa01524\", \"Platinum drug resistance\", \"   7\", 5.58684, 0.320687, 0.812452, 0.643738, 1.0, 0.809765, 0.99999], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  14\", 12.13562, 0.321657, 0.778202, 0.643738, 1.0, 0.809765, 0.99999], [210, \"hsa04530\", \"Tight junction\", \"  25\", 22.76325, 0.328377, 0.751542, 0.646179, 1.0, 0.817117, 0.99999], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  16\", 14.12575, 0.329117, 0.766252, 0.646179, 1.0, 0.817117, 0.99999], [296, \"hsa04979\", \"Cholesterol metabolism\", \"   6\", 4.7776, 0.338677, 0.810062, 0.660123, 1.0, 0.835093, 0.99999], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  11\", 9.47803, 0.343547, 0.774332, 0.665636, 1.0, 0.837259, 0.99999], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"   3\", 2.07463, 0.344207, 0.851251, 0.665636, 1.0, 0.837259, 0.99999], [356, \"hsa05224\", \"Breast cancer\", \"  16\", 14.31215, 0.356016, 0.742723, 0.687954, 1.0, 0.860174, 0.99999], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"   3\", 2.14847, 0.364466, 0.840212, 0.693488, 1.0, 0.874719, 0.99999], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  16\", 14.52991, 0.376456, 0.724033, 0.713333, 1.0, 0.889685, 0.99999], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \"  29\", 27.15303, 0.376906, 0.700493, 0.713333, 1.0, 0.889685, 0.99999], [31, \"hsa00380\", \"Tryptophan metabolism\", \"   4\", 3.1077, 0.378116, 0.804062, 0.713333, 1.0, 0.889685, 0.99999], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \"  18\", 16.55143, 0.388176, 0.707293, 0.723051, 1.0, 0.907425, 0.99999], [235, \"hsa04710\", \"Circadian rhythm\", \"   5\", 4.10219, 0.391796, 0.782262, 0.729291, 1.0, 0.909978, 0.99999], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"   2\", 1.34054, 0.396746, 0.864431, 0.733033, 1.0, 0.913428, 0.99999], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"   9\", 7.96041, 0.398356, 0.742693, 0.733201, 1.0, 0.913428, 0.99999], [196, \"hsa04330\", \"Notch signaling pathway\", \"   5\", 4.16064, 0.404196, 0.770282, 0.738388, 1.0, 0.915686, 0.99999], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"   2\", 1.37256, 0.406376, 0.850701, 0.738877, 1.0, 0.915686, 0.99999], [8, \"hsa00062\", \"Fatty acid elongation\", \"   3\", 2.31205, 0.410056, 0.804852, 0.741027, 1.0, 0.915686, 0.99999], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"   2\", 1.39026, 0.411996, 0.844782, 0.741707, 1.0, 0.915686, 0.99999], [373, \"hsa05416\", \"Viral myocarditis\", \"   7\", 6.14826, 0.415206, 0.744473, 0.741707, 1.0, 0.915686, 0.99999], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"   9\", 8.06172, 0.415736, 0.718063, 0.741707, 1.0, 0.915686, 0.99999], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"   3\", 2.33265, 0.417146, 0.798292, 0.741707, 1.0, 0.915686, 0.99999], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"   2\", 1.41639, 0.421246, 0.836122, 0.746614, 1.0, 0.919082, 0.99999], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \"  18\", 16.9788, 0.431476, 0.676043, 0.770825, 1.0, 0.925317, 0.99999], [300, \"hsa05016\", \"Huntington disease\", \"  25\", 23.8595, 0.431816, 0.654353, 0.770825, 1.0, 0.925317, 0.99999], [152, \"hsa04054\", \"Pattern recognition receptors\", \"   4\", 3.35275, 0.433676, 0.756282, 0.770825, 1.0, 0.925317, 0.99999], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  12\", 11.12153, 0.435806, 0.687563, 0.770825, 1.0, 0.925317, 0.99999], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \"  25\", 23.96417, 0.439066, 0.651713, 0.770825, 1.0, 0.925317, 0.99999], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"   2\", 1.47752, 0.439526, 0.820302, 0.770825, 1.0, 0.925317, 0.99999], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"   2\", 1.49948, 0.445406, 0.812472, 0.770825, 1.0, 0.932244, 0.99999], [347, \"hsa05215\", \"Prostate cancer\", \"  13\", 12.2032, 0.449196, 0.669343, 0.774274, 1.0, 0.934742, 0.99999], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"   8\", 7.31389, 0.452705, 0.705483, 0.774274, 1.0, 0.936632, 0.99999], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  13\", 12.25804, 0.455935, 0.665303, 0.774274, 1.0, 0.937924, 0.99999], [298, \"hsa05012\", \"Parkinson disease\", \"  18\", 17.25395, 0.460315, 0.645124, 0.778624, 1.0, 0.938017, 0.99999], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"   5\", 4.42892, 0.461455, 0.723173, 0.778624, 1.0, 0.938017, 0.99999], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  20\", 19.31004, 0.469875, 0.626684, 0.79189, 1.0, 0.938017, 0.99999], [90, \"hsa01001\", \"Protein kinases\", \"  81\", 80.00242, 0.470755, 0.581324, 0.79189, 1.0, 0.938017, 0.99999], [177, \"hsa04142\", \"Lysosome\", \"  10\", 9.44203, 0.472865, 0.661043, 0.79189, 1.0, 0.938017, 0.99999], [190, \"hsa04217\", \"Necroptosis\", \"   9\", 8.46062, 0.472895, 0.661603, 0.79189, 1.0, 0.938017, 0.99999], [132, \"hsa03320\", \"PPAR signaling pathway\", \"   6\", 5.50896, 0.476485, 0.689203, 0.79189, 1.0, 0.938017, 0.99999], [314, \"hsa05133\", \"Pertussis\", \"   4\", 3.5376, 0.476825, 0.723653, 0.79189, 1.0, 0.938017, 0.99999], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \"  33\", 32.39256, 0.484425, 0.589804, 0.793072, 1.0, 0.947788, 0.99999], [138, \"hsa03450\", \"Non-homologous end-joining\", \"   2\", 1.63732, 0.499535, 0.781362, 0.809563, 1.0, 0.967287, 0.99999], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"   6\", 5.58926, 0.499765, 0.684953, 0.809563, 1.0, 0.967287, 0.99999], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"   5\", 4.68388, 0.512625, 0.685333, 0.820993, 1.0, 0.983304, 0.99999], [340, \"hsa05205\", \"Proteoglycans in cancer\", \"  27\", 26.77664, 0.513925, 0.572554, 0.820993, 1.0, 0.983304, 0.99999], [253, \"hsa04812\", \"Cytoskeleton proteins\", \"  57\", 56.86606, 0.516235, 0.544855, 0.820993, 1.0, 0.983304, 0.99999], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"   1\", 0.70758, 0.519625, 0.844762, 0.82182, 1.0, 0.984552, 0.99999], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"   7\", 6.75955, 0.535765, 0.653223, 0.841698, 1.0, 1.0, 0.99999], [85, \"hsa00920\", \"Sulfur metabolism\", \"   1\", 0.74736, 0.538995, 0.830902, 0.844675, 1.0, 1.0, 0.99999], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"   3\", 2.80806, 0.539235, 0.691673, 0.844675, 1.0, 1.0, 0.99999], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"   4\", 3.77692, 0.541335, 0.687963, 0.844675, 1.0, 1.0, 0.99999], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"   3\", 2.80173, 0.542035, 0.693233, 0.844675, 1.0, 1.0, 0.99999], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  19\", 19.03778, 0.547175, 0.560624, 0.844675, 1.0, 1.0, 0.99999], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \"  19\", 19.10396, 0.555664, 0.551364, 0.848094, 1.0, 1.0, 0.99999], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"   6\", 5.94268, 0.559694, 0.616854, 0.848295, 1.0, 1.0, 0.99999], [306, \"hsa05033\", \"Nicotine addiction\", \"   8\", 8.11502, 0.581364, 0.576514, 0.883385, 1.0, 1.0, 0.99999], [273, \"hsa04929\", \"GnRH secretion\", \"  13\", 13.28767, 0.591844, 0.537445, 0.897307, 1.0, 1.0, 0.99999], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"   3\", 3.07061, 0.598384, 0.632444, 0.903435, 1.0, 1.0, 0.99999], [209, \"hsa04520\", \"Adherens junction\", \"  14\", 14.41297, 0.600214, 0.522485, 0.903435, 1.0, 1.0, 0.99999], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  10\", 10.41989, 0.602934, 0.528835, 0.903816, 1.0, 1.0, 0.99999], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"   5\", 5.21469, 0.603284, 0.576754, 0.903816, 1.0, 1.0, 0.99999], [307, \"hsa05034\", \"Alcoholism\", \"  13\", 13.4728, 0.605104, 0.517095, 0.903816, 1.0, 1.0, 0.99999], [349, \"hsa05217\", \"Basal cell carcinoma\", \"   5\", 5.21953, 0.610574, 0.575014, 0.907739, 1.0, 1.0, 0.99999], [324, \"hsa05152\", \"Tuberculosis\", \"  11\", 11.61525, 0.623164, 0.502645, 0.925626, 1.0, 1.0, 0.99999], [112, \"hsa03012\", \"Translation factors\", \"   4\", 4.2628, 0.626774, 0.576404, 0.927968, 1.0, 1.0, 0.99999], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"  17\", 17.85912, 0.627854, 0.474915, 0.927968, 1.0, 1.0, 0.99999], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  10\", 10.63107, 0.634784, 0.498615, 0.935167, 1.0, 1.0, 0.99999], [155, \"hsa04062\", \"Chemokine signaling pathway\", \"  20\", 21.12191, 0.647424, 0.448936, 0.94816, 1.0, 1.0, 0.99999], [80, \"hsa00790\", \"Folate biosynthesis\", \"   2\", 2.09557, 0.648134, 0.652723, 0.94816, 1.0, 1.0, 0.99999], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  14\", 14.90775, 0.653993, 0.462795, 0.953361, 1.0, 1.0, 0.99999], [345, \"hsa05213\", \"Endometrial cancer\", \"   7\", 7.67184, 0.669373, 0.491605, 0.973847, 1.0, 1.0, 0.99999], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"   1\", 1.02816, 0.680853, 0.728143, 0.987578, 1.0, 1.0, 0.99999], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  11\", 12.04271, 0.680983, 0.446006, 0.987578, 1.0, 1.0, 0.99999], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"   5\", 5.66314, 0.684853, 0.492355, 0.987578, 1.0, 1.0, 0.99999], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"   2\", 2.3578, 0.688943, 0.579064, 0.989298, 1.0, 1.0, 0.99999], [60, \"hsa00565\", \"Ether lipid metabolism\", \"   4\", 4.60014, 0.689523, 0.506905, 0.989298, 1.0, 1.0, 0.99999], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"   9\", 10.11227, 0.702063, 0.431296, 1.0, 1.0, 1.0, 0.99999], [71, \"hsa00650\", \"Butanoate metabolism\", \"   2\", 2.41719, 0.707363, 0.560454, 1.0, 1.0, 1.0, 0.99999], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  12\", 13.31313, 0.708493, 0.412106, 1.0, 1.0, 1.0, 0.99999], [249, \"hsa04742\", \"Taste transduction\", \"   8\", 9.02452, 0.711893, 0.435686, 1.0, 1.0, 1.0, 0.99999], [341, \"hsa05206\", \"MicroRNAs in cancer\", \"  20\", 21.89893, 0.714523, 0.375976, 1.0, 0.935697, 1.0, 0.99999], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"   7\", 7.98631, 0.714793, 0.439536, 1.0, 1.0, 1.0, 0.99999], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \"  17\", 18.58954, 0.718083, 0.386726, 1.0, 0.935982, 1.0, 0.99999], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"   2\", 2.34919, 0.724033, 0.575614, 1.0, 1.0, 1.0, 0.99999], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"   5\", 5.85993, 0.727193, 0.452535, 1.0, 1.0, 1.0, 0.99999], [150, \"hsa04050\", \"Cytokine receptors\", \"   6\", 7.18735, 0.733683, 0.415836, 1.0, 1.0, 1.0, 0.99999], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  23\", 25.32134, 0.739983, 0.344497, 1.0, 0.908443, 1.0, 0.99999], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"   1\", 1.29863, 0.740303, 0.623854, 1.0, 1.0, 1.0, 0.99999], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  11\", 12.58657, 0.740383, 0.376776, 1.0, 0.935697, 1.0, 0.99999], [17, \"hsa00220\", \"Arginine biosynthesis\", \"   1\", 1.3019, 0.741313, 0.621134, 1.0, 1.0, 1.0, 0.99999], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"   2\", 2.54132, 0.742683, 0.523545, 1.0, 1.0, 1.0, 0.99999], [129, \"hsa03060\", \"Protein export\", \"   2\", 2.29872, 0.746243, 0.600784, 1.0, 1.0, 1.0, 0.99999], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \"  27\", 29.58432, 0.749143, 0.328917, 1.0, 0.88278, 1.0, 0.99999], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"   2\", 2.65988, 0.759232, 0.497615, 1.0, 1.0, 1.0, 0.99999], [330, \"hsa05165\", \"Human papillomavirus infection\", \"  34\", 37.37073, 0.759942, 0.301947, 1.0, 0.861242, 1.0, 0.99999], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"   7\", 8.10334, 0.768362, 0.404006, 1.0, 0.992141, 1.0, 0.99999], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"   1\", 1.37349, 0.776372, 0.592724, 1.0, 1.0, 1.0, 0.99999], [358, \"hsa05226\", \"Gastric cancer\", \"  14\", 16.39196, 0.778132, 0.313107, 1.0, 0.878028, 1.0, 0.99999], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"   1\", 1.43684, 0.780002, 0.572274, 1.0, 1.0, 1.0, 0.99999], [245, \"hsa04727\", \"GABAergic synapse\", \"  14\", 16.27523, 0.781532, 0.314277, 1.0, 0.878028, 1.0, 0.99999], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"   1\", 1.48183, 0.781632, 0.558484, 1.0, 1.0, 1.0, 0.99999], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  14\", 16.2279, 0.788932, 0.311397, 1.0, 0.878028, 1.0, 0.99999], [302, \"hsa05020\", \"Prion diseases\", \"   3\", 3.93233, 0.789632, 0.425426, 1.0, 1.0, 1.0, 0.99999], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"   5\", 6.41554, 0.793842, 0.360816, 1.0, 0.935697, 1.0, 0.99999], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  15\", 17.56858, 0.794462, 0.294867, 1.0, 0.861242, 1.0, 0.99999], [303, \"hsa05030\", \"Cocaine addiction\", \"   5\", 6.38059, 0.795352, 0.364076, 1.0, 0.935697, 1.0, 0.99999], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"   9\", 10.9212, 0.798632, 0.319677, 1.0, 0.878028, 1.0, 0.99999], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"   2\", 2.97144, 0.799232, 0.426686, 1.0, 1.0, 1.0, 0.99999], [53, \"hsa00535\", \"Proteoglycans\", \"   8\", 9.5381, 0.804542, 0.340367, 1.0, 0.89827, 1.0, 0.99999], [174, \"hsa04137\", \"Mitophagy - animal\", \"   5\", 6.3402, 0.808102, 0.362236, 1.0, 0.935697, 1.0, 0.99999], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"   3\", 4.22528, 0.813442, 0.373736, 1.0, 0.935697, 1.0, 0.99999], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"   5\", 6.70737, 0.820132, 0.321897, 1.0, 0.878028, 1.0, 0.99999], [293, \"hsa04976\", \"Bile secretion\", \"   7\", 9.04465, 0.822392, 0.296227, 1.0, 0.861242, 1.0, 0.99999], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"   7\", 8.76601, 0.824602, 0.311197, 1.0, 0.878028, 1.0, 0.99999], [201, \"hsa04371\", \"Apelin signaling pathway\", \"  18\", 21.30443, 0.831162, 0.242188, 1.0, 0.762374, 1.0, 0.99999], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"   3\", 4.32026, 0.832472, 0.351156, 1.0, 0.916322, 1.0, 0.99999], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"   2\", 3.16454, 0.835402, 0.378416, 1.0, 0.935697, 1.0, 0.99999], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"   2\", 2.92088, 0.839762, 0.411316, 1.0, 1.0, 1.0, 0.99999], [39, \"hsa00480\", \"Glutathione metabolism\", \"   1\", 1.81364, 0.841392, 0.455645, 1.0, 1.0, 1.0, 0.99999], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"   8\", 10.3674, 0.843372, 0.264007, 1.0, 0.784409, 1.0, 0.99999], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"   2\", 3.18956, 0.844402, 0.369116, 1.0, 0.935697, 1.0, 0.99999], [211, \"hsa04540\", \"Gap junction\", \"  13\", 15.92035, 0.847222, 0.238718, 1.0, 0.752271, 1.0, 0.99999], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"   4\", 5.7674, 0.850321, 0.294097, 1.0, 0.861242, 1.0, 0.99999], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"   1\", 1.81089, 0.851401, 0.448286, 1.0, 1.0, 1.0, 0.99999], [180, \"hsa04146\", \"Peroxisome\", \"   4\", 5.94575, 0.856511, 0.280147, 1.0, 0.820919, 1.0, 0.99999], [29, \"hsa00350\", \"Tyrosine metabolism\", \"   1\", 1.86403, 0.856631, 0.433966, 1.0, 1.0, 1.0, 0.99999], [216, \"hsa04614\", \"Renin-angiotensin system\", \"   1\", 1.8575, 0.857681, 0.434966, 1.0, 1.0, 1.0, 0.99999], [136, \"hsa03430\", \"Mismatch repair\", \"   1\", 1.84687, 0.859101, 0.433566, 1.0, 1.0, 1.0, 0.99999], [205, \"hsa04510\", \"Focal adhesion\", \"  29\", 34.10559, 0.865191, 0.184368, 1.0, 0.674667, 1.0, 0.986339], [175, \"hsa04140\", \"Autophagy - animal\", \"  12\", 15.41195, 0.865241, 0.209318, 1.0, 0.686588, 1.0, 0.99999], [163, \"hsa04090\", \"CD molecules\", \"  25\", 30.18101, 0.868811, 0.180928, 1.0, 0.674667, 1.0, 0.986339], [304, \"hsa05031\", \"Amphetamine addiction\", \"   9\", 11.72619, 0.869261, 0.225128, 1.0, 0.729249, 1.0, 0.99999], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \"  18\", 22.05794, 0.870541, 0.191598, 1.0, 0.674667, 1.0, 0.986339], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \"  21\", 25.45647, 0.873511, 0.183548, 1.0, 0.674667, 1.0, 0.986339], [350, \"hsa05218\", \"Melanoma\", \"   6\", 8.49599, 0.873941, 0.232478, 1.0, 0.752251, 1.0, 0.99999], [103, \"hsa02010\", \"ABC transporters\", \"   5\", 7.21516, 0.873961, 0.245018, 1.0, 0.762374, 1.0, 0.99999], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  13\", 16.82672, 0.882341, 0.184768, 1.0, 0.674667, 1.0, 0.986339], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \"  20\", 24.61294, 0.882461, 0.172048, 1.0, 0.67113, 1.0, 0.986339], [319, \"hsa05143\", \"African trypanosomiasis\", \"   3\", 4.62749, 0.882591, 0.277987, 1.0, 0.820919, 1.0, 0.99999], [343, \"hsa05211\", \"Renal cell carcinoma\", \"   5\", 7.49191, 0.885231, 0.223168, 1.0, 0.729249, 1.0, 0.99999], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"   1\", 2.09868, 0.888301, 0.368206, 1.0, 0.935697, 1.0, 0.99999], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"   1\", 2.22582, 0.892751, 0.347057, 1.0, 0.910836, 1.0, 0.99999], [342, \"hsa05210\", \"Colorectal cancer\", \"   8\", 11.08163, 0.895401, 0.188978, 1.0, 0.674667, 1.0, 0.986339], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  16\", 20.49806, 0.899091, 0.157918, 1.0, 0.624182, 1.0, 0.948711], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"   2\", 3.80637, 0.902751, 0.255107, 1.0, 0.771804, 1.0, 0.99999], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"   3\", 5.24593, 0.903521, 0.221648, 1.0, 0.729249, 1.0, 0.99999], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  12\", 16.08686, 0.904491, 0.158118, 1.0, 0.624182, 1.0, 0.948711], [295, \"hsa04978\", \"Mineral absorption\", \"   2\", 3.75526, 0.906721, 0.255277, 1.0, 0.771804, 1.0, 0.99999], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \"  15\", 19.51409, 0.908441, 0.145999, 1.0, 0.602407, 1.0, 0.938562], [142, \"hsa04014\", \"Ras signaling pathway\", \"  26\", 32.10798, 0.908911, 0.131009, 1.0, 0.544942, 1.0, 0.873391], [238, \"hsa04720\", \"Long-term potentiation\", \"  11\", 14.79576, 0.911421, 0.155378, 1.0, 0.619389, 1.0, 0.948711], [166, \"hsa04114\", \"Oocyte meiosis\", \"   9\", 12.83198, 0.915311, 0.150548, 1.0, 0.61059, 1.0, 0.948711], [244, \"hsa04726\", \"Serotonergic synapse\", \"  14\", 18.54033, 0.916921, 0.137779, 1.0, 0.559536, 1.0, 0.901824], [164, \"hsa04091\", \"Lectins\", \"   3\", 5.48367, 0.917341, 0.196298, 1.0, 0.674667, 1.0, 0.98764], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"   3\", 5.29026, 0.918741, 0.200428, 1.0, 0.674667, 1.0, 0.988412], [73, \"hsa00730\", \"Thiamine metabolism\", \"   1\", 2.22802, 0.922371, 0.309097, 1.0, 0.872833, 1.0, 0.99999], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \"  59\", 68.24165, 0.922591, 0.100719, 1.0, 0.456208, 1.0, 0.755392], [18, \"hsa00230\", \"Purine metabolism\", \"  13\", 17.94197, 0.928671, 0.118389, 1.0, 0.510475, 1.0, 0.831592], [172, \"hsa04131\", \"Membrane trafficking\", \" 166\", 182.56682, 0.935101, 0.077379, 1.0, 0.377522, 1.0, 0.666245], [146, \"hsa04024\", \"cAMP signaling pathway\", \"  25\", 31.7864, 0.935331, 0.096999, 1.0, 0.45012, 1.0, 0.755392], [70, \"hsa00640\", \"Propanoate metabolism\", \"   2\", 4.22238, 0.942331, 0.179138, 1.0, 0.674667, 1.0, 0.986339], [354, \"hsa05222\", \"Small cell lung cancer\", \"   8\", 12.25788, 0.942371, 0.111309, 1.0, 0.487854, 1.0, 0.801424], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  15\", 20.82947, 0.947021, 0.089609, 1.0, 0.415803, 1.0, 0.716873], [346, \"hsa05214\", \"Glioma\", \"   7\", 11.04581, 0.948681, 0.106929, 1.0, 0.475094, 1.0, 0.7856], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"   3\", 5.98492, 0.95185, 0.130259, 1.0, 0.544942, 1.0, 0.873391], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"   1\", 2.99972, 0.95472, 0.191788, 1.0, 0.674667, 1.0, 0.986339], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"   1\", 2.84125, 0.95697, 0.197528, 1.0, 0.674667, 1.0, 0.98764], [260, \"hsa04916\", \"Melanogenesis\", \"   8\", 12.96714, 0.96157, 0.078269, 1.0, 0.377522, 1.0, 0.666245], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  17\", 23.85085, 0.9648, 0.060419, 1.0, 0.314744, 1.0, 0.587864], [143, \"hsa04015\", \"Rap1 signaling pathway\", \"  26\", 34.5389, 0.967, 0.052389, 1.0, 0.303996, 1.0, 0.56972], [336, \"hsa05200\", \"Pathways in cancer\", \"  47\", 58.96483, 0.96889, 0.04359, 1.0, 0.292249, 1.0, 0.56972], [305, \"hsa05032\", \"Morphine addiction\", \"  13\", 19.42936, 0.96915, 0.056999, 1.0, 0.308061, 1.0, 0.569994], [116, \"hsa03018\", \"RNA degradation\", \"   2\", 5.16643, 0.97059, 0.100169, 1.0, 0.456208, 1.0, 0.755392], [243, \"hsa04725\", \"Cholinergic synapse\", \"  14\", 20.839, 0.97287, 0.050529, 1.0, 0.303996, 1.0, 0.56972], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"   5\", 9.237, 0.97318, 0.069799, 1.0, 0.350836, 1.0, 0.628194], [247, \"hsa04730\", \"Long-term depression\", \"  10\", 15.56711, 0.97325, 0.054959, 1.0, 0.307719, 1.0, 0.56972], [131, \"hsa03310\", \"Nuclear receptors\", \"   3\", 6.62621, 0.97366, 0.079579, 1.0, 0.377522, 1.0, 0.666245], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \"  35\", 45.6506, 0.97376, 0.03968, 1.0, 0.282589, 1.0, 0.54941], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  11\", 17.27031, 0.9741, 0.050949, 1.0, 0.303996, 1.0, 0.56972], [289, \"hsa04972\", \"Pancreatic secretion\", \"   8\", 13.30217, 0.97534, 0.055389, 1.0, 0.307719, 1.0, 0.56972], [348, \"hsa05216\", \"Thyroid cancer\", \"   1\", 3.53044, 0.97562, 0.120119, 1.0, 0.51106, 1.0, 0.831592], [256, \"hsa04912\", \"GnRH signaling pathway\", \"   9\", 14.87965, 0.97799, 0.04682, 1.0, 0.298295, 1.0, 0.56972], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  10\", 16.28772, 0.97879, 0.0447, 1.0, 0.292249, 1.0, 0.56972], [242, \"hsa04724\", \"Glutamatergic synapse\", \"  19\", 27.53727, 0.98378, 0.02969, 1.0, 0.273902, 1.0, 0.445244], [236, \"hsa04713\", \"Circadian entrainment\", \"  15\", 22.46689, 0.98398, 0.03092, 1.0, 0.273902, 1.0, 0.445244], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"   2\", 5.18367, 0.98508, 0.067149, 1.0, 0.350836, 1.0, 0.61984], [91, \"hsa01002\", \"Peptidases and inhibitors\", \"  53\", 67.87073, 0.98563, 0.02038, 1.0, 0.273902, 1.0, 0.431572], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"   3\", 7.56516, 0.98593, 0.04797, 1.0, 0.298295, 1.0, 0.56972], [144, \"hsa04020\", \"Calcium signaling pathway\", \"  25\", 35.13752, 0.98594, 0.02369, 1.0, 0.273902, 1.0, 0.445244], [214, \"hsa04611\", \"Platelet activation\", \"  11\", 18.54422, 0.9885, 0.02461, 1.0, 0.273902, 1.0, 0.445244], [322, \"hsa05146\", \"Amoebiasis\", \"   8\", 14.72469, 0.98864, 0.02684, 1.0, 0.273902, 1.0, 0.445244], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"   6\", 11.85839, 0.98923, 0.02921, 1.0, 0.273902, 1.0, 0.445244], [268, \"hsa04924\", \"Renin secretion\", \"   6\", 11.81315, 0.9894, 0.02869, 1.0, 0.273902, 1.0, 0.445244], [149, \"hsa04040\", \"Ion channels\", \"  42\", 55.62317, 0.98949, 0.01607, 1.0, 0.273902, 1.0, 0.431276], [173, \"hsa04136\", \"Autophagy - other\", \"   1\", 3.99528, 0.98969, 0.066079, 1.0, 0.350836, 1.0, 0.61984], [291, \"hsa04974\", \"Protein digestion and absorption\", \"   5\", 11.0959, 0.99081, 0.02486, 1.0, 0.273902, 1.0, 0.445244], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  13\", 21.36277, 0.99161, 0.01797, 1.0, 0.273902, 1.0, 0.431276], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \"  23\", 34.21273, 0.99211, 0.01421, 1.0, 0.273902, 1.0, 0.431276], [147, \"hsa04030\", \"G protein-coupled receptors\", \"  20\", 30.97645, 0.99217, 0.01388, 1.0, 0.273902, 1.0, 0.431276], [288, \"hsa04971\", \"Gastric acid secretion\", \"   5\", 11.65684, 0.99547, 0.0139, 1.0, 0.273902, 1.0, 0.431276], [248, \"hsa04740\", \"Olfactory transduction\", \"   5\", 11.23723, 0.9955, 0.01559, 1.0, 0.273902, 1.0, 0.431276], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"   3\", 8.09105, 0.99556, 0.01918, 1.0, 0.273902, 1.0, 0.431546], [255, \"hsa04911\", \"Insulin secretion\", \"   7\", 15.10297, 0.99792, 0.00645, 1.0, 0.126827, 1.0, 0.331711], [206, \"hsa04512\", \"ECM-receptor interaction\", \"   7\", 15.77346, 0.99802, 0.00541, 1.0, 0.126587, 1.0, 0.324597], [102, \"hsa02000\", \"Transporters\", \"  45\", 64.38543, 0.99825, 0.00291, 1.0, 0.084893, 1.0, 0.209518], [92, \"hsa01003\", \"Glycosyltransferases\", \"  17\", 30.04133, 0.99884, 0.00238, 1.0, 0.084893, 1.0, 0.209518], [208, \"hsa04515\", \"Cell adhesion molecules\", \"  24\", 38.89061, 0.99932, 0.00143, 1.0, 0.08334, 1.0, 0.209518], [287, \"hsa04970\", \"Salivary secretion\", \"   5\", 13.68453, 0.99954, 0.00192, 1.0, 0.084893, 1.0, 0.209518], [199, \"hsa04360\", \"Axon guidance\", \"  20\", 35.44787, 0.99971, 0.00069, 1.0, 0.0794, 1.0, 0.209518], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"   0\", 0.42863, 1.0, 0.647244, 1.0, 1.0, 1.0, 0.99999], [81, \"hsa00830\", \"Retinol metabolism\", \"   0\", 2.43664, 1.0, 0.081589, 1.0, 0.379842, 1.0, 0.667548], [250, \"hsa04744\", \"Phototransduction\", \"   0\", 1.34058, 1.0, 0.251417, 1.0, 0.767547, 1.0, 0.99999], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"   0\", 1.68776, 1.0, 0.175208, 1.0, 0.67113, 1.0, 0.986339], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"   0\", 1.52764, 1.0, 0.207978, 1.0, 0.686588, 1.0, 0.99999], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"   0\", 3.58289, 1.0, 0.01572, 1.0, 0.273902, 1.0, 0.431276], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"   0\", 3.2984, 1.0, 0.01679, 1.0, 0.273902, 1.0, 0.431276], [118, \"hsa03020\", \"RNA polymerase\", \"   0\", 1.37672, 1.0, 0.244058, 1.0, 0.762374, 1.0, 0.99999]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#a3b81c42-d505-46ef-974e-0aceb5ff7d96').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#a3b81c42-d505-46ef-974e-0aceb5ff7d96').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                                       FunctionName  \\\n",
       "226  hsa04658                   Th1 and Th2 cell differentiation   \n",
       "26   hsa00310                                 Lysine degradation   \n",
       "334  hsa05169                       Epstein-Barr virus infection   \n",
       "124  hsa03036                 Chromosome and associated proteins   \n",
       "327  hsa05162                                            Measles   \n",
       "..        ...                                                ...   \n",
       "1    hsa00020                          Citrate cycle (TCA cycle)   \n",
       "82   hsa00860               Porphyrin and chlorophyll metabolism   \n",
       "50   hsa00532  Glycosaminoglycan biosynthesis - chondroitin s...   \n",
       "77   hsa00770                  Pantothenate and CoA biosynthesis   \n",
       "118  hsa03020                                     RNA polymerase   \n",
       "\n",
       "     n_candidates  mean_n_resample  emp_p_e   emp_p_d     fdr_e     fdr_d  \\\n",
       "226            19          7.30410  0.00006  0.999990  0.010240  1.000000   \n",
       "26             16          6.20373  0.00019  0.999950  0.017975  1.000000   \n",
       "334            27         12.84532  0.00022  0.999930  0.017975  1.000000   \n",
       "124           152        118.83746  0.00048  0.999640  0.025065  1.000000   \n",
       "327            18          8.26746  0.00106  0.999630  0.044538  1.000000   \n",
       "..            ...              ...      ...       ...       ...       ...   \n",
       "1               0          1.68776  1.00000  0.175208  1.000000  0.671130   \n",
       "82              0          1.52764  1.00000  0.207978  1.000000  0.686588   \n",
       "50              0          3.58289  1.00000  0.015720  1.000000  0.273902   \n",
       "77              0          3.29840  1.00000  0.016790  1.000000  0.273902   \n",
       "118             0          1.37672  1.00000  0.244058  1.000000  0.762374   \n",
       "\n",
       "     BH_fdr_e  BH_fdr_d  \n",
       "226  0.021600  0.999990  \n",
       "26   0.026400  0.999990  \n",
       "334  0.026400  0.999990  \n",
       "124  0.043200  0.999990  \n",
       "327  0.068399  0.999990  \n",
       "..        ...       ...  \n",
       "1    1.000000  0.986339  \n",
       "82   1.000000  0.999990  \n",
       "50   1.000000  0.431276  \n",
       "77   1.000000  0.431276  \n",
       "118  1.000000  0.999990  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ei_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "79b40671",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table id=\"ff3a5146-f90a-4cc0-a6df-32b7f16b2982\" class=\"display\"style=\"max-width:100%\"><thead><th></th><th>Id</th><th>FunctionName</th><th>n_candidates</th><th>mean_n_resample</th><th>emp_p_e</th><th>emp_p_d</th><th>fdr_e</th><th>fdr_d</th><th>BH_fdr_e</th><th>BH_fdr_d</th></thead><tbody><tr><td>Loading... (need <a href=https://mwouts.github.io/itables/troubleshooting.html>help</a>?)</td></tr></tbody></table>\n",
       "<link rel=\"stylesheet\" type=\"text/css\" href=\"https://cdn.datatables.net/1.11.3/css/jquery.dataTables.min.css\">\n",
       "<style> table td {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<style> table th {\n",
       "    text-overflow: ellipsis;\n",
       "    overflow: hidden;\n",
       "} </style>\n",
       "<script type=\"module\">\n",
       "    // Define the table data\n",
       "    const data = [[317, \"hsa05140\", \"Leishmaniasis\", \"  19\", 6.06254, 1e-05, 1.0, 0.0, 1.0, 0.0036, 1.0], [226, \"hsa04658\", \"Th1 and Th2 cell differentiation\", \"  28\", 11.01205, 3e-05, 1.0, 0.00148, 1.0, 0.0036, 1.0], [334, \"hsa05169\", \"Epstein-Barr virus infection\", \"  39\", 19.50258, 3e-05, 0.99999, 0.00148, 1.0, 0.0036, 1.0], [153, \"hsa04060\", \"Cytokine-cytokine receptor interaction\", \"  38\", 19.65169, 5e-05, 0.99999, 0.00222, 1.0, 0.0045, 1.0], [369, \"hsa05340\", \"Primary immunodeficiency\", \"  10\", 2.22006, 9e-05, 1.0, 0.003524, 1.0, 0.00648, 1.0], [234, \"hsa04672\", \"Intestinal immune network for IgA production\", \"  10\", 2.62632, 0.00023, 0.99995, 0.00818, 1.0, 0.0138, 1.0], [361, \"hsa05235\", \"PD-L1 expression and PD-1 checkpoint pathway in cancer\", \"  27\", 13.95832, 0.00031, 0.9999, 0.009831, 1.0, 0.01485, 1.0], [4, \"hsa00051\", \"Fructose and mannose metabolism\", \"  12\", 4.19257, 0.00033, 0.99991, 0.009831, 1.0, 0.01485, 1.0], [26, \"hsa00310\", \"Lysine degradation\", \"  20\", 9.38545, 0.00048, 0.99985, 0.01206, 1.0, 0.0192, 1.0], [217, \"hsa04620\", \"Toll-like receptor signaling pathway\", \"  18\", 8.30962, 0.00119, 0.99955, 0.026972, 1.0, 0.04284, 1.0], [225, \"hsa04657\", \"IL-17 signaling pathway\", \"  15\", 6.49064, 0.00164, 0.99946, 0.034474, 1.0, 0.050999, 1.0], [47, \"hsa00520\", \"Amino sugar and nucleotide sugar metabolism\", \"  13\", 5.61827, 0.0017, 0.99943, 0.034474, 1.0, 0.050999, 1.0], [321, \"hsa05145\", \"Toxoplasmosis\", \"  27\", 15.45276, 0.00201, 0.9991, 0.03638, 1.0, 0.055661, 1.0], [156, \"hsa04064\", \"NF-kappa B signaling pathway\", \"  22\", 12.04309, 0.00289, 0.9989, 0.048587, 1.0, 0.074314, 1.0], [227, \"hsa04659\", \"Th17 cell differentiation\", \"  25\", 14.03518, 0.00312, 0.99865, 0.049783, 1.0, 0.074879, 1.0], [228, \"hsa04660\", \"T cell receptor signaling pathway\", \"  31\", 19.18226, 0.00356, 0.99834, 0.054065, 1.0, 0.080099, 1.0], [0, \"hsa00010\", \"Glycolysis / Gluconeogenesis\", \"  12\", 4.9448, 0.00409, 0.99855, 0.058368, 1.0, 0.086611, 1.0], [327, \"hsa05162\", \"Measles\", \"  22\", 12.47739, 0.00567, 0.99724, 0.07727, 1.0, 0.111239, 1.0], [364, \"hsa05321\", \"Inflammatory bowel disease (IBD)\", \"  12\", 5.21577, 0.00589, 0.99795, 0.07727, 1.0, 0.111239, 1.0], [124, \"hsa03036\", \"Chromosome and associated proteins\", \" 211\", 179.79668, 0.00618, 0.99502, 0.07727, 1.0, 0.111239, 1.0], [84, \"hsa00910\", \"Nitrogen metabolism\", \"   6\", 1.76729, 0.00657, 0.99878, 0.07727, 1.0, 0.112627, 1.0], [125, \"hsa03040\", \"Spliceosome\", \"  16\", 8.01283, 0.00699, 0.99704, 0.078604, 1.0, 0.114381, 1.0], [264, \"hsa04920\", \"Adipocytokine signaling pathway\", \"  19\", 10.65801, 0.00743, 0.99655, 0.079894, 1.0, 0.116294, 1.0], [218, \"hsa04621\", \"NOD-like receptor signaling pathway\", \"  30\", 19.36171, 0.00816, 0.99598, 0.082737, 1.0, 0.120527, 1.0], [109, \"hsa03009\", \"Ribosome biogenesis\", \"  31\", 19.9735, 0.00837, 0.99531, 0.082737, 1.0, 0.120527, 1.0], [123, \"hsa03032\", \"DNA replication proteins\", \"  20\", 11.291, 0.00988, 0.99523, 0.093858, 1.0, 0.131013, 1.0], [27, \"hsa00330\", \"Arginine and proline metabolism\", \"   8\", 2.99291, 0.01009, 0.99702, 0.093858, 1.0, 0.131013, 1.0], [198, \"hsa04350\", \"TGF-beta signaling pathway\", \"  23\", 14.1147, 0.01019, 0.99509, 0.093858, 1.0, 0.131013, 1.0], [294, \"hsa04977\", \"Vitamin digestion and absorption\", \"   8\", 3.26272, 0.01103, 0.99719, 0.094233, 1.0, 0.136923, 1.0], [100, \"hsa01523\", \"Antifolate resistance\", \"   7\", 2.63607, 0.0121, 0.9969, 0.102499, 1.0, 0.145199, 1.0], [338, \"hsa05203\", \"Viral carcinogenesis\", \"  34\", 23.3255, 0.01308, 0.99222, 0.105625, 1.0, 0.148836, 1.0], [374, \"hsa05418\", \"Fluid shear stress and atherosclerosis\", \"  24\", 15.06693, 0.01323, 0.99304, 0.105625, 1.0, 0.148836, 1.0], [219, \"hsa04622\", \"RIG-I-like receptor signaling pathway\", \"  11\", 5.2788, 0.01491, 0.99453, 0.111065, 1.0, 0.162653, 1.0], [126, \"hsa03041\", \"Spliceosome\", \"  49\", 36.86803, 0.01934, 0.98705, 0.146069, 1.0, 0.204774, 1.0], [311, \"hsa05130\", \"Pathogenic Escherichia coli infection\", \"  39\", 28.0491, 0.02003, 0.98718, 0.146069, 1.0, 0.206021, 1.0], [333, \"hsa05168\", \"Herpes simplex virus 1 infection\", \"  40\", 28.52393, 0.02189, 0.98565, 0.157096, 1.0, 0.218898, 1.0], [271, \"hsa04927\", \"Cortisol synthesis and secretion\", \"  25\", 17.24036, 0.02414, 0.98678, 0.167386, 1.0, 0.234873, 1.0], [151, \"hsa04052\", \"Cytokines and growth factors\", \"  30\", 21.28385, 0.02533, 0.98502, 0.173164, 1.0, 0.239966, 1.0], [202, \"hsa04380\", \"Osteoclast differentiation\", \"  25\", 16.91536, 0.02852, 0.98412, 0.190781, 1.0, 0.263259, 1.0], [329, \"hsa05164\", \"Influenza A\", \"  24\", 16.11569, 0.02931, 0.98324, 0.191125, 1.0, 0.263787, 1.0], [68, \"hsa00620\", \"Pyruvate metabolism\", \"   9\", 4.52462, 0.03144, 0.98798, 0.196948, 1.0, 0.264679, 1.0], [335, \"hsa05170\", \"Human immunodeficiency virus 1 infection\", \"  40\", 30.02551, 0.03149, 0.97926, 0.196948, 1.0, 0.264679, 1.0], [107, \"hsa03000\", \"Transcription factors\", \" 136\", 117.1861, 0.03191, 0.97409, 0.196948, 1.0, 0.264679, 1.0], [275, \"hsa04931\", \"Insulin resistance\", \"  26\", 18.16217, 0.03235, 0.98084, 0.196948, 1.0, 0.264679, 1.0], [310, \"hsa05120\", \"Epithelial cell signaling in Helicobacter pylori infection\", \"  16\", 9.88476, 0.03456, 0.98194, 0.197317, 1.0, 0.275632, 1.0], [312, \"hsa05131\", \"Shigellosis\", \"  47\", 36.57943, 0.03522, 0.97649, 0.197317, 1.0, 0.275632, 1.0], [108, \"hsa03008\", \"Ribosome biogenesis in eukaryotes\", \"  12\", 6.87902, 0.03669, 0.98341, 0.203046, 1.0, 0.280365, 1.0], [220, \"hsa04623\", \"Cytosolic DNA-sensing pathway\", \"   7\", 3.161, 0.03857, 0.98651, 0.206491, 1.0, 0.280365, 1.0], [154, \"hsa04061\", \"Viral protein interaction with cytokine and cytokine receptor\", \"   9\", 4.55871, 0.03888, 0.98428, 0.206491, 1.0, 0.280365, 1.0], [134, \"hsa03410\", \"Base excision repair\", \"   5\", 1.8771, 0.03894, 0.98916, 0.206491, 1.0, 0.280365, 1.0], [184, \"hsa04152\", \"AMPK signaling pathway\", \"  30\", 21.92976, 0.04123, 0.97486, 0.207912, 1.0, 0.282797, 1.0], [192, \"hsa04260\", \"Cardiac muscle contraction\", \"  24\", 17.57358, 0.04196, 0.9777, 0.209082, 1.0, 0.282797, 1.0], [121, \"hsa03029\", \"Mitochondrial biogenesis\", \"  52\", 41.22276, 0.04223, 0.97003, 0.209082, 1.0, 0.282797, 1.0], [215, \"hsa04612\", \"Antigen processing and presentation\", \"   7\", 3.20742, 0.04242, 0.98488, 0.209082, 1.0, 0.282797, 1.0], [261, \"hsa04917\", \"Prolactin signaling pathway\", \"  16\", 10.31473, 0.04536, 0.97689, 0.217246, 1.0, 0.294818, 1.0], [5, \"hsa00052\", \"Galactose metabolism\", \"   7\", 3.33406, 0.04659, 0.98312, 0.221244, 1.0, 0.294818, 1.0], [278, \"hsa04934\", \"Cushing syndrome\", \"  39\", 30.16355, 0.04668, 0.96881, 0.221244, 1.0, 0.294818, 1.0], [221, \"hsa04625\", \"C-type lectin receptor signaling pathway\", \"  20\", 13.78774, 0.04965, 0.97236, 0.229977, 1.0, 0.308169, 1.0], [99, \"hsa01522\", \"Endocrine resistance\", \"  25\", 18.15835, 0.051929, 0.96967, 0.236215, 1.0, 0.316858, 1.0], [292, \"hsa04975\", \"Fat digestion and absorption\", \"   7\", 3.42963, 0.053909, 0.97974, 0.239998, 1.0, 0.323457, 1.0], [42, \"hsa00511\", \"Other glycan degradation\", \"   4\", 1.51518, 0.060149, 0.98447, 0.264471, 1.0, 0.350706, 1.0], [362, \"hsa05310\", \"Asthma\", \"   3\", 0.88297, 0.060399, 0.98854, 0.264471, 1.0, 0.350706, 1.0], [237, \"hsa04714\", \"Thermogenesis\", \"  36\", 28.2259, 0.063559, 0.95719, 0.268527, 1.0, 0.360606, 1.0], [179, \"hsa04145\", \"Phagosome\", \"  19\", 13.09882, 0.064119, 0.96287, 0.268527, 1.0, 0.360606, 1.0], [130, \"hsa03110\", \"Chaperones and folding catalysts\", \"  27\", 19.98004, 0.065109, 0.95826, 0.268527, 1.0, 0.360606, 1.0], [140, \"hsa04010\", \"MAPK signaling pathway\", \"  71\", 60.17621, 0.066389, 0.949551, 0.268527, 1.0, 0.362124, 1.0], [229, \"hsa04662\", \"B cell receptor signaling pathway\", \"  20\", 14.26666, 0.068429, 0.96038, 0.268527, 1.0, 0.363179, 1.0], [150, \"hsa04050\", \"Cytokine receptors\", \"  16\", 10.69653, 0.069019, 0.96124, 0.268527, 1.0, 0.363179, 1.0], [9, \"hsa00071\", \"Fatty acid degradation\", \"   7\", 3.59769, 0.069609, 0.97271, 0.268527, 1.0, 0.363179, 1.0], [64, \"hsa00600\", \"Sphingolipid metabolism\", \"  12\", 7.61756, 0.072129, 0.96471, 0.2767, 1.0, 0.369934, 1.0], [137, \"hsa03440\", \"Homologous recombination\", \"   9\", 5.17209, 0.072959, 0.96771, 0.2767, 1.0, 0.369934, 1.0], [28, \"hsa00340\", \"Histidine metabolism\", \"   4\", 1.59289, 0.074569, 0.97975, 0.280924, 1.0, 0.372846, 1.0], [30, \"hsa00360\", \"Phenylalanine metabolism\", \"   3\", 1.06222, 0.085829, 0.98196, 0.316389, 1.0, 0.415464, 1.0], [314, \"hsa05133\", \"Pertussis\", \"   9\", 5.38247, 0.085909, 0.96024, 0.316389, 1.0, 0.415464, 1.0], [367, \"hsa05330\", \"Allograft rejection\", \"   4\", 1.69748, 0.087509, 0.97417, 0.317899, 1.0, 0.415464, 1.0], [119, \"hsa03021\", \"Transcription machinery\", \"  39\", 31.3852, 0.087709, 0.937971, 0.317899, 1.0, 0.415464, 1.0], [353, \"hsa05221\", \"Acute myeloid leukemia\", \"  15\", 10.4253, 0.090349, 0.948551, 0.317899, 1.0, 0.422411, 1.0], [296, \"hsa04979\", \"Cholesterol metabolism\", \"  11\", 7.16975, 0.092479, 0.95419, 0.32225, 1.0, 0.426827, 1.0], [15, \"hsa00190\", \"Oxidative phosphorylation\", \"  12\", 7.84778, 0.094779, 0.949321, 0.32989, 1.0, 0.431905, 1.0], [85, \"hsa00920\", \"Sulfur metabolism\", \"   3\", 1.13528, 0.100189, 0.9755, 0.34233, 1.0, 0.442923, 1.0], [366, \"hsa05323\", \"Rheumatoid arthritis\", \"  11\", 7.1654, 0.100679, 0.947491, 0.34233, 1.0, 0.442923, 1.0], [135, \"hsa03420\", \"Nucleotide excision repair\", \"   7\", 4.01336, 0.102619, 0.95554, 0.343989, 1.0, 0.442923, 1.0], [326, \"hsa05161\", \"Hepatitis B\", \"  27\", 21.08919, 0.102919, 0.931591, 0.343989, 1.0, 0.442923, 1.0], [16, \"hsa00199\", \"Cytochrome P450\", \"   8\", 4.76286, 0.103469, 0.95162, 0.343989, 1.0, 0.442923, 1.0], [328, \"hsa05163\", \"Human cytomegalovirus infection\", \"  44\", 36.58978, 0.104579, 0.924231, 0.343989, 1.0, 0.442923, 1.0], [315, \"hsa05134\", \"Legionellosis\", \"   6\", 3.26992, 0.108799, 0.95527, 0.350142, 1.0, 0.455437, 1.0], [277, \"hsa04933\", \"AGE-RAGE signaling pathway in diabetic complications\", \"  25\", 19.71435, 0.112619, 0.926971, 0.357656, 1.0, 0.463168, 1.0], [86, \"hsa00970\", \"Aminoacyl-tRNA biosynthesis\", \"  10\", 6.60097, 0.113219, 0.943811, 0.357656, 1.0, 0.463168, 1.0], [212, \"hsa04550\", \"Signaling pathways regulating pluripotency of stem cells\", \"  23\", 17.73969, 0.115449, 0.923691, 0.359101, 1.0, 0.466984, 1.0], [269, \"hsa04925\", \"Aldosterone synthesis and secretion\", \"  31\", 25.62845, 0.128149, 0.913531, 0.391252, 1.0, 0.512595, 1.0], [21, \"hsa00250\", \"Alanine, aspartate and glutamate metabolism\", \"   7\", 4.24374, 0.130099, 0.939741, 0.397289, 1.0, 0.514676, 1.0], [232, \"hsa04668\", \"TNF signaling pathway\", \"  18\", 13.77114, 0.139789, 0.911921, 0.423649, 1.0, 0.541278, 1.0], [29, \"hsa00350\", \"Tyrosine metabolism\", \"   5\", 2.78341, 0.141439, 0.943821, 0.424199, 1.0, 0.541278, 1.0], [14, \"hsa00140\", \"Steroid hormone biosynthesis\", \"   6\", 3.58396, 0.144789, 0.935501, 0.430437, 1.0, 0.541278, 1.0], [313, \"hsa05132\", \"Salmonella infection\", \"  34\", 28.3095, 0.145189, 0.894081, 0.430437, 1.0, 0.541278, 1.0], [22, \"hsa00260\", \"Glycine, serine and threonine metabolism\", \"   5\", 2.82018, 0.148209, 0.940031, 0.431006, 1.0, 0.541278, 1.0], [281, \"hsa04950\", \"Maturity onset diabetes of the young\", \"   3\", 1.35994, 0.150348, 0.95791, 0.436828, 1.0, 0.541278, 1.0], [331, \"hsa05166\", \"Human T-cell leukemia virus 1 infection\", \"  34\", 28.44632, 0.151188, 0.889321, 0.436828, 1.0, 0.541278, 1.0], [316, \"hsa05135\", \"Yersinia infection\", \"  27\", 22.12156, 0.151518, 0.894851, 0.436828, 1.0, 0.541278, 1.0], [223, \"hsa04640\", \"Hematopoietic cell lineage\", \"  11\", 7.73214, 0.151578, 0.912921, 0.436828, 1.0, 0.541278, 1.0], [120, \"hsa03022\", \"Basal transcription factors\", \"   7\", 4.44979, 0.151858, 0.928781, 0.436828, 1.0, 0.541278, 1.0], [254, \"hsa04910\", \"Insulin signaling pathway\", \"  25\", 20.3242, 0.155968, 0.893061, 0.436828, 1.0, 0.550477, 1.0], [370, \"hsa05410\", \"Hypertrophic cardiomyopathy (HCM)\", \"  31\", 26.32562, 0.158258, 0.890591, 0.436828, 1.0, 0.553136, 1.0], [191, \"hsa04218\", \"Cellular senescence\", \"  27\", 22.2444, 0.163098, 0.885291, 0.440989, 1.0, 0.56444, 1.0], [171, \"hsa04130\", \"SNARE interactions in vesicular transport\", \"   6\", 3.79063, 0.164628, 0.929211, 0.442723, 1.0, 0.56444, 1.0], [320, \"hsa05144\", \"Malaria\", \"   6\", 3.77496, 0.173368, 0.919531, 0.460274, 1.0, 0.585792, 1.0], [115, \"hsa03016\", \"Transfer RNA biogenesis\", \"  23\", 18.79994, 0.175028, 0.877771, 0.460274, 1.0, 0.585792, 1.0], [148, \"hsa04031\", \"GTP-binding proteins\", \"  25\", 20.6222, 0.177518, 0.874841, 0.460533, 1.0, 0.585792, 1.0], [182, \"hsa04150\", \"mTOR signaling pathway\", \"  29\", 24.40346, 0.179758, 0.869931, 0.46257, 1.0, 0.585792, 1.0], [258, \"hsa04914\", \"Progesterone-mediated oocyte maturation\", \"  19\", 15.29604, 0.180508, 0.881901, 0.463695, 1.0, 0.585792, 1.0], [351, \"hsa05219\", \"Bladder cancer\", \"   8\", 5.53588, 0.182708, 0.904631, 0.466665, 1.0, 0.585792, 1.0], [240, \"hsa04722\", \"Neurotrophin signaling pathway\", \"  25\", 20.78746, 0.185068, 0.869311, 0.470094, 1.0, 0.585792, 1.0], [181, \"hsa04147\", \"Exosome\", \" 111\", 102.17992, 0.185078, 0.841662, 0.470094, 1.0, 0.585792, 1.0], [113, \"hsa03013\", \"RNA transport\", \"  16\", 12.50794, 0.185718, 0.878381, 0.470094, 1.0, 0.585792, 1.0], [193, \"hsa04261\", \"Adrenergic signaling in cardiomyocytes\", \"  41\", 36.00666, 0.187128, 0.859991, 0.470094, 1.0, 0.585792, 1.0], [111, \"hsa03011\", \"Ribosome\", \"   8\", 5.52444, 0.190828, 0.895991, 0.470094, 1.0, 0.592225, 1.0], [263, \"hsa04919\", \"Thyroid hormone signaling pathway\", \"  28\", 23.77146, 0.193408, 0.861451, 0.470871, 1.0, 0.594992, 1.0], [132, \"hsa03320\", \"PPAR signaling pathway\", \"  11\", 8.22096, 0.196538, 0.883871, 0.475499, 1.0, 0.594992, 1.0], [286, \"hsa04966\", \"Collecting duct acid secretion\", \"   4\", 2.29557, 0.196678, 0.920811, 0.475499, 1.0, 0.594992, 1.0], [307, \"hsa05034\", \"Alcoholism\", \"  24\", 20.20745, 0.203718, 0.856131, 0.490322, 1.0, 0.608335, 1.0], [266, \"hsa04922\", \"Glucagon signaling pathway\", \"  22\", 18.42531, 0.205968, 0.857971, 0.490322, 1.0, 0.608335, 1.0], [190, \"hsa04217\", \"Necroptosis\", \"  16\", 12.78232, 0.206158, 0.862861, 0.490322, 1.0, 0.608335, 1.0], [276, \"hsa04932\", \"Non-alcoholic fatty liver disease (NAFLD)\", \"  18\", 14.73033, 0.215768, 0.853431, 0.505329, 1.0, 0.631516, 1.0], [306, \"hsa05033\", \"Nicotine addiction\", \"  15\", 12.13585, 0.218178, 0.860971, 0.505329, 1.0, 0.632458, 1.0], [155, \"hsa04062\", \"Chemokine signaling pathway\", \"  36\", 31.73076, 0.221788, 0.831412, 0.510436, 1.0, 0.632458, 1.0], [363, \"hsa05320\", \"Autoimmune thyroid disease\", \"   5\", 3.27177, 0.222948, 0.901511, 0.510436, 1.0, 0.632458, 1.0], [303, \"hsa05030\", \"Cocaine addiction\", \"  12\", 9.48296, 0.224228, 0.862151, 0.510436, 1.0, 0.632458, 1.0], [200, \"hsa04370\", \"VEGF signaling pathway\", \"  14\", 11.30002, 0.226298, 0.857841, 0.511682, 1.0, 0.632458, 1.0], [158, \"hsa04068\", \"FoxO signaling pathway\", \"  22\", 18.60074, 0.227638, 0.837892, 0.511682, 1.0, 0.632458, 1.0], [138, \"hsa03450\", \"Non-homologous end-joining\", \"   4\", 2.47744, 0.228388, 0.907991, 0.511682, 1.0, 0.632458, 1.0], [114, \"hsa03015\", \"mRNA surveillance pathway\", \"  13\", 10.42993, 0.234768, 0.850671, 0.520943, 1.0, 0.645163, 1.0], [297, \"hsa05010\", \"Alzheimer disease\", \"  51\", 46.24046, 0.240138, 0.806372, 0.528291, 1.0, 0.652189, 1.0], [230, \"hsa04664\", \"Fc epsilon RI signaling pathway\", \"  17\", 14.18947, 0.240948, 0.837032, 0.528291, 1.0, 0.652189, 1.0], [6, \"hsa00053\", \"Ascorbate and aldarate metabolism\", \"   2\", 0.9773, 0.255077, 0.926851, 0.550277, 1.0, 0.683384, 1.0], [185, \"hsa04210\", \"Apoptosis\", \"  19\", 16.15974, 0.256567, 0.818972, 0.550277, 1.0, 0.683384, 1.0], [159, \"hsa04070\", \"Phosphatidylinositol signaling system\", \"  32\", 28.60719, 0.258167, 0.805312, 0.550277, 1.0, 0.683384, 1.0], [95, \"hsa01007\", \"Amino acid related enzymes\", \"  11\", 8.83683, 0.263127, 0.837302, 0.55668, 1.0, 0.687932, 1.0], [169, \"hsa04121\", \"Ubiquitin system\", \" 116\", 109.60438, 0.263707, 0.769242, 0.55668, 1.0, 0.687932, 1.0], [257, \"hsa04913\", \"Ovarian steroidogenesis\", \"  11\", 8.92422, 0.270907, 0.830802, 0.566006, 1.0, 0.70163, 1.0], [324, \"hsa05152\", \"Tuberculosis\", \"  20\", 17.44704, 0.290907, 0.786592, 0.603316, 1.0, 0.735843, 1.0], [347, \"hsa05215\", \"Prostate cancer\", \"  21\", 18.4263, 0.291727, 0.787782, 0.603316, 1.0, 0.735843, 1.0], [110, \"hsa03010\", \"Ribosome\", \"   5\", 3.59511, 0.292437, 0.847702, 0.603316, 1.0, 0.735843, 1.0], [332, \"hsa05167\", \"Kaposi sarcoma-associated herpesvirus infection\", \"  28\", 25.07277, 0.292987, 0.774952, 0.603316, 1.0, 0.735843, 1.0], [196, \"hsa04330\", \"Notch signaling pathway\", \"   8\", 6.33283, 0.294337, 0.825262, 0.603316, 1.0, 0.735843, 1.0], [222, \"hsa04630\", \"Jak-STAT signaling pathway\", \"  18\", 15.62226, 0.296927, 0.784542, 0.603316, 1.0, 0.737198, 1.0], [216, \"hsa04614\", \"Renin-angiotensin system\", \"   4\", 2.78414, 0.302077, 0.858541, 0.605342, 1.0, 0.742249, 1.0], [274, \"hsa04930\", \"Type II diabetes mellitus\", \"  13\", 11.09628, 0.303367, 0.803162, 0.605927, 1.0, 0.742249, 1.0], [165, \"hsa04110\", \"Cell cycle\", \"  17\", 14.78546, 0.305147, 0.780342, 0.606924, 1.0, 0.742249, 1.0], [90, \"hsa01001\", \"Protein kinases\", \" 125\", 120.07919, 0.315317, 0.719183, 0.626199, 1.0, 0.761008, 1.0], [122, \"hsa03030\", \"DNA replication\", \"   4\", 2.84816, 0.317087, 0.846272, 0.627535, 1.0, 0.761008, 1.0], [295, \"hsa04978\", \"Mineral absorption\", \"   7\", 5.60958, 0.326227, 0.810312, 0.643928, 1.0, 0.777759, 1.0], [365, \"hsa05322\", \"Systemic lupus erythematosus\", \"   8\", 6.55114, 0.329027, 0.797062, 0.64412, 1.0, 0.779274, 1.0], [160, \"hsa04071\", \"Sphingolipid signaling pathway\", \"  29\", 26.61068, 0.333087, 0.740323, 0.647509, 1.0, 0.783733, 1.0], [53, \"hsa00535\", \"Proteoglycans\", \"  16\", 14.35054, 0.336357, 0.775292, 0.649935, 1.0, 0.785373, 1.0], [371, \"hsa05412\", \"Arrhythmogenic right ventricular cardiomyopathy (ARVC)\", \"  31\", 28.76785, 0.338147, 0.739273, 0.649935, 1.0, 0.785373, 1.0], [177, \"hsa04142\", \"Lysosome\", \"  16\", 14.25211, 0.346517, 0.747703, 0.663407, 1.0, 0.796357, 1.0], [83, \"hsa00900\", \"Terpenoid backbone biosynthesis\", \"   3\", 2.08834, 0.347437, 0.853361, 0.663407, 1.0, 0.796357, 1.0], [66, \"hsa00603\", \"Glycosphingolipid biosynthesis - globo and isoglobo series\", \"   3\", 2.09136, 0.349997, 0.851501, 0.663407, 1.0, 0.796357, 1.0], [139, \"hsa03460\", \"Fanconi anemia pathway\", \"   8\", 6.69312, 0.352426, 0.776172, 0.665528, 1.0, 0.796357, 1.0], [299, \"hsa05014\", \"Amyotrophic lateral sclerosis (ALS)\", \"  11\", 9.55161, 0.353936, 0.763252, 0.665528, 1.0, 0.796357, 1.0], [7, \"hsa00061\", \"Fatty acid biosynthesis\", \"   3\", 2.11253, 0.356556, 0.843722, 0.665528, 1.0, 0.797269, 1.0], [128, \"hsa03051\", \"Proteasome\", \"   6\", 4.90316, 0.366746, 0.781802, 0.673566, 1.0, 0.814992, 1.0], [344, \"hsa05212\", \"Pancreatic cancer\", \"  14\", 12.58052, 0.376886, 0.727443, 0.686393, 1.0, 0.824305, 1.0], [300, \"hsa05016\", \"Huntington disease\", \"  38\", 35.91641, 0.377706, 0.689463, 0.686393, 1.0, 0.824305, 1.0], [127, \"hsa03050\", \"Proteasome\", \"   4\", 3.11754, 0.379836, 0.799732, 0.687629, 1.0, 0.824305, 1.0], [133, \"hsa03400\", \"DNA repair and recombination proteins\", \"  41\", 38.84272, 0.380096, 0.683383, 0.687629, 1.0, 0.824305, 1.0], [94, \"hsa01006\", \"Prenyltransferases\", \"   3\", 2.23887, 0.391516, 0.823212, 0.705552, 1.0, 0.841749, 1.0], [11, \"hsa00100\", \"Steroid biosynthesis\", \"   2\", 1.34936, 0.392816, 0.848662, 0.705552, 1.0, 0.841749, 1.0], [36, \"hsa00450\", \"Selenocompound metabolism\", \"   3\", 2.27857, 0.401126, 0.809882, 0.716663, 1.0, 0.849867, 1.0], [340, \"hsa05205\", \"Proteoglycans in cancer\", \"  42\", 40.18344, 0.401326, 0.666373, 0.716663, 1.0, 0.849867, 1.0], [180, \"hsa04146\", \"Peroxisome\", \"  10\", 8.97418, 0.407456, 0.716163, 0.727972, 1.0, 0.857802, 1.0], [65, \"hsa00601\", \"Glycosphingolipid biosynthesis - lacto and neolacto series\", \"   4\", 3.28527, 0.418706, 0.771892, 0.742096, 1.0, 0.876361, 1.0], [372, \"hsa05414\", \"Dilated cardiomyopathy (DCM)\", \"  29\", 27.75006, 0.423196, 0.661783, 0.742263, 1.0, 0.880639, 1.0], [57, \"hsa00562\", \"Inositol phosphate metabolism\", \"  20\", 18.944, 0.431786, 0.664583, 0.755439, 1.0, 0.89335, 1.0], [325, \"hsa05160\", \"Hepatitis C\", \"  19\", 18.01139, 0.439676, 0.658183, 0.763981, 1.0, 0.904476, 1.0], [373, \"hsa05416\", \"Viral myocarditis\", \"  10\", 9.22556, 0.442286, 0.696243, 0.763981, 1.0, 0.904675, 1.0], [20, \"hsa00240\", \"Pyrimidine metabolism\", \"   8\", 7.30349, 0.447486, 0.705443, 0.765046, 1.0, 0.90802, 1.0], [301, \"hsa05017\", \"Spinocerebellar ataxia\", \"  33\", 31.95831, 0.448966, 0.631184, 0.765046, 1.0, 0.90802, 1.0], [8, \"hsa00062\", \"Fatty acid elongation\", \"   4\", 3.47585, 0.461885, 0.734993, 0.791018, 1.0, 0.925531, 1.0], [157, \"hsa04066\", \"HIF-1 signaling pathway\", \"  19\", 18.26199, 0.462765, 0.637424, 0.791018, 1.0, 0.925531, 1.0], [166, \"hsa04114\", \"Oocyte meiosis\", \"  20\", 19.31668, 0.471985, 0.626644, 0.796918, 1.0, 0.938755, 1.0], [13, \"hsa00130\", \"Ubiquinone and other terpenoid-quinone biosynthesis\", \"   1\", 0.65084, 0.483555, 0.863121, 0.821334, 1.0, 0.956483, 1.0], [98, \"hsa01521\", \"EGFR tyrosine kinase inhibitor resistance\", \"  20\", 19.53231, 0.492445, 0.605814, 0.830239, 1.0, 0.961113, 1.0], [105, \"hsa02044\", \"Secretion system\", \"   2\", 1.64249, 0.493025, 0.774412, 0.830341, 1.0, 0.961113, 1.0], [31, \"hsa00380\", \"Tryptophan metabolism\", \"   5\", 4.61195, 0.493905, 0.687663, 0.830341, 1.0, 0.961113, 1.0], [308, \"hsa05100\", \"Bacterial invasion of epithelial cells\", \"  17\", 16.63782, 0.505915, 0.608554, 0.839207, 1.0, 0.972273, 1.0], [33, \"hsa00410\", \"beta-Alanine metabolism\", \"   6\", 5.6584, 0.508725, 0.677143, 0.839862, 1.0, 0.972273, 1.0], [356, \"hsa05224\", \"Breast cancer\", \"  22\", 21.71965, 0.509325, 0.582954, 0.839862, 1.0, 0.972273, 1.0], [71, \"hsa00650\", \"Butanoate metabolism\", \"   4\", 3.69497, 0.511115, 0.690363, 0.839862, 1.0, 0.972273, 1.0], [368, \"hsa05332\", \"Graft-versus-host disease\", \"   2\", 1.7096, 0.515025, 0.754402, 0.839862, 1.0, 0.972273, 1.0], [39, \"hsa00480\", \"Glutathione metabolism\", \"   3\", 2.72822, 0.515845, 0.706943, 0.839862, 1.0, 0.972273, 1.0], [117, \"hsa03019\", \"Messenger RNA biogenesis\", \"  49\", 49.00141, 0.523535, 0.536805, 0.848926, 1.0, 0.972732, 1.0], [224, \"hsa04650\", \"Natural killer cell mediated cytotoxicity\", \"  17\", 16.84418, 0.524935, 0.581694, 0.848926, 1.0, 0.972732, 1.0], [337, \"hsa05202\", \"Transcriptional misregulation in cancer\", \"  29\", 28.92937, 0.525645, 0.555524, 0.848926, 1.0, 0.972732, 1.0], [360, \"hsa05231\", \"Choline metabolism in cancer\", \"  22\", 21.90247, 0.529125, 0.568764, 0.848926, 1.0, 0.972732, 1.0], [40, \"hsa00500\", \"Starch and sucrose metabolism\", \"   5\", 4.80563, 0.532825, 0.653173, 0.848926, 1.0, 0.972732, 1.0], [318, \"hsa05142\", \"Chagas disease (American trypanosomiasis)\", \"  16\", 15.93021, 0.534775, 0.575364, 0.849622, 1.0, 0.972732, 1.0], [302, \"hsa05020\", \"Prion diseases\", \"   6\", 5.79695, 0.535605, 0.648264, 0.849622, 1.0, 0.972732, 1.0], [241, \"hsa04723\", \"Retrograde endocannabinoid signaling\", \"  33\", 33.06987, 0.537705, 0.543135, 0.849622, 1.0, 0.972732, 1.0], [187, \"hsa04213\", \"Longevity regulating pathway - multiple species\", \"  12\", 11.95556, 0.547005, 0.581614, 0.855321, 1.0, 0.984608, 1.0], [72, \"hsa00670\", \"One carbon pool by folate\", \"   3\", 2.86583, 0.558584, 0.679963, 0.869556, 1.0, 0.996495, 1.0], [178, \"hsa04144\", \"Endocytosis\", \"  43\", 43.50575, 0.559144, 0.508855, 0.869556, 1.0, 0.996495, 1.0], [207, \"hsa04514\", \"Cell adhesion molecules (CAMs)\", \"  28\", 28.34419, 0.564864, 0.523725, 0.869556, 1.0, 0.997402, 1.0], [167, \"hsa04115\", \"p53 signaling pathway\", \"   7\", 7.05942, 0.565194, 0.589854, 0.869556, 1.0, 0.997402, 1.0], [59, \"hsa00564\", \"Glycerophospholipid metabolism\", \"  16\", 16.27284, 0.571044, 0.539855, 0.871955, 1.0, 1.0, 1.0], [152, \"hsa04054\", \"Pattern recognition receptors\", \"   5\", 5.08597, 0.578764, 0.600584, 0.882058, 1.0, 1.0, 1.0], [189, \"hsa04216\", \"Ferroptosis\", \"   4\", 4.04261, 0.584444, 0.620904, 0.885934, 1.0, 1.0, 1.0], [67, \"hsa00604\", \"Glycosphingolipid biosynthesis - ganglio series\", \"   3\", 2.98095, 0.590134, 0.655323, 0.889844, 1.0, 1.0, 1.0], [291, \"hsa04974\", \"Protein digestion and absorption\", \"  16\", 16.5221, 0.596024, 0.510755, 0.894587, 1.0, 1.0, 1.0], [341, \"hsa05206\", \"MicroRNAs in cancer\", \"  32\", 32.87633, 0.599294, 0.479325, 0.894587, 1.0, 1.0, 1.0], [55, \"hsa00537\", \"Glycosylphosphatidylinositol (GPI)-anchored proteins\", \"  12\", 12.26011, 0.599494, 0.549545, 0.894587, 1.0, 1.0, 1.0], [239, \"hsa04721\", \"Synaptic vesicle cycle\", \"  15\", 15.51294, 0.601694, 0.510185, 0.894587, 1.0, 1.0, 1.0], [298, \"hsa05012\", \"Parkinson disease\", \"  25\", 25.83406, 0.607444, 0.480175, 0.894587, 1.0, 1.0, 1.0], [293, \"hsa04976\", \"Bile secretion\", \"  13\", 13.52853, 0.607644, 0.510365, 0.894587, 1.0, 1.0, 1.0], [3, \"hsa00040\", \"Pentose and glucuronate interconversions\", \"   2\", 2.01216, 0.608044, 0.673243, 0.894587, 1.0, 1.0, 1.0], [101, \"hsa01524\", \"Platinum drug resistance\", \"   8\", 8.38182, 0.610024, 0.537035, 0.894587, 1.0, 1.0, 1.0], [97, \"hsa01040\", \"Biosynthesis of unsaturated fatty acids\", \"   4\", 4.15987, 0.610394, 0.596294, 0.894587, 1.0, 1.0, 1.0], [262, \"hsa04918\", \"Thyroid hormone synthesis\", \"  17\", 17.65976, 0.616964, 0.492295, 0.894587, 1.0, 1.0, 1.0], [280, \"hsa04940\", \"Type I diabetes mellitus\", \"   3\", 3.13663, 0.617264, 0.614584, 0.894587, 1.0, 1.0, 1.0], [210, \"hsa04530\", \"Tight junction\", \"  33\", 34.11689, 0.620074, 0.458725, 0.894587, 1.0, 1.0, 1.0], [62, \"hsa00591\", \"Linoleic acid metabolism\", \"   3\", 3.15865, 0.622944, 0.610804, 0.894587, 1.0, 1.0, 1.0], [51, \"hsa00533\", \"Glycosaminoglycan biosynthesis - keratan sulfate\", \"   2\", 2.01787, 0.624034, 0.674033, 0.894587, 1.0, 1.0, 1.0], [145, \"hsa04022\", \"cGMP-PKG signaling pathway\", \"  37\", 38.2858, 0.624484, 0.448506, 0.894587, 1.0, 1.0, 1.0], [282, \"hsa04960\", \"Aldosterone-regulated sodium reabsorption\", \"   8\", 8.37376, 0.624564, 0.534965, 0.894587, 1.0, 1.0, 1.0], [285, \"hsa04964\", \"Proximal tubule bicarbonate reclamation\", \"   2\", 2.06431, 0.633224, 0.659273, 0.894587, 1.0, 1.0, 1.0], [80, \"hsa00790\", \"Folate biosynthesis\", \"   3\", 3.14364, 0.633914, 0.616344, 0.894587, 1.0, 1.0, 1.0], [270, \"hsa04926\", \"Relaxin signaling pathway\", \"  24\", 25.16069, 0.636674, 0.450755, 0.894966, 1.0, 1.0, 1.0], [323, \"hsa05150\", \"Staphylococcus aureus infection\", \"   4\", 4.38337, 0.642394, 0.553814, 0.900013, 1.0, 1.0, 1.0], [273, \"hsa04929\", \"GnRH secretion\", \"  19\", 19.94609, 0.642624, 0.461015, 0.900013, 1.0, 1.0, 1.0], [359, \"hsa05230\", \"Central carbon metabolism in cancer\", \"   9\", 9.72953, 0.649284, 0.487345, 0.901107, 1.0, 1.0, 1.0], [279, \"hsa04935\", \"Growth hormone synthesis, secretion and action\", \"  28\", 29.38791, 0.650613, 0.433596, 0.901107, 1.0, 1.0, 1.0], [186, \"hsa04211\", \"Longevity regulating pathway\", \"  17\", 18.08425, 0.652153, 0.450785, 0.901107, 1.0, 1.0, 1.0], [142, \"hsa04014\", \"Ras signaling pathway\", \"  46\", 48.01613, 0.652413, 0.410656, 0.901107, 1.0, 1.0, 1.0], [259, \"hsa04915\", \"Estrogen signaling pathway\", \"  25\", 26.38525, 0.654813, 0.431006, 0.901107, 1.0, 1.0, 1.0], [163, \"hsa04090\", \"CD molecules\", \"  43\", 45.12416, 0.656123, 0.405926, 0.901107, 1.0, 1.0, 1.0], [56, \"hsa00561\", \"Glycerolipid metabolism\", \"  11\", 11.84219, 0.661123, 0.469185, 0.901107, 1.0, 1.0, 1.0], [58, \"hsa00563\", \"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis\", \"   2\", 2.26426, 0.671913, 0.604834, 0.910117, 1.0, 1.0, 1.0], [2, \"hsa00030\", \"Pentose phosphate pathway\", \"   2\", 2.27832, 0.672923, 0.598414, 0.910117, 1.0, 1.0, 1.0], [290, \"hsa04973\", \"Carbohydrate digestion and absorption\", \"   8\", 8.79237, 0.677283, 0.471085, 0.916792, 1.0, 1.0, 1.0], [201, \"hsa04371\", \"Apelin signaling pathway\", \"  30\", 31.96591, 0.688163, 0.388326, 0.928894, 1.0, 1.0, 1.0], [339, \"hsa05204\", \"Chemical carcinogenesis\", \"   4\", 4.64643, 0.688193, 0.503045, 0.928894, 1.0, 1.0, 1.0], [18, \"hsa00230\", \"Purine metabolism\", \"  25\", 26.877, 0.688883, 0.391046, 0.928894, 1.0, 1.0, 1.0], [61, \"hsa00590\", \"Arachidonic acid metabolism\", \"   5\", 5.7391, 0.689373, 0.484765, 0.928894, 1.0, 1.0, 1.0], [265, \"hsa04921\", \"Oxytocin signaling pathway\", \"  42\", 44.44155, 0.696203, 0.369536, 0.93035, 1.0, 1.0, 1.0], [209, \"hsa04520\", \"Adherens junction\", \"  20\", 21.62599, 0.699083, 0.397166, 0.93035, 1.0, 1.0, 1.0], [252, \"hsa04810\", \"Regulation of actin cytoskeleton\", \"  38\", 40.67953, 0.704623, 0.359536, 0.935178, 1.0, 1.0, 1.0], [88, \"hsa00982\", \"Drug metabolism - cytochrome P450\", \"   3\", 3.62013, 0.706603, 0.508635, 0.935178, 1.0, 1.0, 1.0], [23, \"hsa00270\", \"Cysteine and methionine metabolism\", \"   4\", 4.74921, 0.708493, 0.478595, 0.935178, 1.0, 1.0, 1.0], [289, \"hsa04972\", \"Pancreatic secretion\", \"  18\", 19.91047, 0.732583, 0.363556, 0.961161, 1.0, 1.0, 1.0], [129, \"hsa03060\", \"Protein export\", \"   3\", 3.43949, 0.733873, 0.541145, 0.961161, 1.0, 1.0, 1.0], [249, \"hsa04742\", \"Taste transduction\", \"  12\", 13.58407, 0.736713, 0.379456, 0.961161, 1.0, 1.0, 1.0], [246, \"hsa04728\", \"Dopaminergic synapse\", \"  33\", 35.90216, 0.739503, 0.326497, 0.961161, 1.0, 1.0, 1.0], [89, \"hsa00983\", \"Drug metabolism - other enzymes\", \"   6\", 7.08648, 0.742833, 0.422056, 0.961161, 1.0, 1.0, 1.0], [235, \"hsa04710\", \"Circadian rhythm\", \"   5\", 6.06273, 0.744713, 0.422346, 0.961161, 1.0, 1.0, 1.0], [238, \"hsa04720\", \"Long-term potentiation\", \"  20\", 22.17083, 0.745793, 0.342887, 0.961161, 1.0, 1.0, 1.0], [168, \"hsa04120\", \"Ubiquitin mediated proteolysis\", \"  19\", 21.32726, 0.748823, 0.336197, 0.961161, 1.0, 1.0, 1.0], [245, \"hsa04727\", \"GABAergic synapse\", \"  22\", 24.43264, 0.749343, 0.331867, 0.961161, 1.0, 1.0, 1.0], [350, \"hsa05218\", \"Melanoma\", \"  11\", 12.77679, 0.750812, 0.359986, 0.961161, 1.0, 1.0, 1.0], [345, \"hsa05213\", \"Endometrial cancer\", \"  10\", 11.65403, 0.755162, 0.365046, 0.961161, 1.0, 1.0, 1.0], [188, \"hsa04215\", \"Apoptosis - multiple species\", \"   3\", 3.84845, 0.760522, 0.451265, 0.961161, 1.0, 1.0, 1.0], [24, \"hsa00280\", \"Valine, leucine and isoleucine degradation\", \"   7\", 8.49163, 0.761752, 0.373476, 0.961161, 1.0, 1.0, 1.0], [63, \"hsa00592\", \"alpha-Linolenic acid metabolism\", \"   2\", 2.72637, 0.771552, 0.479245, 0.966083, 1.0, 1.0, 1.0], [70, \"hsa00640\", \"Propanoate metabolism\", \"   5\", 6.26602, 0.775312, 0.388036, 0.967492, 1.0, 1.0, 1.0], [76, \"hsa00760\", \"Nicotinate and nicotinamide metabolism\", \"   3\", 4.0089, 0.777352, 0.423416, 0.967579, 1.0, 1.0, 1.0], [136, \"hsa03430\", \"Mismatch repair\", \"   2\", 2.79613, 0.787242, 0.458545, 0.979342, 1.0, 1.0, 1.0], [352, \"hsa05220\", \"Chronic myeloid leukemia\", \"  10\", 12.13095, 0.788122, 0.318337, 0.979342, 1.0, 1.0, 1.0], [211, \"hsa04540\", \"Gap junction\", \"  21\", 23.82452, 0.788182, 0.291227, 0.979342, 0.99142, 1.0, 1.0], [112, \"hsa03012\", \"Translation factors\", \"   5\", 6.48973, 0.788312, 0.361406, 0.979342, 1.0, 1.0, 1.0], [348, \"hsa05216\", \"Thyroid cancer\", \"   4\", 5.33575, 0.794272, 0.372846, 0.979342, 1.0, 1.0, 1.0], [304, \"hsa05031\", \"Amphetamine addiction\", \"  15\", 17.52351, 0.800732, 0.291077, 0.979342, 0.99142, 1.0, 1.0], [284, \"hsa04962\", \"Vasopressin-regulated water reabsorption\", \"   5\", 6.48552, 0.801552, 0.352126, 0.979342, 1.0, 1.0, 1.0], [34, \"hsa00430\", \"Taurine and hypotaurine metabolism\", \"   1\", 1.49839, 0.808482, 0.543645, 0.986099, 1.0, 1.0, 1.0], [233, \"hsa04670\", \"Leukocyte transendothelial migration\", \"  17\", 19.96912, 0.811732, 0.268117, 0.986099, 0.970225, 1.0, 1.0], [69, \"hsa00630\", \"Glyoxylate and dicarboxylate metabolism\", \"   3\", 4.17805, 0.813152, 0.380766, 0.986099, 1.0, 1.0, 1.0], [251, \"hsa04750\", \"Inflammatory mediator regulation of TRP channels\", \"  21\", 24.40209, 0.816832, 0.253787, 0.987358, 0.930118, 1.0, 1.0], [52, \"hsa00534\", \"Glycosaminoglycan biosynthesis - heparan sulfate / heparin\", \"   6\", 7.64996, 0.825002, 0.319727, 0.996965, 1.0, 1.0, 1.0], [60, \"hsa00565\", \"Ether lipid metabolism\", \"   5\", 6.8467, 0.828232, 0.307637, 0.996965, 1.0, 1.0, 1.0], [309, \"hsa05110\", \"Vibrio cholerae infection\", \"   6\", 7.94669, 0.828262, 0.300567, 0.996965, 1.0, 1.0, 1.0], [214, \"hsa04611\", \"Platelet activation\", \"  24\", 27.88967, 0.829362, 0.234798, 0.996965, 0.881113, 1.0, 1.0], [247, \"hsa04730\", \"Long-term depression\", \"  20\", 23.35903, 0.831812, 0.241418, 0.996965, 0.892564, 1.0, 1.0], [244, \"hsa04726\", \"Serotonergic synapse\", \"  24\", 27.89197, 0.832292, 0.230978, 0.996965, 0.881113, 1.0, 1.0], [164, \"hsa04091\", \"Lectins\", \"   6\", 8.17498, 0.833002, 0.285337, 0.996965, 0.986908, 1.0, 1.0], [305, \"hsa05032\", \"Morphine addiction\", \"  25\", 29.13045, 0.836162, 0.222628, 0.996965, 0.860853, 1.0, 1.0], [146, \"hsa04024\", \"cAMP signaling pathway\", \"  42\", 47.68531, 0.848552, 0.196238, 1.0, 0.789857, 1.0, 1.0], [87, \"hsa00980\", \"Metabolism of xenobiotics by cytochrome P450\", \"   2\", 3.43158, 0.857781, 0.334777, 1.0, 1.0, 1.0, 1.0], [319, \"hsa05143\", \"African trypanosomiasis\", \"   5\", 6.90703, 0.863041, 0.271877, 1.0, 0.979278, 1.0, 1.0], [17, \"hsa00220\", \"Arginine biosynthesis\", \"   1\", 1.961, 0.868801, 0.407346, 1.0, 1.0, 1.0, 1.0], [103, \"hsa02010\", \"ABC transporters\", \"   8\", 10.80614, 0.871491, 0.221458, 1.0, 0.860853, 1.0, 1.0], [250, \"hsa04744\", \"Phototransduction\", \"   1\", 2.0117, 0.874331, 0.394766, 1.0, 1.0, 1.0, 1.0], [330, \"hsa05165\", \"Human papillomavirus infection\", \"  49\", 56.28038, 0.880551, 0.153268, 1.0, 0.6887, 1.0, 0.935197], [231, \"hsa04666\", \"Fc gamma R-mediated phagocytosis\", \"  18\", 22.36894, 0.884631, 0.173208, 1.0, 0.71865, 1.0, 0.989762], [161, \"hsa04072\", \"Phospholipase D signaling pathway\", \"  32\", 37.7752, 0.885781, 0.158088, 1.0, 0.6887, 1.0, 0.947381], [243, \"hsa04725\", \"Cholinergic synapse\", \"  26\", 31.29686, 0.886971, 0.160528, 1.0, 0.6887, 1.0, 0.947381], [102, \"hsa02000\", \"Transporters\", \"  86\", 96.11325, 0.887191, 0.136489, 1.0, 0.636751, 1.0, 0.883148], [343, \"hsa05211\", \"Renal cell carcinoma\", \"   8\", 11.22079, 0.887221, 0.195068, 1.0, 0.789857, 1.0, 1.0], [272, \"hsa04928\", \"Parathyroid hormone synthesis, secretion and action\", \"  21\", 25.86274, 0.888221, 0.164058, 1.0, 0.6887, 1.0, 0.952597], [213, \"hsa04610\", \"Complement and coagulation cascades\", \"   5\", 7.73269, 0.893371, 0.206818, 1.0, 0.817504, 1.0, 1.0], [197, \"hsa04340\", \"Hedgehog signaling pathway\", \"   7\", 10.06949, 0.894651, 0.191898, 1.0, 0.785812, 1.0, 1.0], [12, \"hsa00120\", \"Primary bile acid biosynthesis\", \"   1\", 2.15524, 0.896051, 0.351296, 1.0, 1.0, 1.0, 1.0], [204, \"hsa04392\", \"Hippo signaling pathway - multiple species\", \"   4\", 6.41102, 0.898901, 0.213438, 1.0, 0.841154, 1.0, 1.0], [172, \"hsa04131\", \"Membrane trafficking\", \" 257\", 274.29863, 0.899721, 0.113749, 1.0, 0.616204, 1.0, 0.841422], [49, \"hsa00531\", \"Glycosaminoglycan degradation\", \"   2\", 3.52378, 0.904001, 0.275887, 1.0, 0.986908, 1.0, 1.0], [236, \"hsa04713\", \"Circadian entrainment\", \"  28\", 33.68272, 0.905141, 0.137379, 1.0, 0.636751, 1.0, 0.883148], [283, \"hsa04961\", \"Endocrine and other factor-regulated calcium reabsorption\", \"  10\", 13.76125, 0.913831, 0.152798, 1.0, 0.6887, 1.0, 0.935197], [54, \"hsa00536\", \"Glycosaminoglycan binding proteins\", \"  30\", 36.65733, 0.913851, 0.121089, 1.0, 0.616204, 1.0, 0.841422], [349, \"hsa05217\", \"Basal cell carcinoma\", \"   5\", 7.96395, 0.914041, 0.176198, 1.0, 0.725782, 1.0, 0.991115], [357, \"hsa05225\", \"Hepatocellular carcinoma\", \"  21\", 27.02077, 0.918521, 0.121539, 1.0, 0.616204, 1.0, 0.841422], [91, \"hsa01002\", \"Peptidases and inhibitors\", \"  90\", 101.85507, 0.920481, 0.098709, 1.0, 0.54791, 1.0, 0.807619], [355, \"hsa05223\", \"Non-small cell lung cancer\", \"  12\", 16.41356, 0.922631, 0.131459, 1.0, 0.636751, 1.0, 0.883148], [1, \"hsa00020\", \"Citrate cycle (TCA cycle)\", \"   1\", 2.50176, 0.924061, 0.277597, 1.0, 0.986908, 1.0, 1.0], [43, \"hsa00512\", \"Mucin type O-glycan biosynthesis\", \"   7\", 10.05573, 0.928111, 0.151718, 1.0, 0.6887, 1.0, 0.935197], [346, \"hsa05214\", \"Glioma\", \"  12\", 16.67275, 0.931501, 0.119229, 1.0, 0.616204, 1.0, 0.841422], [268, \"hsa04924\", \"Renin secretion\", \"  13\", 17.78033, 0.933551, 0.115499, 1.0, 0.616204, 1.0, 0.841422], [143, \"hsa04015\", \"Rap1 signaling pathway\", \"  43\", 51.71572, 0.933651, 0.090219, 1.0, 0.54791, 1.0, 0.781611], [144, \"hsa04020\", \"Calcium signaling pathway\", \"  44\", 52.61673, 0.933651, 0.091569, 1.0, 0.54791, 1.0, 0.781611], [205, \"hsa04510\", \"Focal adhesion\", \"  42\", 50.85813, 0.936431, 0.088069, 1.0, 0.54791, 1.0, 0.781611], [203, \"hsa04390\", \"Hippo signaling pathway\", \"  24\", 30.94094, 0.941051, 0.089099, 1.0, 0.54791, 1.0, 0.781611], [175, \"hsa04140\", \"Autophagy - animal\", \"  17\", 23.21955, 0.942481, 0.093359, 1.0, 0.54791, 1.0, 0.781611], [253, \"hsa04812\", \"Cytoskeleton proteins\", \"  73\", 85.45047, 0.945501, 0.069759, 1.0, 0.456762, 1.0, 0.701493], [174, \"hsa04137\", \"Mitophagy - animal\", \"   6\", 9.5706, 0.95245, 0.111409, 1.0, 0.612228, 1.0, 0.841422], [141, \"hsa04012\", \"ErbB signaling pathway\", \"  18\", 24.3039, 0.9543, 0.076319, 1.0, 0.481116, 1.0, 0.742566], [256, \"hsa04912\", \"GnRH signaling pathway\", \"  16\", 22.38364, 0.95934, 0.070149, 1.0, 0.456762, 1.0, 0.701493], [176, \"hsa04141\", \"Protein processing in endoplasmic reticulum\", \"  17\", 23.91206, 0.9612, 0.065579, 1.0, 0.454337, 1.0, 0.701493], [46, \"hsa00515\", \"Mannose type O-glycan biosynthesis\", \"   2\", 4.43233, 0.96412, 0.134459, 1.0, 0.636751, 1.0, 0.883148], [342, \"hsa05210\", \"Colorectal cancer\", \"  11\", 16.71954, 0.96556, 0.066679, 1.0, 0.454337, 1.0, 0.701493], [322, \"hsa05146\", \"Amoebiasis\", \"  15\", 21.82499, 0.96758, 0.057259, 1.0, 0.439451, 1.0, 0.644169], [206, \"hsa04512\", \"ECM-receptor interaction\", \"  16\", 23.32022, 0.97151, 0.04998, 1.0, 0.439451, 1.0, 0.644169], [248, \"hsa04740\", \"Olfactory transduction\", \"  11\", 16.86331, 0.97165, 0.055759, 1.0, 0.439451, 1.0, 0.644169], [96, \"hsa01009\", \"Protein phosphatases and associated proteins\", \"  87\", 102.54618, 0.97169, 0.03672, 1.0, 0.366155, 1.0, 0.574742], [287, \"hsa04970\", \"Salivary secretion\", \"  14\", 20.46433, 0.9737, 0.04981, 1.0, 0.439451, 1.0, 0.644169], [183, \"hsa04151\", \"PI3K-Akt signaling pathway\", \"  55\", 68.21147, 0.97422, 0.03592, 1.0, 0.366155, 1.0, 0.574742], [93, \"hsa01004\", \"Lipid biosynthesis proteins\", \"   6\", 11.28636, 0.97514, 0.056839, 1.0, 0.439451, 1.0, 0.644169], [45, \"hsa00514\", \"Other types of O-glycan biosynthesis\", \"   8\", 13.05535, 0.97541, 0.055839, 1.0, 0.439451, 1.0, 0.644169], [73, \"hsa00730\", \"Thiamine metabolism\", \"   1\", 3.39133, 0.97928, 0.113999, 1.0, 0.616204, 1.0, 0.841422], [44, \"hsa00513\", \"Various types of N-glycan biosynthesis\", \"   4\", 8.58188, 0.97985, 0.054519, 1.0, 0.439451, 1.0, 0.644169], [131, \"hsa03310\", \"Nuclear receptors\", \"   5\", 9.93031, 0.98006, 0.051639, 1.0, 0.439451, 1.0, 0.644169], [242, \"hsa04724\", \"Glutamatergic synapse\", \"  31\", 41.24677, 0.98011, 0.03142, 1.0, 0.366155, 1.0, 0.571194], [194, \"hsa04270\", \"Vascular smooth muscle contraction\", \"  23\", 32.12616, 0.9803, 0.03267, 1.0, 0.366155, 1.0, 0.571194], [336, \"hsa05200\", \"Pathways in cancer\", \"  72\", 88.63232, 0.98152, 0.02494, 1.0, 0.333552, 1.0, 0.561144], [354, \"hsa05222\", \"Small cell lung cancer\", \"  11\", 18.23795, 0.98375, 0.03332, 1.0, 0.366155, 1.0, 0.571194], [358, \"hsa05226\", \"Gastric cancer\", \"  16\", 24.75703, 0.98382, 0.02924, 1.0, 0.349585, 1.0, 0.571194], [260, \"hsa04916\", \"Melanogenesis\", \"  12\", 19.63973, 0.98445, 0.03131, 1.0, 0.366155, 1.0, 0.571194], [149, \"hsa04040\", \"Ion channels\", \"  67\", 83.09557, 0.9854, 0.02063, 1.0, 0.333552, 1.0, 0.538075], [147, \"hsa04030\", \"G protein-coupled receptors\", \"  34\", 46.30356, 0.98582, 0.02242, 1.0, 0.333552, 1.0, 0.538075], [173, \"hsa04136\", \"Autophagy - other\", \"   2\", 5.97092, 0.99028, 0.04237, 1.0, 0.382098, 1.0, 0.635544], [162, \"hsa04080\", \"Neuroactive ligand-receptor interaction\", \"  37\", 50.82714, 0.99147, 0.01331, 1.0, 0.327327, 1.0, 0.532395], [267, \"hsa04923\", \"Regulation of lipolysis in adipocytes\", \"   6\", 12.0764, 0.99254, 0.02166, 1.0, 0.333552, 1.0, 0.538075], [195, \"hsa04310\", \"Wnt signaling pathway\", \"  20\", 31.22507, 0.99329, 0.01225, 1.0, 0.327327, 1.0, 0.532395], [41, \"hsa00510\", \"N-Glycan biosynthesis\", \"   3\", 8.85967, 0.99579, 0.01707, 1.0, 0.328948, 1.0, 0.538075], [288, \"hsa04971\", \"Gastric acid secretion\", \"   9\", 17.4438, 0.99581, 0.01036, 1.0, 0.327327, 1.0, 0.532395], [255, \"hsa04911\", \"Insulin secretion\", \"  13\", 22.59343, 0.9965, 0.008, 1.0, 0.282584, 1.0, 0.532395], [116, \"hsa03018\", \"RNA degradation\", \"   2\", 7.73153, 0.99704, 0.01329, 1.0, 0.327327, 1.0, 0.532395], [50, \"hsa00532\", \"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate\", \"   1\", 5.36112, 0.99808, 0.01708, 1.0, 0.328948, 1.0, 0.538075], [208, \"hsa04515\", \"Cell adhesion molecules\", \"  41\", 58.01265, 0.99829, 0.00303, 1.0, 0.17147, 1.0, 0.272697], [92, \"hsa01003\", \"Glycosyltransferases\", \"  29\", 44.85514, 0.99863, 0.00261, 1.0, 0.17147, 1.0, 0.272697], [199, \"hsa04360\", \"Axon guidance\", \"  33\", 52.99081, 0.9998, 0.00042, 1.0, 0.05591, 1.0, 0.151198], [82, \"hsa00860\", \"Porphyrin and chlorophyll metabolism\", \"   0\", 2.3702, 1.0, 0.088049, 1.0, 0.54791, 1.0, 0.781611], [77, \"hsa00770\", \"Pantothenate and CoA biosynthesis\", \"   0\", 4.90116, 1.0, 0.00222, 1.0, 0.17147, 1.0, 0.272697], [81, \"hsa00830\", \"Retinol metabolism\", \"   0\", 3.72665, 1.0, 0.02139, 1.0, 0.333552, 1.0, 0.538075], [118, \"hsa03020\", \"RNA polymerase\", \"   0\", 2.06199, 1.0, 0.120399, 1.0, 0.616204, 1.0, 0.841422]];\n",
       "\n",
       "    if (typeof require === 'undefined') {\n",
       "        // TODO: This should become the default (use a simple import)\n",
       "        // when the ESM version works independently of whether\n",
       "        // require.js is there or not, see\n",
       "        // https://datatables.net/forums/discussion/69066/esm-es6-module-support?\n",
       "        const {default: $} = await import(\"https://esm.sh/jquery@3.5.0\");\n",
       "        const {default: initDataTables} = await import(\"https://esm.sh/datatables.net@1.11.3?deps=jquery@3.5.0\");\n",
       "\n",
       "        initDataTables();\n",
       "\n",
       "        // Define the dt_args\n",
       "        let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "        dt_args[\"data\"] = data;\n",
       "\n",
       "        // Display the table\n",
       "        $(document).ready(function () {\n",
       "            $('#ff3a5146-f90a-4cc0-a6df-32b7f16b2982').DataTable(dt_args);\n",
       "        });\n",
       "    } else {\n",
       "        require([\"jquery\", \"datatables\"], ($, datatables) => {\n",
       "                // Define the dt_args\n",
       "                let dt_args = {\"columnDefs\": [{\"width\": \"70px\", \"targets\": \"_all\"}]};\n",
       "                dt_args[\"data\"] = data;\n",
       "\n",
       "                // Display the table\n",
       "                $(document).ready(function () {\n",
       "                    $('#ff3a5146-f90a-4cc0-a6df-32b7f16b2982').DataTable(dt_args);\n",
       "                });\n",
       "            }\n",
       "        )\n",
       "    }\n",
       "</script>\n"
      ],
      "text/plain": [
       "           Id                            FunctionName  n_candidates  \\\n",
       "317  hsa05140                           Leishmaniasis            19   \n",
       "226  hsa04658        Th1 and Th2 cell differentiation            28   \n",
       "334  hsa05169            Epstein-Barr virus infection            39   \n",
       "153  hsa04060  Cytokine-cytokine receptor interaction            38   \n",
       "369  hsa05340                Primary immunodeficiency            10   \n",
       "..        ...                                     ...           ...   \n",
       "199  hsa04360                           Axon guidance            33   \n",
       "82   hsa00860    Porphyrin and chlorophyll metabolism             0   \n",
       "77   hsa00770       Pantothenate and CoA biosynthesis             0   \n",
       "81   hsa00830                      Retinol metabolism             0   \n",
       "118  hsa03020                          RNA polymerase             0   \n",
       "\n",
       "     mean_n_resample  emp_p_e   emp_p_d     fdr_e     fdr_d  BH_fdr_e  \\\n",
       "317          6.06254  0.00001  1.000000  0.000000  1.000000   0.00360   \n",
       "226         11.01205  0.00003  1.000000  0.001480  1.000000   0.00360   \n",
       "334         19.50258  0.00003  0.999990  0.001480  1.000000   0.00360   \n",
       "153         19.65169  0.00005  0.999990  0.002220  1.000000   0.00450   \n",
       "369          2.22006  0.00009  1.000000  0.003524  1.000000   0.00648   \n",
       "..               ...      ...       ...       ...       ...       ...   \n",
       "199         52.99081  0.99980  0.000420  1.000000  0.055910   1.00000   \n",
       "82           2.37020  1.00000  0.088049  1.000000  0.547910   1.00000   \n",
       "77           4.90116  1.00000  0.002220  1.000000  0.171470   1.00000   \n",
       "81           3.72665  1.00000  0.021390  1.000000  0.333552   1.00000   \n",
       "118          2.06199  1.00000  0.120399  1.000000  0.616204   1.00000   \n",
       "\n",
       "     BH_fdr_d  \n",
       "317  1.000000  \n",
       "226  1.000000  \n",
       "334  1.000000  \n",
       "153  1.000000  \n",
       "369  1.000000  \n",
       "..        ...  \n",
       "199  0.151198  \n",
       "82   0.781611  \n",
       "77   0.272697  \n",
       "81   0.538075  \n",
       "118  0.841422  \n",
       "\n",
       "[360 rows x 10 columns]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cei_results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "af9da1ee",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
